Section 59

EurekaMag Full Text Articles Chapter 58,648


Vitale, V.; Monami, M.; Mannucci, E. 2016: Prostanoids in patients with peripheral arterial disease: a meta-analysis of placebo-controlled randomized clinical trials. Journal of Diabetes and its Complications 30(1): 161-166
Hoang, K.G.; Allison, S.; Murray, M.; Petrovic, N. 2015: Prostanoids regulate angiogenesis acting primarily on IP and EP4 receptors. Microvascular Research 101: 127-134
Uchimura, K.; Kitamura, K. 2015: Prostasin (PRSS8) as a new pathological factor. Nihon Rinsho. Japanese Journal of Clinical Medicine 73(3): 523-533
Frederiksen-Møller, B.; Jørgensen, J.S.; Hansen, M.R.; Krigslund, O.; Vogel, L.K.; Andersen, L.B.; Jensen, B.L. 2016: Prostasin and matriptase (ST14) in placenta from preeclamptic and healthy pregnant women. Journal of Hypertension 34(2): 298-306
Small, H.Y.; Currie, G.E.; Delles, C. 2016: Prostasin, proteases, and preeclampsia. Journal of Hypertension 34(2): 193-195
Aggarwal, S.; Dabla, P.K.; Arora, S. 2013: Prostasin: An Epithelial Sodium Channel Regulator. Journal of Biomarkers 2013: 179864
Zijlstra, C.; Stoorvogel, W. 2016: Prostasomes as a source of diagnostic biomarkers for prostate cancer. Journal of Clinical Investigation 126(4): 1144-1151
Mogielnicka-Brzozowska, M.; Strzeżek, R.; Wasilewska, K.; Kordan, W. 2015: Prostasomes of canine seminal plasma - zinc-binding ability and effects on motility characteristics and plasma membrane integrity of spermatozoa. Reproduction in Domestic Animals 50(3): 484-491
Saez, F.; Sullivan, R. 2016: Prostasomes, post-testicular sperm maturation and fertility. Frontiers in Bioscience 21(7): 1464-1473
Ronquist, G. 2015: Prostasomes: their Characterisation: Implications for Human Reproduction: Prostasomes and Human Reproduction. Advances in Experimental Medicine and Biology 868: 191-209
McAllister, S.C.; Beneri, C. 2015: Prostate Abscess in an Adolescent with AIDS. Global Pediatric Health 2: 2333794x15582260
Roy, S.; Ambelil, M.; Ayala, G.; Buja, L.M. 2016: Prostate Adenocarcinoma Metastasis to the Bilateral Ureters: a Rare but Potentially Important Finding. Annals of Clinical and Laboratory Science 46(4): 425-427
Satherley, L.K.; Sun, P.-H.; Ji, K.E.; Mason, M.; Hargest, R.; Jiang, W.G.; Ye, L. 2016: Prostate Apoptosis Response-4 (PAR4) Suppresses Growth and Invasion of Breast Cancer Cells and Is Positively Associated with Patient Survival. Anticancer Research 36(3): 1227-1235
Kably, I.; Pereira, K.; Chong, W.; Bhatia, S. 2016: Prostate Artery Embolization (PAE) in the Management of Refractory Hematuria of Prostatic Origin Secondary to Iatrogenic Urological Trauma: a Safe and Effective Technique. Urology 88: 218-221
Noor, A.; Fischman, A.M. 2016: Prostate Artery Embolization as a new Treatment for Benign Prostate Hyperplasia: Contemporary Status in 2016. Current Urology Reports 17(7): 51
Mirakhur, A.; McWilliams, J.P. 2017: Prostate Artery Embolization for Benign Prostatic Hyperplasia: Current Status. Canadian Association of Radiologists Journal 68(1): 84-89
Yu, S.C.H.; Cho, C.C.M.; Hung, E.H.Y.; Chiu, P.K.F.; Yee, C.H.; Ng, C.F. 2017: Prostate Artery Embolization for Complete Urinary Outflow Obstruction Due to Benign Prostatic Hypertrophy. Cardiovascular and Interventional Radiology 40(1): 33-40
Bhatia, S.; Kava, B.; Pereira, K.; Kably, I.; Harward, S.; Narayanan, G. 2015: Prostate Artery Embolization for Giant Prostatic Hyperplasia. Journal of Vascular and Interventional Radiology: Jvir 26(10): 1583-1585
Gaylis, F.; Nasseri, R.; Fink, L.; Calabrese, R.; Dato, P.; Cohen, E. 2016: Prostate Biopsy Complications: a Dual Analysis. Urology 93: 135-140
Pryalukhin, A.E.; Vandromme, A.; Dellmann, A.; Donhuijsen, K.; Hammerer, P.G. 2015: Prostate Biopsy Core Handling: Comparison of Contemporary Preembedding Methods. Urologia Internationalis 95(2): 203-208
Torkko, K.C.; Wilson, R.S.; Smith, E.E.; Kusek, J.W.; van Bokhoven, A.; Lucia, M.S. 2015: Prostate Biopsy Markers of Inflammation are Associated with Risk of Clinical Progression of Benign Prostatic Hyperplasia: Findings from the MTOPS Study. Journal of Urology 194(2): 454-461
Khani, F.; Epstein, J.I. 2015: Prostate Biopsy Specimens with Gleason 3+3=6 and Intraductal Carcinoma: Radical Prostatectomy Findings and Clinical Outcomes. American Journal of Surgical Pathology 39(10): 1383-1389
Ghafoori, M.; Velayati, M.; Aliyari Ghasabeh, M.; Shakiba, M.; Alavi, M. 2015: Prostate Biopsy Using Transrectal Ultrasonography; the Optimal Number of Cores Regarding Cancer Detection Rate and Complications. Iranian Journal of Radiology: a Quarterly Journal Published by the Iranian Radiological Society 12(2): E13257
Whitson, J.M.; Murray, K.S.; Thrasher, J.B. 2016: Prostate Biopsy is Associated with an Increased Risk of Erectile Dysfunction. Journal of Urology 196(1): 21-23
Orio, P.F.; Nguyen, P.L.; Buzurovic, I.; Cail, D.W.; Chen, Y-Wei. 2016: Prostate Brachytherapy Case Volumes by Academic and Nonacademic Practices: Implications for Future Residency Training. International Journal of Radiation Oncology Biology Physics 96(3): 624-628
Haroun, R.R.; Nance, J.W.; Fishman, E.K. 2016: Prostate Brachytherapy seed migration to the Bladder presenting with Gross Hematuria. Journal of Radiology Case Reports 10(1): 22-26
Doddamani, D.; Kayastha, A. 2008: Prostate Cancer - What's New?. Medical Journal Armed Forces India 64(1): 51-56
Vines, A.I.; Hunter, J.C.; Carlisle, V.A.; Richmond, A.N. 2017: Prostate Cancer Ambassadors: Enhancing a Theory-Informed Training Program for Informed Decision-Making. Journal of cancer education: the official journal of the American Association for Cancer Education 32(3): 454-459
Vines, A.I.; Hunter, J.C.; Carlisle, V.A.; Richmond, A.N. 2017: Prostate Cancer Ambassadors: Process and Outcomes of a Prostate Cancer Informed Decision-Making Training Program. American journal of men's health 11(1): 54-62
Duscharla, D.; Bhumireddy, S.R.; Lakshetti, S.; Pospisil, H.; Murthy, P.V.L.N.; Walther, R.; Sripadi, P.; Ummanni, R. 2016: Prostate Cancer Associated Lipid Signatures in Serum Studied by ESI-Tandem Mass Spectrometryas Potential new Biomarkers. Plos one 11(3): E0150253
Huesch, M.D.; Ong, M.K. 2016: Prostate Cancer Care Before and After Medicare Eligibility. Inquiry: a Journal of Medical Care Organization Provision and Financing 53
Otsuki, H.; Kimura, T.; Yamaga, T.; Kosaka, T.; Suehiro, J.-I.; Sakurai, H. 2017: Prostate Cancer Cells in Different Androgen Receptor Status Employ Different Leucine Transporters. Prostate 77(2): 222-233
Lazzeri, M. 2015: Prostate Cancer Claims for a Personalized Medicine. North American Journal of Medical Sciences 7(10): 436-437
Oderda, M.; Faletti, R.; Battisti, G.; Dalmasso, E.; Falcone, M.; Marra, G.; Palazzetti, A.; Zitella, A.; Bergamasco, L.; Gandini, G.; Gontero, P. 2016: Prostate Cancer Detection Rate with Koelis Fusion Biopsies versus Cognitive Biopsies: a Comparative Study. Urologia Internationalis 97(2): 230-237
Khan, S.; Mahara, A.; Hyams, E.S.; Schned, A.R.; Halter, R.J. 2016: Prostate Cancer Detection Using Composite Impedance Metric. IEEE Transactions on Medical Imaging 35(12): 2513-2523
Rosenkrantz, A.B.; Parikh, N.; Kierans, A.S.; Kong, M.X.; Babb, J.S.; Taneja, S.S.; Ream, J.M. 2016: Prostate Cancer Detection Using Computed very High b-value Diffusion-weighted Imaging: how High Should we Go?. Academic Radiology 23(6): 704-711
Filella, X.; Foj, L. 2016: Prostate Cancer Detection and Prognosis: from Prostate Specific Antigen (PSA) to Exosomal Biomarkers. International Journal of Molecular Sciences 17(11)
Feng, Z-Yan.; Wang, L.; Min, X-De.; Wang, S-Gang.; Wang, G-Ping.; Cai, J. 2016: Prostate Cancer Detection with Multiparametric Magnetic Resonance Imaging: Prostate Imaging Reporting and Data System Version 1 versus Version 2. Chinese Medical Journal 129(20): 2451-2459
Tombal, B.F.; Van Nieuwenhove, S.; Lecouvet, F.E. 2015: Prostate Cancer Diagnosis Using MR/Ultrasound-Fusion Guided Biopsy: Ending the "Needle in a Haystack" Conundrum?. JAMA Oncology 1(6): 831-832
Chelluri, R.; Kilchevsky, A.; George, A.K.; Sidana, A.; Frye, T.P.; Su, D.; Fascelli, M.; Ho, R.; Abboud, S.F.; Turkbey, B.; Merino, M.J.; Choyke, P.L.; Wood, B.J.; Pinto, P.A. 2016: Prostate Cancer Diagnosis on Repeat Magnetic Resonance Imaging-Transrectal Ultrasound Fusion Biopsy of Benign Lesions: Recommendations for Repeat Sampling. Journal of Urology 196(1): 62-67
Luque, J.S.; Ross, L.; Gwede, C.K. 2016: Prostate Cancer Education in African American Barbershops: Baseline Client Survey Results and Differences in Decisional Conflict and Stage of Decision Making. American journal of men's health 10(6): 533-536
Ashorobi, O.S.; Frost, J.; Wang, X.; Roberson, P.; Lin, E.; Volk, R.J.; Lopez, D.S.; Jones, L.A.; Pettaway, C.A. 2017: Prostate Cancer Education, Detection, and Follow-Up in a Community-Based Multiethnic Cohort of Medically Underserved Men. American Journal of Men's Health 11(1): 82-91
Schade, G.R.; Holt, S.K.; Zhang, X.; Song, D.; Wright, J.L.; Zhao, S.; Kolb, S.; Lam, H.-M.; Levin, L.; Leung, Y.-K.; Ho, S.-M.; Stanford, J.L. 2016: Prostate Cancer Expression Profiles of Cytoplasmic ERβ1 and Nuclear ERβ2 are Associated with Poor Outcomes following Radical Prostatectomy. Journal of Urology 195(6): 1760-1766
Rouvière, O.; Chapelon, J.-Y.; Crouzet, S.éb.; Gelet, A. 2017: Prostate Cancer Focal Therapy: just because you can Does not Mean you Should. European Urology 71(1): 35-36
Wallis, C.J.D.; Nam, R.K. 2015: Prostate Cancer Genetics: a Review. Ejifcc 26(2): 79-91
Epstein, J.I. 2016: Prostate Cancer Grading: a Contemporary Photomontage. American Journal of Surgical Pathology 40(1): 137
Kryvenko, O.N.; Epstein, J.I. 2016: Prostate Cancer Grading: a Decade After the 2005 Modified Gleason Grading System. Archives of Pathology and Laboratory Medicine 140(10): 1140-1152
Zhang, L.; Wu, C.; Hoffman, R.M. 2015: Prostate Cancer Heterogeneous High-Metastatic Multi-Organ-Colonizing Chemo-Resistant Variants Selected by Serial Metastatic Passage in Nude Mice Are Highly Enriched for Multinucleate Giant Cells. Plos one 10(11): E0140721
Kilcoyne, A.; Harisinghani, M.G.; Mahmood, U. 2016: Prostate Cancer Imaging and Therapy: Potential Role of Nanoparticles. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 57(Suppl. 3): 105s-110s
Lindenberg, L.; Choyke, P.; Dahut, W. 2016: Prostate Cancer Imaging with Novel PET Tracers. Current Urology Reports 17(3): 18
Wei, X.X.; Fong, L.; Small, E.J. 2015: Prostate Cancer Immunotherapy with Sipuleucel-T: Current Standards and Future Directions. Expert Review of Vaccines 14(12): 1529-1541
Doonan, B.P.; Haque, A. 2015: Prostate Cancer Immunotherapy: Exploiting the HLA Class Ii Pathway in Vaccine Design. Journal of Clinical and Cellular Immunology 6(4)
Shen, N.; Zhao, J.; Schipper, J.L.; Zhang, Y.; Bepler, T.; Leehr, D.; Bradley, J.; Horton, J.; Lapp, H.; Gordan, R. 2018: Divergence in DNA Specificity among Paralogous Transcription Factors Contributes to Their Differential In Vivo Binding. Cell Systems 6(4): 470-483.E8
Jemal, A.; Fedewa, S.A.; Ma, J.; Siegel, R.; Lin, C.C.; Brawley, O.; Ward, E.M. 2015: Prostate Cancer Incidence and PSA Testing Patterns in Relation to USPSTF Screening Recommendations. JAMA 314(19): 2054-2061
Owens, O.L.; Jackson, Déa.D.; Thomas, T.L.; Friedman, D.B.; Hébert, J.R. 2015: Prostate Cancer Knowledge and Decision Making Among African-American Men and Women in the Southeastern United States. International journal of men's health 14(1): 55-70
Anderson, T.; Wallace, T.; Aung, M.; Jolly, P.E. 2015: Prostate Cancer Knowledge, Attitudes and Screening Practices among Men in Western Jamaica. West Indian Medical Journal 65(1): 67-77
Morrison, B.F.; Aiken, W.D.; Mayhew, R.; Gordon, Y.; Odedina, F.T. 2017: Prostate Cancer Knowledge, Prevention, and Screening Behaviors in Jamaican Men. Journal of Cancer Education: the Official Journal of the American Association for Cancer Education 32(2): 352-356
Chen, H.; Sutedjo, J.; Wang, L.; Yin, X. 2016: Prostate Cancer Magnetic Resonance Spectroscopy Imaging at 1.5 and 3.0 T: a Meta-Analysis. Technology in Cancer Research and Treatment 15(4): 625-631
Shah, V.A.; Rixey, A.; Dusing, R. 2016: Prostate Cancer Metastases to Inguinal Lymph Nodes Detected by Attenuation-Corrected 11C-Acetate PET/CT. Journal of Nuclear Medicine Technology 44(1): 46-48
Xiao, H.; Tan, F.; Adunlin, G.; Ali, A.A.; Goovaerts, P.; Huang, Y.; Gwede, C. 2014: Prostate Cancer Overall Survival: Multilevel Analysis of a Population-Based Cancer Registry Data. Value in Health: the Journal of the International Society for Pharmacoeconomics and Outcomes Research 17(7): A733
Zaorsky, N.G.; Shaikh, T.; Ruth, K.; Sharda, P.; Hayes, S.B.; Sobczak, M.L.; Hallman, M.A.; Smaldone, M.C.; Chen, D.Y.T.; Horwitz, E.M. 2017: Prostate Cancer Patients with Unmanaged Diabetes or Receiving Insulin Experience Inferior Outcomes and Toxicities After Treatment with Radiation Therapy. Clinical Genitourinary Cancer 15(2): 326-335.E3
Gentile, N.; Johansen, M.E. 2016: Prostate Cancer Patients' Survival Expectations With and Without Their Chosen Treatment. Annals of Family Medicine 14(3): Iii-Iii
Spyropoulos, E.; Kotsiris, D.; Spyropoulos, K.; Panagopoulos, A.; Galanakis, I.; Mavrikos, S. 2017: Prostate Cancer Predictive Simulation Modelling, Assessing the Risk Technique (PCP-SMART): Introduction and Initial Clinical Efficacy Evaluation Data Presentation of a Simple Novel Mathematical Simulation Modelling Method, Devised to Predict the Outcome of Prostate Biopsy on an Individual Basis. Clinical genitourinary cancer 15(1): 129-138.e1
Hamilton, Z.; Parsons, J.Kellogg. 2016: Prostate Cancer Prevention: Concepts and Clinical Trials. Current Urology Reports 17(4): 35
Kenfield, S.A.; Stampfer, M.J. 2015: Prostate Cancer Progression: the Smoking Gun?. European Urology 68(6): 957-958
Gandaglia, G.; Bray, F.; Cooperberg, M.R.; Karnes, R.J.; Leveridge, M.J.; Moretti, K.; Murphy, D.G.; Penson, D.F.; Miller, D.C. 2016: Prostate Cancer Registries: Current Status and Future Directions. European Urology 69(6): 998-1012
Wang, K.-S.; Zuo, L.; Owusu, D.; Pan, Y.; Luo, X. 2014: Prostate Cancer Related JAZF1 Gene is Associated with Schizophrenia. Journal of Schizophrenia Research 1(1)
Anonymous 2016: Prostate Cancer Risk Loci Are Associated with Gene Regulatory Mechanisms. Cancer Discovery 6(5): OF13
Eggener, S.E.; Cifu, A.S.; Nabhan, C. 2015: Prostate Cancer Screening. JAMA 314(8): 825-826
Mulhem, E.; Fulbright, N.; Duncan, N. 2015: Prostate Cancer Screening. American Family Physician 92(8): 683-688
Goins, R.Turner.; Schure, M.B.; Noonan, C.; Buchwald, D. 2015: Prostate Cancer Screening Among American Indians and Alaska Natives: The Health and Retirement Survey, 1996-2008. Preventing chronic disease 12: E123
Eggener, S. 2016: Prostate Cancer Screening Biomarkers: An Emerging Embarrassment of 'Riches'?. European Urology 70(1): 54-55
Mkanta, W.N.; Ndjakani, Y.; Bandiera, F.C.; Blumenthal, D.S.; Nseyo, U.O.; Asal, N.R. 2015: Prostate Cancer Screening and Mortality in Blacks and Whites: a Hospital-based Case-Control Study. Journal of the National Medical Association 107(2): 32-38
Tabayoyong, W.; Abouassaly, R. 2015: Prostate Cancer Screening and the Associated Controversy. Surgical Clinics of North America 95(5): 1023-1039
Morrison, B.F.; Aiken, W.; Mayhew, R.; Gordon, Y.; Reid, M. 2016: Prostate Cancer Screening in Jamaica: Results of the Largest National Screening Clinic. Journal of Cancer Epidemiology 2016: 2606805
Misra-Hebert, A.D.; Kattan, M.W. 2016: Prostate Cancer Screening: A Brief Tool to Incorporate Patient Preferences in a Clinical Encounter. Frontiers in Oncology 6: 235
Obana, M.; O'Lawrence, H. 2015: Prostate Cancer Screening: Psa test Awareness among Adult Males. Journal of Health and Human Services Administration 38(1): 17-43
Prasad, V. 2015: Prostate Cancer Screening: the Pendulum has Swung, and the Burden of Proof Is with Proponents. American Family Physician 92(8): 678-680
Jaworska, D.; Król, W.; Szliszka, E. 2015: Prostate Cancer Stem Cells: Research Advances. International Journal of Molecular Sciences 16(11): 27433-27449
Lin, X.; Farooqi, A.A.; Qureshi, M.Z.; Romero, M.A.; Tabassum, S.; Ismail, M. 2016: Prostate Cancer Stem Cells: Viewing Signaling Cascades at a Finer Resolution. Archivum Immunologiae et Therapiae Experimentalis 64(3): 217-223
Ojo, D.; Lin, X.; Wong, N.; Gu, Y.; Tang, D. 2015: Prostate Cancer Stem-like Cells Contribute to the Development of Castration-Resistant Prostate Cancer. Cancers 7(4): 2290-2308
Han, Y.; Rand, K.A.; Hazelett, D.J.; Ingles, S.A.; Kittles, R.A.; Strom, S.S.; Rybicki, B.A.; Nemesure, B.; Isaacs, W.B.; Stanford, J.L.; Zheng, W.; Schumacher, F.R.; Berndt, S.I.; Wang, Z.; Xu, J.; Rohland, N.; Reich, D.; Tandon, A.; Pasaniuc, B.; Allen, A.; Quinque, D.; Mallick, S.; Notani, D.; Rosenfeld, M.G.; Jayani, R.S.; Kolb, S.; Gapstur, S.M.; Stevens, V.L.; Pettaway, C.A.; Yeboah, E.D.; Tettey, Y.; Biritwum, R.B.; Adjei, A.A.; Tay, E.; Truelove, A.; Niwa, S.; Chokkalingam, A.P.; John, E.M.; Murphy, A.B.; Signorello, L.B.; Carpten, J.; Leske, M.C.; Wu, S.-Y.; Hennis, A.J.M.; Neslund-Dudas, C.; Hsing, A.W.; Chu, L.; Goodman, P.J.; Klein, E.A.; Zheng, S.L.; Witte, J.S.; Casey, G.; Lubwama, A.; Pooler, L.C.; Sheng, X.; Coetzee, G.A.; C 2016: Prostate Cancer Susceptibility in Men of African Ancestry at 8q24. Journal of the National Cancer Institute 108(7)
Valdagni, R.; Van Poppel, H.; Aitchison, M.; Albers, P.; Berthold, D.; Bossi, A.; Brausi, M.; Denis, L.; Drudge-Coates, L.; De Santis, M.; Feick, Günther.; Harrison, C.; Haustermans, K.; Hollywood, D.; Hoyer, M.; Hummel, H.; Mason, M.; Mirone, V.; Müller, S.C.; Parker, C.; Saghatchian, M.; Sternberg, C.N.; Tombal, B.; van Muilekom, E.; Watson, M.; Wesselmann, S.; Wiegel, T.; Magnani, T.; Costa, A. 2015: Prostate Cancer Unit Initiative in Europe: A position paper by the European School of Oncology. Critical reviews in oncology/hematology 95(2): 133-143
Jena, R. 2016: Prostate Cancer Virtual Special Issue. Clinical Oncology ) 28(3): 163-164
Matsugasumi, T.; Baco, E.; Palmer, S.; Aron, M.; Sato, Y.; Fukuda, N.; Süer, E.; Bernhard, J-Christophe.; Nakagawa, H.; Azhar, R.A.; Gill, I.S.; Ukimura, O. 2015: Prostate Cancer Volume Estimation by Combining Magnetic Resonance Imaging and Targeted Biopsy Proven Cancer Core Length: Correlation with Cancer Volume. Journal of Urology 194(4): 957-965
Bird, V.Y.; Domino, P.M.; Sutkowski, R.; Stillings, S.A.; Trejo-Lopez, J.A. 2016: Prostate Cancer with Metastatic Lytic Bone Lesions: Positive Bone Scan Post Docetaxel Chemotherapy in the Setting of Clinically Successful Treatment. Urology Case Reports 6: 12-14
Tuck, S.P. 2017: Prostate Cancer and Fracture: Identifying at-Risk Groups. Journal of Clinical Densitometry: the Official Journal of the International Society for Clinical Densitometry 20(2): 196-197
Lolkema, M.; Debets, R.; de Wit, R. 2017: Prostate Cancer and Immune Monitoring: Are We Heading Towards Better Selection of Patients and Treatment Strategies?. European Urology 71(5): 788-789
Spees, C.K.; Kelleher, K.J.; Abaza, R.; Clinton, S.K. 2015: Prostate Cancer and Li-Fraumeni Syndrome: Implications for Screening and Therapy. Urology Case Reports 3(2): 21-23
Olsen, G.W.; Ley, C.A. 2015: Prostate Cancer and PFOA. Journal of Occupational and Environmental Medicine 57(6): E60
Kilpeläinen, T.P.; Talala, K.; Raitanen, J.; Taari, K.; Kujala, P.; Tammela, T.L.J.; Auvinen, A. 2016: Prostate Cancer and Socioeconomic Status in the Finnish Randomized Study of Screening for Prostate Cancer. American Journal of Epidemiology 184(10): 720-731
Carson, C.C.; Kirby, R. 2015: Prostate Cancer and Testosterone Replacement Therapy--What is the Risk?. Journal of Urology 194(6): 1527-1528
Jaiswal, S.; Sarmad, R.; Arora, S.; Dasaraju, R.; Sarmad, K. 2015: Prostate Cancer for the Internist. North American Journal of Medical Sciences 7(10): 429-435
Nwaneri, A.C.; McBeth, L.; Hinds, T.D. 2016: Prostate Cancer in African American Men: The Effect of Androgens and micro RNAs on Epidermal Growth Factor Signaling. Hormones and Cancer 7(5-6): 296-304
Skalski, M.; Gierej, B.; Ziarkiewicz-Wróblewska, B.; Hołówko, W.; Krawczyk, M. 2016: Prostate Cancer in Deceased Liver Donors. Transplantation Proceedings 48(5): 1378-1380
Roussel, B.; Ouellet, G.M.; Mohile, S.G.; Dale, W. 2015: Prostate Cancer in Elderly Men: Screening, Active Surveillance, and Definitive Therapy. Clinics in Geriatric Medicine 31(4): 615-629
Pakzad, R.; Rafiemanesh, H.; Ghoncheh, M.; Sarmad, A.; Salehiniya, H.; Hosseini, S.; Sepehri, Z.; Afshari-Moghadam, A. 2016: Prostate Cancer in Iran: Trends in Incidence and Morphological and Epidemiological Characteristics. Asian Pacific Journal of Cancer Prevention: Apjcp 17(2): 839-843
Gestaut, M.M.; Pruszynski, J.E.; Swanson, G.P. 2017: Prostate Cancer in Patients with High Prostate-Specific Antigen Levels but Otherwise Very-Low-Risk Disease Behaves like Prostate Cancer in High-Risk Patients. Clinical Genitourinary Cancer 15(4): 445-449
Raslau, D.; Abu Dabrh, A.M.; Summerfield, D.T.; Wang, Z.; Steinkraus, L.W.; Murad, M.H. 2016: Prostate Cancer in Pilots. Aerospace Medicine and Human Performance 87(6): 565-570
Hilal, L.; Shahait, M.; Mukherji, D.; Charafeddine, M.; Farhat, Z.; Temraz, S.; Khauli, R.; Shamseddine, A. 2015: Prostate Cancer in the Arab World: a View from the Inside. Clinical Genitourinary Cancer 13(6): 505-511
Borgmann, H.; Wölm, J-Henning.; Vallo, S.; Mager, R.; Huber, J.; Breyer, J.; Salem, J.; Loeb, S.; Haferkamp, A.; Tsaur, I. 2017: Prostate Cancer on the Web-Expedient Tool for Patients' Decision-Making?. Journal of Cancer Education: the Official Journal of the American Association for Cancer Education 32(1): 135-140
Fabre, B.; Grosman, H.; Gonzalez, D.; Machulsky, N.F.; Repetto, E.M.; Mesch, V.; Lopez, M.A.; Mazza, O.; Berg, G. 2016: Prostate Cancer, High Cortisol Levels and Complex Hormonal Interaction. Asian Pacific Journal of Cancer Prevention: Apjcp 17(7): 3167-3171
Mohler, J.L.; Armstrong, A.J.; Bahnson, R.R.; D'Amico, A.V.; Davis, B.J.; Eastham, J.A.; Enke, C.A.; Farrington, T.A.; Higano, C.S.; Horwitz, E.M.; Hurwitz, M.; Kane, C.J.; Kawachi, M.H.; Kuettel, M.; Lee, R.J.; Meeks, J.J.; Penson, D.F.; Plimack, E.R.; Pow-Sang, J.M.; Raben, D.; Richey, S.; Roach, M.; Rosenfeld, S.; Schaeffer, E.; Skolarus, T.A.; Small, E.J.; Sonpavde, G.; Srinivas, S.; Strope, S.A.; Tward, J.; Shead, D.A.; Freedman-Cass, D.A. 2016: Prostate Cancer, Version 1.2016. Journal of the National Comprehensive Cancer Network: Jnccn 14(1): 19-30
Ong, S.Y.; Taverna, J.; Jokerst, C.; Enzler, T.; Hammode, E.; Rogowitz, E.; Green, M.R.; Babiker, H.M. 2015: Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix. Case Reports in Oncological Medicine 2015: 212543
Fuhrman-Luck, R.A.; Stansfield, S.H.; Stephens, C.R.; Loessner, D.; Clements, J.A. 2016: Prostate Cancer-Associated Kallikrein-Related Peptidase 4 Activates Matrix Metalloproteinase-1 and Thrombospondin-1. Journal of Proteome Research 15(8): 2466-2478
Delude, C. 2016: Prostate Cancer: a new Twist on Active Surveillance. Journal of the National Cancer Institute 108(5)
Mandaliya, H.; Sung, J.; Hill, J.; Samali, R.; George, M. 2015: Prostate Cancer: Cases of Rare Presentation and Rare Metastasis. Case Reports in Oncology 8(3): 526-529
Kgatle, M.M.; Kalla, A.A.; Islam, M.M.; Sathekge, M.; Moorad, R. 2016: Prostate Cancer: Epigenetic Alterations, Risk Factors, and Therapy. Prostate Cancer 2016: 5653862
Muller, B.G.; Shih, J.H.; Sankineni, S.; Marko, J.; Rais-Bahrami, S.; George, A.Koruthu.; de la Rosette, J.J.M.C.H.; Merino, M.J.; Wood, B.J.; Pinto, P.; Choyke, P.L.; Turkbey, B. 2015: Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging. Radiology 277(3): 741-750
Park, S.Y.; Jung, D.C.; Oh, Y.T.; Cho, N.H.; Choi, Y.D.; Rha, K.H.; Hong, S.J.; Han, K. 2016: Prostate Cancer: PI-RADS Version 2 Helps Preoperatively Predict Clinically Significant Cancers. Radiology 280(1): 108-116
Pinkney, S.; Fan, M.; Chan, K.; Koczmara, C.; Colvin, C.; Sasangohar, F.; Masino, C.; Easty, A.; Trbovich, P. 2014: Multiple Intravenous Infusions Phase 2b: Laboratory Study. Ontario Health Technology Assessment Series 14(5): 1-163
Kayat Bittencourt, L.; Litjens, G.; Hulsbergen-van de Kaa, C.A.; Turkbey, B.; Gasparetto, E.Leandro.; Barentsz, J.O. 2015: Prostate Cancer: The European Society of Urogenital Radiology Prostate Imaging Reporting and Data System Criteria for Predicting Extraprostatic Extension by Using 3-T Multiparametric MR Imaging. Radiology 276(2): 479-489
Dias, J.ão.L.; Pina, J.ão.M.ãe.; João, R.; Fialho, J.; Carmo, S.; Leal, C.íl.; Bilhim, T.; Marques, R.M.; Pinheiro, L.ís.C. 2015: Prostate Cancer: the Role of Multiparametric Magnetic Resonance Imaging. Acta Medica Portuguesa 28(2): 240-249
Rosenkrantz, A.B.; Ream, J.M.; Nolan, P.; Rusinek, H.; Deng, F.-M.; Taneja, S.S. 2015: Prostate Cancer: Utility of Whole-Lesion Apparent Diffusion Coefficient Metrics for Prediction of Biochemical Recurrence After Radical Prostatectomy. AJR. American Journal of Roentgenology 205(6): 1208-1214
Hötker, A.M.; Mazaheri, Y.; Zheng, J.; Moskowitz, C.S.; Berkowitz, J.; Lantos, J.E.; Pei, X.; Zelefsky, M.J.; Hricak, H.; Akin, O. 2015: Prostate Cancer: assessing the effects of androgen-deprivation therapy using quantitative diffusion-weighted and dynamic contrast-enhanced MRi. European Radiology 25(9): 2665-2672
Uzan, J.; Nahum, A.E.; Syndikus, I. 2016: Prostate Dose-painting Radiotherapy and Radiobiological Guided Optimisation Enhances the Therapeutic Ratio. Clinical Oncology 28(3): 165-170
Pisco, J.ão.; Bilhim, T.; Pinheiro, L.C.; Fernandes, L.úc.; Pereira, J.é; Costa, N.V.; Duarte, M.; Oliveira, A.ón.G. 2016: Prostate Embolization as an Alternative to Open Surgery in Patients with Large Prostate and Moderate to Severe Lower Urinary Tract Symptoms. Journal of Vascular and Interventional Radiology: Jvir 27(5): 700-708
Chapelon, J.-Y.; Rouvière, O.; Crouzet, S.éb.; Gelet, A. 2016: Prostate Focused Ultrasound Therapy. Advances in Experimental Medicine and Biology 880: 21-41
Schwen, Z.R.; Tosoian, J.J.; Sokoll, L.J.; Mangold, L.; Humphreys, E.; Schaeffer, E.M.; Partin, A.W.; Ross, A.E. 2016: Prostate Health Index (PHI) Predicts High-stage Pathology in African American Men. Urology 90: 136-140
Chiu, P.K.-F.; Lai, F.M.-M.; Teoh, J.Y.-C.; Lee, W.-M.; Yee, C.-H.; Chan, E.S.-Y.; Hou, S.-M.; Ng, C.-F. 2016: Prostate Health Index and %p2PSA Predict Aggressive Prostate Cancer Pathology in Chinese Patients Undergoing Radical Prostatectomy. Annals of Surgical Oncology 23(8): 2707-2714
Loeb, S.; Shin, S.S.; Broyles, D.L.; Wei, J.T.; Sanda, M.; Klee, G.; Partin, A.W.; Sokoll, L.; Chan, D.W.; Bangma, C.H.; van Schaik, R.H.N.; Slawin, K.M.; Marks, L.S.; Catalona, W.J. 2017: Prostate Health Index improves multivariable risk prediction of aggressive prostate cancer. Bju International 120(1): 61-68
Sivanandan, M.A.; Walker, G.; Sundar, S. 2016: Prostate Hypofractionated Radiotherapy Trial Results Need to be Interpreted with Caution due to Undertreatment of the Control Arm in the CHHiP Trial. Clinical Oncology 28(12): 797
Rosenkrantz, A.B.; Oto, A.; Turkbey, B.; Westphalen, A.C. 2016: Prostate Imaging Reporting and Data System (PI-RADS), Version 2: A Critical Look. Ajr. American Journal of Roentgenology 206(6): 1179-1183
Renard-Penna, Rëlle.; Mozer, P.; Cornud, Fçois.; Barry-Delongchamps, N.; Bruguière, E.; Portalez, D.; Malavaud, B. 2015: Prostate Imaging Reporting and Data System and Likert Scoring System: Multiparametric MR Imaging Validation Study to Screen Patients for Initial Biopsy. Radiology 275(2): 458-468
Perera, M.; Katelaris, N.; Murphy, D.G.; McGrath, S.; Lawrentschuk, N. 2017: Prostate Imaging Reporting and Data System score of four or more: active surveillance no more. Bju International 119(1): 9-12
Kao, P.-F.; Weng, J.-H.; Hsiao, P.-C.; Kao, Y.-L. 2016: Prostate Lymphoma Complicated with Prostatorectal Fistula and Multifocal Infection After Chemotherapy. Clinical Nuclear Medicine 41(3): 247-248
Czarniecki, M.; Jakuciński, M.; Królicki, L. 2016: Prostate MRI - an update for the referring urologist. Central European Journal of Urology 69(2): 162-169
Steiger, P.; Thoeny, H.C. 2016: Prostate MRI based on PI-RADS version 2: how we review and report. Cancer Imaging: the Official Publication of the International Cancer Imaging Society 16: 9
Rosenkrantz, A.B.; Taneja, S.S. 2015: Prostate MRi can reduce overdiagnosis and overtreatment of prostate cancer. Academic Radiology 22(8): 1000-1006
Manley, B.J.; Brockman, J.A.; Raup, V.T.; Fowler, K.J.; Andriole, G.L. 2016: Prostate MRI: a national survey of Urologist's attitudes and perceptions. International Braz J Urol: Official Journal of the Brazilian Society of Urology 42(3): 464-471
Zakian, K.L.; Hatfield, W.; Aras, O.; Cao, K.; Yakar, D.; Goldman, D.A.; Moskowitz, C.S.; Shukla-Dave, A.; Tehrani, Y.M.; Fine, S.; Eastham, J.; Hricak, H. 2016: Prostate MRSi predicts outcome in radical prostatectomy patients. Magnetic Resonance Imaging 34(5): 674-681
Rosenkrantz, A.B.; Verma, S.; Choyke, P.; Eberhardt, S.C.; Eggener, S.E.; Gaitonde, K.; Haider, M.A.; Margolis, D.J.; Marks, L.S.; Pinto, P.; Sonn, G.A.; Taneja, S.S. 2016: Prostate Magnetic Resonance Imaging and Magnetic Resonance Imaging Targeted Biopsy in Patients with a Prior Negative Biopsy: A Consensus Statement by AUA and SAR. Journal of urology 196(6): 1613-1618
Deng, J.; Auchtung, J.M.; Konstantinidis, K.T.; Caro-Quintero, A.; Brettar, I.; Höfle, M.; Tiedje, J.M. 2018: Divergence in Gene Regulation Contributes to Sympatric Speciation of Shewanella baltica Strains. Applied and Environmental Microbiology 84(4)
Dulaney, C.R.; Osula, D.O.; Yang, E.S.; Rais-Bahrami, S. 2016: Prostate Radiotherapy in the Era of Advanced Imaging and Precision Medicine. Prostate Cancer 2016: 4897515
Cooper, C.S.; Clark, J.; Brewer, D.S.; Edwards, D.R. 2016: Prostate Single Nucleotide Polymorphism Provides a Crucial Clue to Cancer Aggression in Active Surveillance Patients. European Urology 69(2): 229-230
Ecke, T.H.; Huang-Tiel, H.-J.; Golka, K.; Selinski, S.; Geis, B.C.; Koswig, S.; Bathe, K.; Hallmann, S.; Gerullis, H. 2016: Prostate Specific Antigen (PSA) as Predicting Marker for Clinical Outcome and Evaluation of Early Toxicity Rate after High-Dose Rate Brachytherapy (HDR-BT) in Combination with Additional External Beam Radiation Therapy (EBRT) for High Risk Prostate Cancer. International Journal of Molecular Sciences 17(11)
Panach-Navarrete, J.; Carratalá-Calvo, A.; Valls-González, L.; Sales-Maicas, Mía..Ángeles.; Martínez-Jabaloyas, Jé.María. 2015: Prostate Specific Antigen (PSA) use in a national health department. Archivos Espanoles de Urologia 68(8): 647-654
Chen, R.; Sjoberg, D.D.; Huang, Y.; Xie, L.; Zhou, L.; He, D.; Vickers, A.J.; Sun, Y.; Sun, Y.; Huang, Y.; Xie, L.; Zhou, L.; He, D.; Ding, Q.; Wei, Q.; Shao, P.; Tian, Y.; Sun, Z.; Fu, Q.; Ma, L.; Zheng, J.; Ye, Z.; Ye, D.; Xu, D.; Hou, J.; Xu, K.; Yuan, J.; Gao, X.; Liu, C.; Pan, T.; Gao, X.; Ren, S.; Xu, C.; Vickers, A.J.; Roobol, M.J.; Hugosson, J.; Jones, J.S.; Kattan, M.W.; Klein, E.; Hamdy, F.; Neal, D.; Donovan, J.; Parekh, D.J.; Ankerst, D.; Bartsch, G.; Klocker, H.; Horninger, W.; Benchikh, A.; Salama, G.; Villers, A.; Freedland, S.J.; Moreira, D.M.; Schröder, F.H.; Lilja, H.; Cronin, A.M. 2017: Prostate Specific Antigen and Prostate Cancer in Chinese Men Undergoing Initial Prostate Biopsies Compared with Western Cohorts. Journal of Urology 197(1): 90-96
Salman, J.W.; Schoots, I.G.; Carlsson, S.V.; Jenster, G.; Roobol, M.J. 2015: Prostate Specific Antigen as a Tumor Marker in Prostate Cancer: Biochemical and Clinical Aspects. Advances in Experimental Medicine and Biology 867: 93-114
Shoaibi, A.; Rao, G.A.; Cai, B.; Rawl, J.; Haddock, K.S.; Hébert, J.R. 2017: Prostate Specific Antigen-Growth Curve Model to Predict High-Risk Prostate Cancer. Prostate 77(2): 173-184
Pabisiak, K.; Ostrowski, M.; Kram, A.; Safranow, K.; Słojewski, M.; Ciechanowski, K. 2016: Prostate Specific Antigen-Positive Deceased Organ Donor: a Pathologist Is Indispensable. Transplantation Proceedings 48(7): 2450-2453
Rhee, H.; Thomas, P.; Shepherd, B.; Gustafson, S.; Vela, I.; Russell, P.J.; Nelson, C.; Chung, E.; Wood, G.; Malone, G.; Wood, S.; Heathcote, P. 2016: Prostate Specific Membrane Antigen Positron Emission Tomography May Improve the Diagnostic Accuracy of Multiparametric Magnetic Resonance Imaging in Localized Prostate Cancer. Journal of Urology 196(4): 1261-1267
Huang, Y.; Hamana, T.; Liu, J.; Wang, C.; An, L.; You, P.; Chang, J.Y.F.; Xu, J.; McKeehan, W.L.; Wang, F. 2015: Prostate Sphere-forming Stem Cells Are Derived from the P63-expressing Basal Compartment. Journal of Biological Chemistry 290(29): 17745-17752
Kim, S.H.; Park, W.S.; Kim, S.H.; Park, B.; Joo, J.; Lee, G.K.; Joung, J.Y.; Seo, H.K.; Chung, J.; Lee, K.H. 2016: Prostate Stem Cell Antigen Expression in Radical Prostatectomy Specimens Predicts Early Biochemical Recurrence in Patients with High Risk Prostate Cancer Receiving Neoadjuvant Hormonal Therapy. Plos one 11(3): E0151646
Kabarriti, A.E.; Guzzo, T.J.; Wein, A.J. 2014: Prostate Stromal Tumor of Uncertain Malignant Potential: Case Report With 5-Year Follow-up. Urology Case Reports 2(2): 43-44
Yang, Q.; Lin, H.; Wu, S.; Lei, F.; Zhu, X.; Song, L.; Hong, M.; Guo, L. 2015: Prostate Tumor Overexpressed 1 (PTOV1) Is a Novel Prognostic Marker for Nasopharyngeal Carcinoma Progression and Poor Survival Outcomes. Plos one 10(8): E0136448
Porcaro, A.Benito.; Novella, G.; Cacciamani, G.; De Marchi, D.; Corsi, P.; De Luyk, Nò.; Bizzotto, L.; Processali, T.; Cerasuolo, M.; Tamanini, I.; Cerruto, M.Angela.; Brunelli, M.; Siracusano, S.; Artibani, W. 2017: Prostate Volume Index Associates with a Decreased Risk of Prostate Cancer: Results of a Large Cohort of Patients Elected to a First Biopsy Set. Urologia Internationalis 98(1): 22-27
Gravas, S. 2016: Prostate Volume as a Risk Factor for Lower Urinary Tract Symptoms: the Quest Continues. European Urology 69(5): 892-893
De Assis, A.é M.; Maciel, M.S.; Moreira, A.M.; de Paula Rodrigues, V.C.; Antunes, A.A.; Srougi, M.; Cerri, G.G.; Carnevale, F.C. 2017: Prostate Zonal Volumetry as a Predictor of Clinical Outcomes for Prostate Artery Embolization. Cardiovascular and Interventional Radiology 40(2): 245-251
Figueiredo, J.Chaves.; Richter, J.; Borja, N.; Balaca, A.; Costa, S.; Belo, S.; Grácio, M.Amélia. 2015: Prostate adenocarcinoma associated with prostatic infection due to Schistosoma haematobium. Case report and systematic review. Parasitology Research 114(2): 351-358
Kim, I-Kyu.; Lee, D-Hwan.; Cho, H-Young.; Seo, J-Hoon.; Park, S-Hoon.; Kim, J-Mee. 2016: Prostate adenocarcinoma mandibular metastasis associated with numb chin syndrome: a case report. Journal of the Korean Association of Oral and Maxillofacial Surgeons 42(5): 301-306
Dembowski, J.; Hackemer, P.ł; Winkler, A.; Otlewska, A.; Tupikowski, K.; Zdrojowy, R. 2015: Prostate and Bladder Cancer Coexistence in Patients Undergoing Radical Cystoprostatectomy. Advances in Clinical and Experimental Medicine: Official Organ Wroclaw Medical University 24(4): 657-662
Ilunga Tshiswaka, D.; Donley, T.; Okafor, A.; Memiah, P.; Mbizo, J. 2017: Prostate and Colorectal Cancer Screening Uptake among US and Foreign-Born Males: Evidence from the 2015 NHIS Survey. Journal of Community Health 42(3): 612-623
Dorin, R.P.; Wiener, S.; Harris, C.D.; Wagner, J.R. 2015: Prostate atypia: does repeat biopsy detect clinically significant prostate cancer?. Prostate 75(7): 673-678
Anonymous 2002: Prostate awareness goes public. Nursing Standard 1987) 16(29): 6-6
Verma, V.; Chen, S.; Zhou, S.; Enke, C.A.; Wahl, A.O. 2017: Prostate bed target interfractional motion using RTOG consensus definitions and daily CT on rails : Does target motion differ between superior and inferior portions of the clinical target volume?. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 193(1): 38-45
Vitrani, M.-A.; Baumann, M.; Reversat, D.; Morel, G.; Moreau-Gaudry, A.; Mozer, P. 2016: Prostate biopsies assisted by comanipulated probe-holder: first in man. International Journal of Computer Assisted Radiology and Surgery 11(6): 1153-1161
Reddy, B.N.; Bessede, T.; Reddy, A.; Nair, S.; Tewari, A.K.; Rastinehad, A.R. 2016: Prostate biopsies: Available technique, approaches and diagnostic accuracy. Archivos Espanoles de Urologia 69(6): 302-310
Arias-Stella, J.A.; Shah, A.B.; Montoya-Cerrillo, D.; Williamson, S.R.; Gupta, N.S. 2015: Prostate biopsy and radical prostatectomy Gleason score correlation in heterogenous tumors: proposal for a composite Gleason score. American Journal of Surgical Pathology 39(9): 1213-1218
Schreiber, D.; Wong, A.T.; Rineer, J.; Weedon, J.; Schwartz, D. 2015: Prostate biopsy concordance in a large population-based sample: a Surveillance, Epidemiology and End Results study. Journal of Clinical Pathology 68(6): 453-457
Loeb, S. 2016: Prostate biopsy decisions: one-size-fits-all approach with total PSA is out and a multivariable approach with the Prostate Health Index is in. Bju International 117(3): 383
Sitpura, K.; Salmo, E. 2016: Prostate biopsy handling: special tiss1ue embedding technique with sponges affects the yield of prostatic tissue available for microscopic examination. Gulf Journal of Oncology 1(21): 46-48
Song, G.; Fang, D.; Ji, G.J.; Yu, W.; Zhao, C.L.; Li, X.S.; Shan, G.Z.; Li, S.Q.; He, Q.; Xin, Z.C.; Wang, X.Y.; Zhou, L.Q. 2016: Prostate biopsy results and clinicopathological characteristics of the 55 years or younger patients. Zhonghua Yi Xue Za Zhi 96(40): 3218-3221
Kuplevatskiy, V.I.; CherkashiN, M.A.; Roshchin, D.A.; Berezina, N.A.; Vorob'ev, N.A. 2016: Prostate biopsy under magnetic resonance imaging guidance. Vestnik Rentgenologii i Radiologii 97(1): 48-55
Rashid, A. 2015: Prostate biopsy, childhood vaccination, oral health, and medical tourism. British Journal of General Practice: the Journal of the Royal College of General Practitioners 65(636): 363
Roberts, M.J.; Doi, S.A. 2016: Prostate biopsy, targeted prophylaxis and infectious complications: a critique of methods used. Bju International 117(5): 719-721
Enzmann, T.; Tokas, T.; Korte, K.; Ritter, M.; Hammerer, P.; Franzaring, L.; Heynemann, H.; Gottfried, H.-W.; Bertermann, H.; Meyer-Schwickerath, M.; Wirth, B.; Pelzer, A.; Loch, T. 2015: Prostate biopsy: Procedure in the clinical routine. Der Urologe. Ausg. a 54(12): 1811-1820; Quiz: 1821-1822
Burruni, R.; Cerantola, Y.; Meuwly, J.-Y.; Tawadros, T.; Jichlinski, P.; Valerio, M. 2015: Prostate biopsy: which strategy for which patient?. Revue Medicale Suisse 11(497): 2288-2290; 2292
Cheng, J.; Xiong, W.; Gu, Y.; Chia, S.C.; Wang, Y.; Huang, W.; Zhou, J.; Zhou, Y.; Gao, W.; Tay, K.J.; Ho, H. 2014: Prostate boundary segment extraction using cascaded shape regression and optimal surface detection. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2014: 2886-2889
Mensah, J.E.; Yarney, J.; Vanderpuye, V.; Akpakli, E.; Tagoe, S.; Sasu, E. 2016: Prostate brachytherapy in Ghana: our initial experience. Journal of Contemporary BrachyTherapy 8(5): 379-385
Thompson, S.R.; Delaney, G.P.; Gabriel, G.S.; Izard, M.A.; Hruby, G.; Jagavkar, R.; Bucci, J.; Barton, M.B. 2015: Prostate brachytherapy in new South Wales: patterns of care study and impact of caseload on treatment quality. Journal of Contemporary BrachyTherapy 6(4): 344-349
Wallner, K.E.; Merrick, G.S.; Galbreath, R.W.; Butler, W.M.; Brammer, S.G.; Allen, Z.A.; Adamovich, E. 2016: Prostate brachytherapy in men greater than or equal to 75 years of age. Journal of Clinical Oncology 26(15_Suppl): 16069-16069
Minehan, K.J.; Furutani, K.; McNamara, K.; Groshek, D.; Mitchell, E.; Price, M.; Emme, M.; Harms, T. 2016: Prostate brachytherapy post implant dosimetry: Timing matters. Journal of Clinical Oncology 24(18_Suppl): 14597-14597
Bece, A.; Bucci, J. 2016: Prostate brachytherapy: Why do we ignore the evidence?. Journal of Medical Imaging and Radiation Oncology 60(4): 528-530
Gu, M.; Li, W.; Chen, Q.; Chen, Y.; Xu, M.; Wang, Z. 2015: Prostate calculi can higher urinary retention probability and worsen uncomfortable feeling after prostate biopsy but not predict cancer. International Journal of Clinical and Experimental Medicine 8(4): 6282-6286
Cole, E. 2015: A do-it-yourself drive to spread the D word. Nursing Standard: 29(46): 18-19
James, M.L. 2006: Prostate cancer (early). Bmj Clinical Evidence 2006
Attard, G.; Parker, C.; Eeles, R.A.; Schröder, F.; Tomlins, S.A.; Tannock, I.; Drake, C.G.; de Bono, J.S. 2016: Prostate cancer. Lancet 387(10013): 70-82
Anonymous 2016: Prostate cancer. Nursing Standard: 1987) 30(40): 17
Hackshaw-McGeagh, L.; Lane, J.Athene.; Persad, R.; Gillatt, D.; Holly, J.M.P.; Koupparis, A.; Rowe, E.; Johnston, L.; Cloete, J.; Shiridzinomwa, C.; Abrams, P.; Penfold, C.M.; Bahl, A.; Oxley, J.; Perks, C.M.; Martin, R. 2016: Prostate cancer - evidence of exercise and nutrition trial (PrEvENT): study protocol for a randomised controlled feasibility trial. Trials 17(1): 123
Grigorean, V.T.; Nita, G.R.; Nita, R.A.R.; Popescu, M.; Sandu, A.M.; Lupascu, C.D.; Ciuhu, A.-N. 2013: Prostate cancer - peculiarities of the process of adaptation to the disease. Clujul Medical 86(2): 133-137
Füeßl, H.S. 2015: Prostate cancer - unexpected prevalence. MMW Fortschritte der Medizin 157(19): 38
Wang, Y.; Yin, J.; Qu, X.; Mu, Y.; Teng, S. 2015: Prostate cancer Lncap stem-like cells demonstrate resistance to the hydros-induced apoptosis during the formation of spheres. Biomedicine and PharmacoTherapy 74: 1-8
Patel, P.; Nayak, J.G.; Biljetina, Z.; Donnelly, B.; Trpkov, K. 2015: Prostate cancer after initial high-grade prostatic intraepithelial neoplasia and benign prostate biopsy. Canadian Journal of Urology 22(6): 8056-8062
Kawada, T. 2016: Prostate cancer among East Asian men: Screening and management strategies. Urologic Oncology 34(7): 333
Anderson, B.; Marshall-Lucette, S. 2016: Prostate cancer among Jamaican men: exploring the evidence for higher risk. British Journal of Nursing 25(19): 1046-1051
Yamashita, S. 2016: Prostate cancer and epigenetics. Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 3): 75-79
Malik, S.S.; Masood, N.; Yasmin, A. 2015: Prostate cancer and glutathione S-transferase deletions. Excli Journal 14: 1049-1054
Shiozawa, S.; Horie, S. 2014: Prostate cancer and metabolic syndrome. Nihon Rinsho. Japanese Journal of Clinical Medicine 72(12): 2234-2240
Grigore, A.D.; Ben-Jacob, E.; Farach-Carson, M.C. 2015: Prostate cancer and neuroendocrine differentiation: more neuronal, less endocrine?. Frontiers in Oncology 5: 37
Shiota, M.; Yokomizo, A. 2016: Prostate cancer and oxidative stress. Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 3): 71-74
King, A.J.L.; Evans, M.; Moore, T.H.M.; Paterson, C.; Sharp, D.; Persad, R.; Huntley, A.L. 2015: Prostate cancer and supportive care: a systematic review and qualitative synthesis of men's experiences and unmet needs. European Journal of Cancer Care 24(5): 618-634
Rosenberg, M.T.; Spring, A.C.; David Crawford, E. 2015: Prostate cancer and the PCP: the screening dilemma. International Journal of Clinical Practice 69(12): 1438-1447
Storm, M.; Sheng, X.; Arnoldussen, Y.Jildouw.; Saatcioglu, F. 2016: Prostate cancer and the unfolded protein response. Oncotarget 7(33): 54051-54066
Sokal, D.C.; Labrecque, M.; Belker, A.M.; Faraday, M.M.; Honig, S.; Marmar, J.L.; Ross, L.S.; Sandlow, J.I.; Sharlip, I.D. 2015: Prostate cancer and vasectomy: déjà vu!. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 33(6): 669-670
Xue, W.-J.; Ying, X.-L.; Jiang, J.-H.; Xu, Y.-H. 2014: Prostate cancer antigen 3 as a biomarker in the urine for prostate cancer diagnosis: a meta-analysis. Journal of Cancer Research and Therapeutics 10 Suppl: C218-C221
Moradi Sardareh, H.; Goodarzi, M.T.; Yadegar-Azari, R.; Poorolajal, J.; Mousavi-Bahar, S.H.; Saidijam, M. 2014: Prostate cancer antigen 3 gene expression in peripheral blood and urine sediments from prostate cancer and benign prostatic hyperplasia patients versus healthy individuals. Urology Journal 11(6): 1952-1958
Wang, F.-B.; Chen, R.; Ren, S.-C.; Shi, X.-L.; Zhu, Y.-S.; Zhang, W.; Jing, T.-L.; Zhang, C.; Gao, X.; Hou, J.-G.; Xu, C.-L.; Sun, Y.-H. 2017: Prostate cancer antigen 3 moderately improves diagnostic accuracy in Chinese patients undergoing first prostate biopsy. Asian Journal of Andrology 19(2): 238-243
Somwaru, A.S.; Alex, D.; Zaheer, A. 2016: Prostate cancer arising in ectopic prostatic tissue within the left seminal vesicle: a rare case diagnosed with multi-parametric magnetic resonance imaging and magnetic resonance imaging-transrectal ultrasound fusion biopsy. Bmc Medical Imaging 16: 16
Guttilla, A.; Bortolami, A.; Evangelista, L. 2015: Prostate cancer as a chronic disease: cost-effectiveness and proper follow-up. Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 59(4): 439-445
Vargas, H.A.; Schor-Bardach, R.; Long, N.; Kirzner, A.N.; Cunningham, J.D.; Goldman, D.A.; Moskowitz, C.S.; Sosa, R.E.; Sala, E.; Panicek, D.M.; Hricak, H. 2017: Prostate cancer bone metastases on staging prostate MRI: prevalence and clinical features associated with their diagnosis. Abdominal Radiology 42(1): 271-277
Pommier, P.; Guérif, S.; Peiffert, D.; Créhange, G.; Hannoun-Lévi, J.-M.; de Crevoisier, R. 2016: Prostate cancer brachytherapy. Cancer Radiotherapie: Journal de la Societe Francaise de Radiotherapie Oncologique 20 Suppl: S210-S215
Sierra, Mónica.S.; Soerjomataram, I.; Forman, D. 2016: Prostate cancer burden in Central and South America. Cancer Epidemiology 44 Suppl. 1: S131-S140
Alberti, C. 2016: Prostate cancer cell both microRNA aberrant expression-mediated autophagy and radiation therapy resistance with short cross-reference to epigenetic/genetic mechanism implications. European Review for Medical and Pharmacological Sciences 20(6): 1001-1002
Suhovskih, A.V.; Kashuba, V.I.; Klein, G.; Grigorieva, E.V. 2017: Prostate cancer cells specifically reorganize epithelial cell-fibroblast communication through proteoglycan and junction pathways. Cell Adhesion and Migration 11(1): 39-53
Stratton, D.; Moore, C.; Zheng, L.; Lange, S.; Inal, J. 2015: Prostate cancer cells stimulated by calcium-mediated activation of protein kinase C undergo a refractory period before re-releasing calcium-bearing microvesicles. Biochemical and Biophysical Research Communications 460(3): 511-517
Trama, A.; Botta, L.; Nicolai, N.; Rossi, P.Giorgi.; Contiero, P.; Fusco, M.; Lodde, M.; Pannozzo, F.; Piffer, S.; Puppo, A.; Seeber, A.; Tumino, R.; Valdagni, R.; Gatta, G. 2016: Prostate cancer changes in clinical presentation and treatments in two decades: an Italian population-based study. European Journal of Cancer 67: 91-98
Pettenati, C.; Jannot, A.-S.; Hurel, S.; Verkarre, V.; Kreis, H.; Housset, M.; Legendre, C.; Méjean, A.; Timsit, M.-O. 2016: Prostate cancer characteristics and outcome in renal transplant recipients: results from a contemporary single center study. Clinical Transplantation 30(8): 964-971
Hashim, D.; Boffetta, P.; Galsky, M.; Oh, W.; Lucchini, R.; Crane, M.; Luft, B.; Moline, J.; Udasin, I.; Harrison, D.; Taioli, E. 2018: Prostate cancer characteristics in the World Trade Center cohort, 2002-2013. European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 27(4): 347-354
Pellizzon, A.C. 2016: Prostate cancer considered low or intermediate risk for biochemical failure according to the rtog-astro phoenix definition: Results of the use of neoadjuvant androgen deprivation before high-dose rate brachytherapy and external beam radiotherapy. Journal of Clinical Oncology 26(15_Suppl): 16121-16121
Cash, H.; Günzel, K.; Maxeiner, A.; Stephan, C.; Fischer, T.; Durmus, T.; Miller, K.; Asbach, P.; Haas, M.; Kempkensteffen, C. 2016: Prostate cancer detection on transrectal ultrasonography-guided random biopsy despite negative real-time magnetic resonance imaging/ultrasonography fusion-guided targeted biopsy: reasons for targeted biopsy failure. Bju International 118(1): 35-43
Osses, Dël.F.; van Asten, J.J.; Kieft, G.J.; Tijsterman, J.D. 2017: Prostate cancer detection rates of magnetic resonance imaging-guided prostate biopsy related to Prostate Imaging Reporting and Data System score. World Journal of Urology 35(2): 207-212
Türk, Z.; Hollberg, H.; Dill, T.; Kaspers, I.; Isbarn, H. 2015: Prostate cancer detection rates: comparison of standard biopsy with prompt rebiopsy and a one-time extended biopsy. Der Urologe. Ausg. a 54(1): 28-33
Teoh, J.Y.; Yuen, S.K.; Tsu, J.H.; Wong, C.K.; Ho, B.S.; Ng, A.T.; Ma, W.-K.; Ho, K.-L.; Yiu, M.-K. 2015: Prostate cancer detection upon transrectal ultrasound-guided biopsy in relation to digital rectal examination and prostate-specific antigen level: what to expect in the Chinese population?. Asian Journal of Andrology 17(5): 821-825
Mussi, T.C.; Garcia, R.G.; Queiroz, M.R.G.; Lemos, G.C.; Baroni, R.H. 2016: Prostate cancer detection using multiparametric 3 - tesla MRi and fusion biopsy: preliminary results. International Braz J Urol: Official Journal of the Brazilian Society of Urology 42(5): 897-905
Filson, C.P.; Natarajan, S.; Margolis, D.J.A.; Huang, J.; Lieu, P.; Dorey, F.J.; Reiter, R.E.; Marks, L.S. 2016: Prostate cancer detection with magnetic resonance-ultrasound fusion biopsy: the role of systematic and targeted biopsies. Cancer 122(6): 884-892
Lee, A.; Chia, S.J. 2015: Prostate cancer detection: the impact of obesity on Asian men. Urologic Oncology 33(6): 266.E17
Marchena, C.L.; Urcia, S.I.; Canelo-Aybar, C. 2015: Prostate cancer detection: the effect of obesity on Asian men. Urologic Oncology 33(10): 422-423
Muller, B.G.; de Bruin, D.M.; Brandt, M.J.; van den Bos, W.; van Huystee, S.; Faber, D.J.; Savci, D.; Zondervan, P.J.; de Reijke, T.M.; Laguna-Pes, M.P.; van Leeuwen, T.G.; de la Rosette, J.J.M.C.H. 2016: Prostate cancer diagnosis by optical coherence tomography: first results from a needle based optical platform for tissue sampling. Journal of Biophotonics 9(5): 490-498
Muller, B.G.; de Bruin, D.M.; van den Bos, W.; Brandt, M.J.; Velu, J.F.; Bus, M.T.J.; Faber, D.J.; Savci, D.; Zondervan, P.J.; de Reijke, T.M.; Pes, P.L.; de la Rosette, J.; van Leeuwen, T.G. 2015: Prostate cancer diagnosis: the feasibility of needle-based optical coherence tomography. Journal of Medical Imaging 2(3): 037501
Eccleston, M.E. 2015: Prostate cancer diagnostic options: Past, present, and future. Mlo: Medical Laboratory Observer 47(3): 30-31
Sharma, S.; Zapatero-Rodríguez, J.; O'Kennedy, R. 2017: Prostate cancer diagnostics: Clinical challenges and the ongoing need for disruptive and effective diagnostic tools. Biotechnology Advances 35(2): 135-149
Yamauchi, F.I.; Penzkofer, T.; Fedorov, A.; Fennessy, F.M.; Chu, R.; Maier, S.E.; Tempany, C.M.C.; Mulkern, R.V.; Panych, L.P. 2015: Prostate cancer discrimination in the peripheral zone with a reduced field-of-view T(2)-mapping MRi sequence. Magnetic Resonance Imaging 33(5): 525-530
Capanna, C.; Chujutalli, R.; Murray, S.; Lwin, K.; Aung, M.; Jolly, P. 2015: Prostate cancer educational intervention among men in western Jamaica. Preventive Medicine Reports 2: 788-793
Yegnasubramanian, S. 2016: Prostate cancer epigenetics and its clinical implications. Asian Journal of Andrology 18(4): 549-558
De Crevoisier, R.; Pommier, P.; Latorzeff, I.; Chapet, O.; Chauvet, B.; Hennequin, C. 2016: Prostate cancer external beam radiotherapy. Cancer Radiotherapie: Journal de la Societe Francaise de Radiotherapie Oncologique 20 Suppl: S200-S209
Kaufmann, S.; Bedke, J.; Gatidis, S.; Hennenlotter, J.; Kramer, U.; Notohamiprodjo, M.; Nikolaou, K.; Stenzl, A.; Kruck, S. 2016: Prostate cancer gene 3 (PCA3) is of additional predictive value in patients with PI-RADS grade IIi (intermediate) lesions in the MR-guided re-biopsy setting for prostate cancer. World Journal of Urology 34(4): 509-515
Rocco, B.; Boeri, L. 2016: Prostate cancer gene 3 assay in the magnetic resonance imaging (MRI)/ultrasonography fusion target biopsy era: a future to believe in. Bju International 118(5): 672-673
Anonymous 2016: Prostate cancer gene test aids treatment precision. Nursing Standard: 1987) 30(48): 16
Minardi, D.; Mazzucchelli, R.; Scarpelli, M.; Massari, F.; Ciccarese, C.; Lopez-Beltran, A.; Cheng, L.; Montironi, R. 2016: Prostate cancer glands with cribriform architecture and with glomeruloid features should be considered as Gleason pattern 4 and not pattern 3. Future Oncology 12(12): 1431-1433
Gasparrini, S.; Mazzucchelli, R.; Scarpelli, M.; Massari, F.; Raspollini, M.R.; Lopez-Beltran, A.; Cheng, L.; Montironi, R. 2017: Prostate cancer grading in 2016. Minerva Urologica e Nefrologica 69(1): 1-4
Delahunt, B.; Egevad, L.; Grignon, D.J.; Srigley, J.R.; Samaratunga, H. 2016: Prostate cancer grading: recent developments and future directions. Bju International 117(Suppl 4): 7-8
Zhao, K.; Wang, C.; Hu, J.; Yang, X.; Wang, H.; Li, F.; Zhang, X.; Zhang, J.; Wang, X. 2015: Prostate cancer identification: quantitative analysis of T2-weighted MR images based on a back propagation artificial neural network model. Science China. Life Sciences 58(7): 666-673
Zhu, C.; Xu, Q.; Pan, D.; Xu, Y.; Liu, P.; Yang, R.; Wang, L.; Sun, X.; Luo, S.; Yang, M. 2016: Prostate cancer imaging of FSHR antagonist modified with a hydrophilic linker. Contrast Media and Molecular Imaging 11(2): 99-105
Renard Penna, R.; Brenot-Rossi, I.; Salomon, L.; Soulié, M. 2015: Prostate cancer imaging: MRi and nuclear imaging. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 25(15): 933-946
Turkbey, B.; Choyke, P.L. 2016: Prostate cancer imaging: a special focus issue from Future Oncology. Future Oncology 12(21): 2389-2391
Gounder, S.K.; Chang, V.T.; Hoover, D.; Gonzalez, M.L.; Ahmed, S.; Finch-Cruz, C.; Duque, L.; Zhong, F.; Toomey, K.; Kasimis, B.S. 2016: Prostate cancer immunohistochemical (IHC) stains and survival in stage D3 patients (pts). Journal of Clinical Oncology 26(15_Suppl): 22187-22187
Jazayeri, S.Behzad.; Samadi, D.B. 2017: Prostate cancer in African Americans: Early oncological and functional outcomes after robotic prostatectomy. International Journal of Urology: Official Journal of the Japanese Urological Association 24(3): 236-237
Tourinho-Barbosa, R.Rocha.; Pompeo, A.Carlos.Lima.; Glina, S. 2016: Prostate cancer in Brazil and Latin America: epidemiology and screening. International Braz J Urol: Official Journal of the Brazilian Society of Urology 42(6): 1081-1090
Restrepo, J.Alejandro.; Bravo, L.Eduardo.; García-Perdomo, H.Andrés.; García, L.Stella.; Collazos, P.; Carbonell, J. 2014: Prostate cancer in Cali, Colombia, 1962-2011: incidence, mortality and survival. Salud publica de Mexico 56(5): 440-447
Fukuoka, T. 2014: Prostate cancer in a patient with multiple pulmonary metastases alone and respiratory symptoms. Journal of Rural Medicine: Jrm 9(1): 27-31
Kinnear, N.J.; Kichenadasse, G.; Plagakis, S.; O'Callaghan, M.E.; Kopsaftis, T.; Walsh, S.; Foreman, D. 2016: Prostate cancer in men aged less than 50 years at diagnosis. World Journal of Urology 34(11): 1533-1539
Szot, W.; Kostkiewicz, M.; Zając, J.; Owoc, A.; Bojar, I. 2014: Prostate cancer in patients from rural and suburban areas--PSA value, Gleason score and presence of metastases in bone scan. Annals of Agricultural and Environmental Medicine: Aaem 21(4): 888-892
Eke, N. 2012: Prostate cancer in the West African sub-region, the need to know. Journal of the West African College of Surgeons 2(3): X-Xii
Huang, T-Hao.; Kuo, J-Yih.; Huang, Y-Hsiu.; Chung, H-Jen.; Huang, W.J.S.; Wu, H.H.H.; Chang, Y-Hwa.; Lin, A.T.L.; Chen, K-Kuo. 2017: Prostate cancer in young adults-Seventeen-year clinical experience of a single center. Journal of the Chinese Medical Association 80(1): 39-43
Welton, M.; Robb, S.W.; Shen, Y.; Guillebeau, P.; Vena, J. 2015: Prostate cancer incidence and agriculture practices in Georgia, 2000-2010. International journal of occupational and environmental health 21(3): 251-257
Pina, F.; Castro, C.; Ferro, A.; Bento, M.J.; Lunet, N. 2017: Prostate cancer incidence and mortality in Portugal: trends, projections and regional differences. European Journal of Cancer Prevention: the Official Journal of the European Cancer Prevention Organisation 26(5): 404-410
Grosclaude, P.; Belot, A.; Daubisse Marliac, L.; Remontet, L.; Leone, N.; Bossard, N.; Velten, M. 2015: Prostate cancer incidence and mortality trends in France from 1980 to 2011. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 25(9): 536-542
Zhou, C.K.; Check, D.P.; Lortet-Tieulent, J.; Laversanne, M.; Jemal, A.; Ferlay, J.; Bray, F.; Cook, M.B.; Devesa, S.S. 2016: Prostate cancer incidence in 43 populations worldwide: An analysis of time trends overall and by age group. International Journal of Cancer 138(6): 1388-1400
Karczmarek-Borowska, Bżenna.; Radziszewska, A. 2015: Prostate cancer incidence in Podkarpackie province in 2002-2011. Przeglad Epidemiologiczny 69(1): 65-72 163-7
Vaarala, M.H.; Mehik, A.; Ohtonen, P.; Hellström, P.A. 2016: Prostate cancer incidence in men with self-reported prostatitis after 15 years of follow-up. Oncology letters 12(2): 1149-1153
Liu, Z-Hua.; Li, C.; Kang, L.; Zhou, Z-Yang.; Situ, S.; Wang, J-Ping. 2015: Prostate cancer incorrectly diagnosed as a rectal tumor: A case report. Oncology Letters 9(6): 2647-2650
Venniyoor, A. 2016: Prostate cancer is not breast cancer. Indian Journal of Medical and Paediatric Oncology: Official Journal of Indian Society of Medical and Paediatric Oncology 37(1): 4-5
Nickens, K.P.; Ali, A.; Scoggin, T.; Tan, S.-H.; Ravindranath, L.; McLeod, D.G.; Dobi, A.; Tacha, D.; Sesterhenn, I.A.; Srivastava, S.; Petrovics, G. 2015: Prostate cancer marker panel with single cell sensitivity in urine. Prostate 75(9): 969-975
Pentyala, S.; Whyard, T.; Pentyala, S.; Muller, J.; Pfail, J.; Parmar, S.; Helguero, C.G.; Khan, S. 2016: Prostate cancer markers: An update. Biomedical Reports 4(3): 263-268
McCarthy, M.T.; Ebrahem, H.; Aibdeen, Z.; Hodnett, P.A.; Mulcahy, E.; Osman, N. 2016: Prostate cancer metastasis to calcaneus: a solitary lesion at an atypical site, dormant for more than 10 years. Jrsm Open 7(10): 2054270416660934
Sui, X.; Hu, Y.; Zhang, C.; Pan, H.; Li, D. 2016: Prostate cancer metastasis to the distal phalanx of the left hallux: The first confirmed case and literature review. Oncology Letters 12(2): 1074-1078
Ziaee, S.; Chu, G.Chia-Yi.; Huang, J-Ming.; Sieh, S.; Chung, L.W.K. 2015: Prostate cancer metastasis: roles of recruitment and reprogramming, cell signal network and three-dimensional growth characteristics. Translational Andrology and Urology 4(4): 438-454
Feng, J.; Xu, X.; Li, B.; Brown, E.; Farris, A.B.; Sun, S.-Y.; Yang, J.J. 2014: Prostate cancer metastatic to bone has higher expression of the calcium-sensing receptor (CaSR) than primary prostate cancer. Receptors and Clinical Investigation 1(6)
Sepúlveda, L.; Gorgal, T.; Pires, V.; Rodrigues, F. 2015: Prostate cancer metastatic to the cervical lymph nodes. Case Reports in Urology 2015: 263978
Lorion, R.; Bladou, F.; Spatz, A.; van Kempen, L.; Irani, J. 2016: Prostate cancer microenvironment: its structure, functions and therapeutic applications. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 26(8): 464-476
Torres-Sánchez, L.E.; Espinoza-Giacinto, R.; Rojas-Martínez, R.; Escamilla-Nuñez, C.; Vázquez-Salas, R.A.; Campuzano, J.C.és.; Lazcano-Ponce, E. 2016: Prostate cancer mortality according to marginalization status in Mexican states from 1980 to 2013. Salud Publica de Mexico 58(2): 179-186
Ilic, M.; Ilic, I. 2016: Prostate cancer mortality in Serbia, 1991-2010: a joinpoint regression analysis. Journal of Public Health 38(2): E63-E67
O'Kane, D.B.; Lawrentschuk, N.; Bolton, D.M. 2016: Prostate cancer nodal oligometastasis accurately assessed using prostate-specific membrane antigen positron emission tomography-computed tomography and confirmed histologically following robotic-assisted lymph node dissection. Urology Annals 8(2): 255-257
Méry, B.; Vallard, A.; Espenel, S.; Badie, N.; Thiermant, M.; Lambert, V.; Soulier, V.; Piqueres, S.; Del Santo, K.; Ben Mrad, M.; Wang, G.; Diao, P.; Langrand-Escure, J.; Rivoirard, R.; Guy, J.-B.; Guillot, A.; Chanelière, A.-F.; Gonthier, R.; Achour, E.; Fournel, P.; Magné, N. 2016: Prostate cancer of elderly patients: Place and role of geriatric assessment. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 26(9): 524-531
Haraoka, M.; Takamuki, M.; Toyonaga, Y.; Tanaka, M.; Hanazawa, K.; Sakamoto, Y.; Horie, S. 2014: Prostate cancer of unknown primary origin with multiple lymph nodes metastasis; a case report. Nihon Hinyokika Gakkai Zasshi. Japanese Journal of Urology 105(4): 212-217
Jia, J.B.; Houshyar, R.; Verma, S.; Uchio, E.; Lall, C. 2016: Prostate cancer on computed tomography: a direct comparison with multi-parametric magnetic resonance imaging and tissue pathology. European Journal of Radiology 85(1): 261-267
Vela, I.; Chen, Y. 2015: Prostate cancer organoids: a potential new tool for testing drug sensitivity. Expert Review of Anticancer Therapy 15(3): 261-263
Beckmann, K.R.; O'Callaghan, M.E.; Ruseckaite, R.; Kinnear, N.; Miller, C.; Evans, S.; Roder, D.M.; Moretti, K. 2017: Prostate cancer outcomes for men who present with symptoms at diagnosis. Bju International 119(6): 862-871
Kweldam, C.F.; Kümmerlin, I.P.; Nieboer, D.; Verhoef, E.I.; Steyerberg, E.W.; Incrocci, L.; Bangma, C.H.; van der Kwast, T.H.; Roobol, M.J.; van Leenders, G.J. 2016: Prostate cancer outcomes of men with biopsy Gleason score 6 and 7 without cribriform or intraductal carcinoma. European Journal of Cancer 66: 26-33
Glaser, A.W.; Corner, J.L. 2015: Prostate cancer outcomes: the three questions. European Urology 67(3): 357-358
Knoll, N.; Wiedemann, A.U.; Schultze, M.; Schrader, M.; Heckhausen, J. 2014: Prostate cancer patients gradually advance goals for rehabilitation after radical prostatectomy: applying a lines-of-defense model to rehabilitation. Psychology and Aging 29(4): 787-792
Ko, S-Hye.; Baeg, M.Ki.; Bae, W.Jin.; Kim, P.; Choi, M-Gyu. 2016: Prostate cancer patients may have an increased risk of coexisting advanced colorectal neoplasms. Oncotargets and Therapy 9: 5611-5617
Gerlich, C.; Schuler, M.; Jelitte, M.; Neuderth, S.; Flentje, M.; Graefen, M.; Krüger, A.; Mehnert, A.; Faller, H. 2016: Prostate cancer patients' quality of life assessments across the primary treatment trajectory: 'True' change or response shift?. Acta Oncologica 55(7): 814-820
Islam, K.M.; Wen, J. 2015: Prostate cancer patients' refusal of cancer-directed surgery: a statewide analysis. Prostate Cancer 2015: 829439
Jung, B.; Stoll, C.; Feick, G.; Prott, F.J.; Zell, J.; Rudolph, I.; Huebner, J. 2016: Prostate cancer patients' report on communication about endocrine therapy and its association with adherence. Journal of Cancer Research and Clinical Oncology 142(2): 465-470
Estévez, S.V.áz.; Herranz, U.A.; Calvo, O.F.án.; Afonso Afonso, F.J.; Couto, L.ía.S.é; Quintela, M.ín.L.áz.; Mateos, L.L.ón.; Maciá Escalante, S. 2016: Prostate cancer perspectives after chaarted: Optimizing treatment sequence. Critical Reviews in Oncology/Hematology 107: 119-127
May, E.J.; Viers, L.D.; Viers, B.R.; Kawashima, A.; Kwon, E.D.; Karnes, R.J.; Froemming, A.T. 2016: Prostate cancer post-treatment follow-up and recurrence evaluation. Abdominal Radiology 41(5): 862-876
Xiao, L.-H.; Chen, P.-R.; Gou, Z.-P.; Li, Y.-Z.; Li, M.; Xiang, L.-C.; Feng, P. 2017: Prostate cancer prediction using the random forest algorithm that takes into account transrectal ultrasound findings, age, and serum levels of prostate-specific antigen. Asian Journal of Andrology 19(5): 586-590
Hult, M.; Sandstrøm, H.; Wittendorff, H.-E. 2015: Prostate cancer presenting with diffuse infiltration of metastases to the pancreas. Ugeskrift for Laeger 177(5): V09140491
Yu, X.Q.; Luo, Q.; Smith, D.P.; Clements, M.S.; O'Connell, D.L. 2015: Prostate cancer prevalence in new South Wales Australia: a population-based study. Cancer Epidemiology 39(1): 29-36
Peisch, S.F.; Van Blarigan, E.L.; Chan, J.M.; Stampfer, M.J.; Kenfield, S.A. 2017: Prostate cancer progression and mortality: a review of diet and lifestyle factors. World Journal of Urology 35(6): 867-874
Evans, C.A.; Glen, A.; Eaton, C.L.; Larré, S.ép.; Catto, J.W.F.; Hamdy, F.C.; Wright, P.C.; Rehman, I. 2009: Prostate cancer proteomics: the urgent need for clinically validated biomarkers. PROTEOMICS. Clinical Applications 3(2): 197-212
Dal Pra, A.; Souhami, L. 2016: Prostate cancer radiation therapy: a physician's perspective. Physica Medica: Pm: An International Journal Devoted to the Applications of Physics to Medicine and Biology: Official Journal of the Italian Association of Biomedical Physics 32(3): 438-445
Coulter, J.A.; Butterworth, K.T.; Jain, S. 2015: Prostate cancer radiotherapy: potential applications of metal nanoparticles for imaging and therapy. British Journal of Radiology 88(1054): 20150256
Anonymous 2016: Prostate cancer rates decreasing as screening declines. Some experts question the wisdom of reduced screening. Dukemedicine Healthnews 22(2): 6
Hamid, S.; Guillaumier, S.; Shah, T.; Arya, M.; Ahmed, H.U. 2016: Prostate cancer recurrence after Focal Therapy: Treatment options. Archivos Espanoles de Urologia 69(6): 375-383
Golshani, P.; Edalat, F.; Patel, T.H. 2015: Prostate cancer recurrence manifesting as superior vena cava syndrome. Journal of Vascular and Interventional Radiology: Jvir 26(6): 855
McBride, D. 2014: Prostate cancer recurrence risk linked to high lipid levels. Ons Connect 29(4): 10
Mapelli, P.; Panebianco, V.; Picchio, M. 2015: Prostate cancer recurrence: can PSA guide imaging?. European Journal of Nuclear Medicine and Molecular Imaging 42(12): 1781-1783
Lemarchand, C.ém.; Tual, S.év.; Boulanger, M.; Levêque-Morlais, N.ém.; Perrier, S.ép.; Clin, B.én.éd.; Guizard, A.-V.ér.; Velten, M.; Rigaud, E.; Baldi, I.; Lebailly, P. 2016: Prostate cancer risk among French farmers in the AGRICAN cohort. Scandinavian Journal of Work Environment and Health 42(2): 144-152
Kaapu, K.J.; Murtola, T.J.; Määttänen, L.; Talala, K.; Taari, K.; Tammela, T.L.J.; Auvinen, A. 2016: Prostate cancer risk among users of digoxin and other antiarrhythmic drugs in the Finnish Prostate Cancer Screening Trial. Cancer Causes and Control: Ccc 27(2): 157-164
Tormey, W.P. 2015: Prostate cancer risk calculators using ERSPC-derived data underestimate the risk if the WHO IRP 96/670 standard is used in prostate-specific antigen analysis. European Urology 68(3): 541-542
Poyet, Cédric.; Hermanns, T. 2016: Prostate cancer risk calculators: still much work ahead. Bju International 118(5): 670-671
Zhou, Y.; Sun, D.; Quan, W.-L.; Ding, N.; Liu, W.; Ma, W.-H.; Wang, X.-P. 2018: Divergence in larval diapause induction between the rice and water-oat populations of the striped stem borer, Chilo suppressalis (Walker) (Lepidoptera: Crambidae). Environmental Science and Pollution Research International 25(29): 29715-29724
Lundon, D.J. 2016: Prostate cancer risk prediction and the persistence of uncertainty. Bju International 117(3): 382
Poyet, Cédric.; Nieboer, D.; Bhindi, B.; Kulkarni, G.S.; Wiederkehr, C.; Wettstein, M.S.; Largo, R.; Wild, P.; Sulser, T.; Hermanns, T. 2016: Prostate cancer risk prediction using the novel versions of the European Randomised Study for Screening of Prostate Cancer (ERSPC) and Prostate Cancer Prevention Trial (PCPT) risk calculators: independent validation and comparison in a contemporary European cohort. Bju International 117(3): 401-408
Luedeke, M.; Rinckleb, A.E.; FitzGerald, L.M.; Geybels, M.S.; Schleutker, J.; Eeles, R.A.; Teixeira, M.R.; Cannon-Albright, L.; Ostrander, E.A.; Weikert, S.; Herkommer, K.; Wahlfors, T.; Visakorpi, T.; Leinonen, K.A.; Tammela, T.L.J.; Cooper, C.S.; Kote-Jarai, Z.; Edwards, S.; Goh, C.L.; McCarthy, F.; Parker, C.; Flohr, P.; Paulo, P.; Jerónimo, C.; Henrique, R.; Krause, H.; Wach, S.; Lieb, V.; Rau, T.T.; Vogel, W.; Kuefer, R.; Hofer, M.D.; Perner, S.; Rubin, M.A.; Agarwal, A.M.; Easton, D.F.; Al Olama, A.A.; Benlloch, S.; Hoegel, J.; Stanford, J.L.; Maier, C. 2016: Prostate cancer risk regions at 8q24 and 17q24 are differentially associated with somatic TMPRSS2:ERG fusion status. Human Molecular Genetics 25(24): 5490-5499
Felker, E.R.; Margolis, D.J.; Nassiri, N.; Marks, L.S. 2016: Prostate cancer risk stratification with magnetic resonance imaging. Urologic Oncology 34(7): 311-319
Blanker, M.H.; Noordzij, M.A.A. 2014: Prostate cancer screening benefit very low, even after 13 years. Nederlands Tijdschrift Voor Geneeskunde 158: A8349
Walker, R.; Louis, A.; Berlin, A.; Horsburgh, S.; Bristow, R.G.; Trachtenberg, J. 2014: Prostate cancer screening characteristics in men with BRCA1/2 mutations attending a high-risk prevention clinic. Canadian Urological Association Journal 8(11-12): E783-E788
Naish, J. 1995: Prostate cancer screening considered. Nursing Standard 1987) 9(43): 12-12
Busato, W.F.S.; Almeida, G.L. 2016: Prostate cancer screening in Brazil: should it be done or not?. International Braz J Urol: Official Journal of the Brazilian Society of Urology 42(6): 1069-1080
Caicoya, M. 2015: Prostate cancer screening in Europe. Lancet 385(9977): 1507
Ranasinghe, W.K.; Kim, S.P.; Papa, N.P.; Sengupta, S.; Frydenberg, M.; Bolton, D.; Pond, D.; Ried, K.; Marshall, M.J.; Persad, R.; Lawrentschuk, N. 2015: Prostate cancer screening in Primary Health Care: the current state of affairs. Springerplus 4: 78
Guessous, I.; Cullati, S.ép.; Fedewa, S.A.; Burton-Jeangros, C.; Courvoisier, D.S.; Manor, O.; Bouchardy, C. 2016: Prostate cancer screening in Switzerland: 20-year trends and socioeconomic disparities. Preventive Medicine 82: 83-91
Grönberg, H.; Adolfsson, J.; Aly, M.; Nordström, T.; Wiklund, P.; Brandberg, Y.; Thompson, J.; Wiklund, F.; Lindberg, J.; Clements, M.; Egevad, L.; Eklund, M. 2015: Prostate cancer screening in men aged 50-69 years (STHLM3): a prospective population-based diagnostic study. LANCET. Oncology 16(16): 1667-1676
Murray, N.P.; Reyes, E.; Orellana, N.; Fuentealba, C.; Jacob, O. 2015: Prostate cancer screening in the fit Chilean elderly: a head to head comparison of total serum PSA versus age adjusted PSA versus primary circulating prostate cells to detect prostate cancer at initial biopsy. Asian Pacific Journal of Cancer Prevention: Apjcp 16(2): 601-606
Novoa, C.; Anguita, C.; Badilla-O, Sán.; Aliaga, A.; Reyes, D. 2014: Prostate cancer screening is associated with educational level and knowledge about the disease. Revista medica de Chile 142(9): 1136-1141
Rezaee, M.E.; Ward, C.E.; Odom, B.D.; Pollock, M. 2016: Prostate cancer screening practices and diagnoses in patients age 50 and older, Southeastern Michigan, pre/post 2012. Preventive Medicine 82: 73-76
Yen, A.M.-F.; Auvinen, A.; Schleutker, J.; Wu, Y.-Y.; Fann, J.C.-Y.; Tammela, T.; Chen, S.L.-S.; Chiu, S.Y.-H.; Chen, H.-H. 2015: Prostate cancer screening using risk stratification based on a multi-state model of genetic variants. Prostate 75(8): 825-835
Lu-Yao, G.L.; Albertsen, P.C.; Stanford, J.L.; Stukel, T.A.; Walker-Corkery, E.S.; Barry, M.J. 2016: Prostate cancer screening, treatment, and outcomes- A population-based study. Journal of Clinical Oncology 24(18_Suppl): 10017-10017
Kearns, J.T.; Gore, J.L. 2016: Prostate cancer screening: Do guidelines matter?. Cancer 122(24): 3760-3761
Kwiatkowski, M.; Randazzo, M.; Kluth, L.; Manka, L.; Huber, A.; Recker, F. 2015: Prostate cancer screening: and yet it moves!. Asian Journal of Andrology 17(3): 437-438
Eisinger, F.; Morère, J.F.; Touboul, C.; Pivot, X.; Coscas, Y.; Blay, J.Y.; Lhomel, C.; Viguier, J. 2015: Prostate cancer screening: contrasting trends. Cancer Causes and Control: Ccc 26(6): 949-952
Mayor, S. 2014: Prostate cancer services vary in England and Wales. LANCET. Oncology 15(13): E593
Boesen, L.; Chabanova, E.; Løgager, V.; Balslev, I.; Mikines, K.; Thomsen, H.S. 2015: Prostate cancer staging with extracapsular extension risk scoring using multiparametric MRI: a correlation with histopathology. European Radiology 25(6): 1776-1785
Kosaka, T.; Oya, M. 2016: Prostate cancer stem cell and drug resistance. Nihon Rinsho. Japanese Journal of Clinical Medicine 74(1): 45-49
Wu, G.; Wu, D.-l. 2015: Prostate cancer stem cells: advances in current research. Zhonghua Nan Ke Xue 21(2): 170-174
Rybak, A.P.; Bristow, R.G.; Kapoor, A. 2015: Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression. Oncotarget 6(4): 1900-1919
Di Zazzo, E.; Galasso, G.; Giovannelli, P.; Di Donato, M.; Di Santi, A.; Cernera, G.; Rossi, V.; Abbondanza, C.; Moncharmont, B.; Sinisi, A.A.; Castoria, G.; Migliaccio, A. 2016: Prostate cancer stem cells: the role of androgen and estrogen receptors. Oncotarget 7(1): 193-208
Krušlin, B.žo.; Ulamec, M.; Tomas, D. 2015: Prostate cancer stroma: an important factor in cancer growth and progression. Bosnian Journal of Basic Medical Sciences 15(2): 1-8
Cuypers, M.; Lamers, R.E.D.; de Vries, M.; Husson, O.; Kil, P.J.M.; van de Poll-Franse, L.V. 2016: Prostate cancer survivors with a passive role preference in treatment decision-making are less satisfied with information received: Results from the PROFILES registry. Urologic Oncology 34(11): 482.E11-482.E18
Goonewardene, S.S.; Persad, R.; Young, A.; Grover, L.; Makar, A. 2015: Prostate cancer survivorship and psychosexual care. European Journal of Cancer Care 24(2): 281-282
Resnick, M.J.; Lacchetti, C.; Bergman, J.; Hauke, R.J.; Hoffman, K.E.; Kungel, T.M.; Morgans, A.K.; Penson, D.F. 2015: Prostate cancer survivorship care guideline: American Society of Clinical Oncology Clinical Practice Guideline endorsement. Journal of clinical oncology: official journal of the American Society of Clinical Oncology 33(9): 1078-1085
Resnick, M.J.; Lacchetti, C.; Penson, D.F. 2015: Prostate cancer survivorship care guidelines: American Society of Clinical Oncology practice guideline endorsement. Journal of oncology practice 11(3): e445-e449
Ferguson, J.; Aning, J. 2015: Prostate cancer survivorship: a nurse-led service model. British Journal of Nursing 24(18): S14-S21
Hennequin, C.; Bruyère, F.; Sedefdjian, A.; Bourouina, R.; Rouprêt, M. 2015: Prostate cancer treated with androgen deprivation therapy: Care and monitoring in daily practice. Progres en Urologie: Journal de l'Association Francaise d'Urologie et de la Societe Francaise d'Urologie 25(16): 1132-1139
Drozdz, S.; Schwedas, M.; Salz, H.; Foller, S.; Wendt, T.G. 2016: Prostate cancer treated with image-guided helical TomoTherapy® and image-guided LINAC-IMRT : Correlation between high-dose bladder volume, margin reduction, and genitourinary toxicity. Strahlentherapie und Onkologie: Organ der Deutschen Rontgengesellschaft . 192(4): 223-231
Ojha, R.P.; Thertulien, R.; Zhou, Y.; Fischbach, L.A. 2016: Prostate cancer treatment and risk of acute myeloid leukemia in a population-based prospective cohort. Journal of Clinical Oncology 26(15_Suppl): 5073-5073
Akaza, H.; Onozawa, M.; Hinotsu, S. 2017: Prostate cancer trends in Asia. World Journal of Urology 35(6): 859-865
Emtage, J.B.; Poch, M.A.; Hutton, M.T.; Emtage, J.B. 2015: Prostate cancer trends in Barbados: An analysis of the Barbados Urologic Diseases Survey database. Cancer Epidemiology 39(6): 825-830
Plonis, J.; Bokums, K.; Cauce, V.; Miklasevics, E.; Vaganovs, P.; Irmejs, A.; Gardovskis, J.; Vjaters, E. 2014: Prostate cancer trends in Latvia during 1990-2012: incidence, prevalence, mortality, and survival rates. Medicina 50(6): 313-317
Carlson, R.H. 2016: Prostate cancer urine assay could spare biopsies. LANCET. Oncology 17(5): E185
Baxevanis, C.N.; Papamichail, M.; Perez, S.A. 2015: Prostate cancer vaccines: the long road to clinical application. Cancer Immunology Immunotherapy: Cii 64(4): 401-408
Konyalioglu, E.; Tarhan, H.; Cakmak, O.; Pala, E.E.; Zorlu, F. 2015: Prostate cancer volume estimations based on transrectal ultrasonography-guided biopsy in order to predict clinically significant prostate cancer. International Braz J Urol: Official Journal of the Brazilian Society of Urology 41(3): 442-448
Bonde, A.A.; Korngold, E.K.; Foster, B.R.; Westphalen, A.C.; Pettersson, D.R.; Troxell, M.L.; Simko, J.P.; Coakley, F.V. 2016: Prostate cancer with a pseudocapsule at MR imaging: a marker of high grade and stage disease?. Clinical Imaging 40(3): 365-369
Capek, S.; Howe, B.M.; Tracy, J.A.; García, Jín.J.; Amrami, K.K.; Spinner, R.J. 2015: Prostate cancer with perineural spread and dural extension causing bilateral lumbosacral plexopathy: case report. Journal of Neurosurgery 122(4): 778-783
Storstein, A.; Raspotnig, M.; Vitaliani, R.; Giometto, B.; Graus, F.; Grisold, W.; Honnorat, J.; Vedeler, C.A. 2016: Prostate cancer, Hu antibodies and paraneoplastic neurological syndromes. Journal of Neurology 263(5): 1001-1007
Ording, A.G.; Horváth-Puhó, Eébet.; Lash, T.L.; Ehrenstein, V.; Borre, M.; Vyberg, M.; Sørensen, H.T. 2015: Prostate cancer, comorbidity, and the risk of venous thromboembolism: A cohort study of 44,035 Danish prostate cancer patients, 1995-2011. Cancer 121(20): 3692-3699
Bratt, O.; Damber, J-Erik.; Aldehag, A.; Brändström, H. 2015: Prostate cancer--new guidelines and the first care program. Lakartidningen 112
Ummanni, R.; Duscharla, D.; Barett, C.; Venz, S.; Schlomm, T.; Heinzer, H.; Walther, R.; Bokemeyer, C.; Brümmendorf, T.H.; Murthy, P.V.L.N.; Balabanov, S. 2015: Prostate cancer-associated autoantibodies in serum against tumor-associated antigens as potential new biomarkers. Journal of Proteomics 119: 218-229
Wu, F.; Dai, X.; Gan, W.; Wan, L.; Li, M.; Mitsiades, N.; Wei, W.; Ding, Q.; Zhang, J. 2017: Prostate cancer-associated mutation in SPOP impairs its ability to target Cdc20 for poly-ubiquitination and degradation. Cancer Letters 385: 207-214
Cha, H.-R.; Lee, J.H.; Hensel, J.A.; Sawant, A.B.; Davis, B.H.; Lee, C.M.; Deshane, J.S.; Ponnazhagan, S. 2016: Prostate cancer-derived cathelicidin-related antimicrobial peptide facilitates macrophage differentiation and polarization of immature myeloid progenitors to protumorigenic macrophages. Prostate 76(7): 624-636
Woo, S.; Cho, J.Y.; Ku, J.H.; Kim, S.Y.; Kim, S.H. 2016: Prostate cancer-specific mortality after radical prostatectomy: value of preoperative MRi. Acta Radiologica 57(8): 1006-1013
Sabourin, G. 2014: Prostate cancer. Advantages of active surveillance. Perspective Infirmiere: Revue Officielle de l'Ordre des Infirmieres et Infirmiers du Quebec 11(5): 51
Helpap, B.; Bubendorf, L. 2016: Prostate cancer. Part 1: Review of cell kinetics over the years 1966-2015 and future perspectives of the new grading of the International Society of Urological Pathology (ISUP). Der Pathologe 37(1): 3-10
Helpap, B.; Bubendorf, L.; Kristiansen, G. 2016: Prostate cancer. Part 2: Review of the various tumor grading systems over the years 1966-2015 and future perspectives of the new grading of the International Society of Urological Pathology (ISUP). Der Pathologe 37(1): 11-16
Lasalvia-Prisco, E.M.; Garcia-Giralt, E.; Cucchi, S.; Larrañaga, J.; Wagner, D. 2016: Prostate cancer: Autologous immunotherapy optimized by indoleamine-2,3-dioxygenase (IDO)-inhibitor as immune-tolerance breaker. Journal of Clinical Oncology 24(18_Suppl): 12509-12509
Francini, E.; Taplin, M.-E. 2017: Prostate cancer: Developing novel approaches to castration-sensitive disease. Cancer 123(1): 29-42
Adjakly, M.; Ngollo, M.; Dagdemir, A.; Judes, G.ël.; Pajon, A.; Karsli-Ceppioglu, S.; Penault-Llorca, F.éd.ér.; Boiteux, J.-P.; Bignon, Y.-J.; Guy, L.; Bernard-Gallon, D. 2015: Prostate cancer: the main risk and protective factors-Epigenetic modifications. Annales d'Endocrinologie 76(1): 25-41
Mazeron, J.-J. 2017: Prostate cancer: to treat or not to treat?. Bulletin du Cancer 104(1): 4-5
Li, H.; Xia, J.; Xie, S.; Guo, Y.; Xin, M.; Li, F. 2015: Prostate cancer: a comparison of the diagnostic performance of transrectal ultrasound versus contrast enhanced transrectal ultrasound in different clinical characteristics. International Journal of Clinical and Experimental Medicine 8(11): 21428-21434
Tormey, W.P. 2015: Prostate cancer: active surveillance may prove organisationally impossible. Irish Journal of Medical Science 184(3): 715-717
Desai, M.; John, B.; Evans, G.; Eddy, B. 2015: Prostate cancer: beware of disseminated intravascular coagulation. BMJ Case Reports
Tan, W.; Wu, K. 2016: Prostate cancer: biopsy proven rare sites of metastases. Journal of Clinical Oncology 23(16_Suppl): 4794-4794
Falcinelli, L.; Palumbo, I.; Radicchia, V.; Arcidiacono, F.; Lancellotta, V.; Montesi, G.; Matrone, F.; Zucchetti, C.; Marcantonini, M.; Bini, V.; Aristei, C. 2015: Prostate cancer: contouring target and organs at risk by kilovoltage and megavoltage CT and MRi in patients with and without hip prostheses. British Journal of Radiology 88(1056): 20150509
Yang, D.M.; Kim, H.C.; Kim, S.W.; Jahng, G.-H.; Won, K.Y.; Lim, S.J.; Oh, J.-H. 2016: Prostate cancer: correlation of intravoxel incoherent motion MR parameters with Gleason score. Clinical Imaging 40(3): 445-450
Correas, J.-M.; Tissier, A.-M.; Khairoune, A.; Vassiliu, V.; Méjean, A.; Hélénon, O.; Memo, R.; Barr, R.G. 2015: Prostate cancer: diagnostic performance of real-time shear-wave elastography. Radiology 275(1): 280-289
McCoy, O.O.; Prasad, M.M.; Singer, N. 2016: Prostate cancer: endogenous chemical castration. BMJ Case Reports
Montironi, R.; Santoni, M.; Mazzucchelli, R.; Burattini, L.; Berardi, R.; Galosi, A.B.; Cheng, L.; Lopez-Beltran, A.; Briganti, A.; Montorsi, F.; Scarpelli, M. 2016: Prostate cancer: from Gleason scoring to prognostic grade grouping. Expert Review of Anticancer Therapy 16(4): 433-440
Morisot, A.; Bessaoud, F.ïz.; Landais, P.; Rébillard, X.; Trétarre, B.; Daurès, J.-P. 2015: Prostate cancer: net survival and cause-specific survival rates after multiple imputation. Bmc Medical Research Methodology 15: 54
Volgareva, G.M. 2015: Prostate cancer: papillomaviruses as a possible cause. Vestnik Rossiiskoi Akademii Meditsinskikh Nauk 1: 95-100
Rosenkrantz, A.B.; Verma, S.; Turkbey, B. 2015: Prostate cancer: top places where tumors hide on multiparametric MRi. AJR. American Journal of Roentgenology 204(4): W449-W456
Bayoud, Y.; Loock, P.Y.; Messaoudi, R.; Ripert, T.; Pierrevelcin, J.; Kozal, S.; Leon, P.; Kamdoum, M.; Irène, C.; Menard, J. 2015: Prostate cancer: what about reproducibility of decision made at multidisciplinary team management?. Urology Journal 12(2): 2078-2082
Glina, S.; Pasternak, J. 2015: Prostate cancer: what is the right message?. Einstein 13(4): 7-8
Smith, Z.L.; Soloway, M.S. 2016: Prostate capsule sparing radical cystectomy - a safe procedure for few. Central European Journal of Urology 69(1): 32-33
Tillou, X.; Chiche, L.; Guleryuz, K.; Hervé, S.; Bensadoun, H.; Doerfler, A. 2015: Prostate carcinoma in liver transplant recipients: think about it!. Urologic Oncology 33(6): 265.E9
Bradley, L.H.; Burton, M.; Gokden, M.; Serletis, D. 2015: Prostate carcinoma mimicking a sphenoid wing meningioma. International Journal of Surgery Case Reports 15: 63-65
O'Neil, L.M.; Walsh, S.; Cohen, R.J.; Lee, S. 2015: Prostate carcinoma with positive margins at radical prostatectomy: role of tumour zonal origin in biochemical recurrence. Bju International 116(Suppl 3): 42-48
Agheli, A.; Patsiornik, Y.; Chen, Y.; Chaudhry, M.R.; Gerber, H.; Wang, J.C. 2009: Prostate carcinoma, presenting with a solitary osteolytic bone lesion to the right hip. Radiology Case Reports 4(4): 288
Harzendorf, C.; Schmidt, A.; Hirsch, T. 2017: Prostate carcinoma + swelling of the leg = lymphedema : Is the equation correct?. Der Internist 58(4): 402-408
Derraz, F.; Forzy, G.ér.; Delebarre, A.; Taleb-Ahmed, A.; Oussalah, M.; Peyrodie, L.; Verclytte, S. 2015: Prostate contours delineation using interactive directional active contours model and parametric shape prior model. International Journal for Numerical Methods in Biomedical Engineering 31(11)
Lian, J.; Shao, Y.; Potter, L.D.; Chen, R.C.; Holmes, J.A.; Pryser, E.A.; Shen, J.; Shen, D.; Wang, A.Z. 2016: Prostate deformation from inflatable rectal probe cover and dosimetric effects in prostate seed implant brachytherapy. Medical Physics 43(12): 6569
Rakow-Penner, R.A.; White, N.S.; Margolis, D.J.A.; Parsons, J.Kellogg.; Schenker-Ahmed, N.; Kuperman, J.M.; Bartsch, H.; Choi, H.W.; Bradley, W.G.; Shabaik, A.; Huang, J.; Liss, M.A.; Marks, L.; Kane, C.J.; Reiter, R.E.; Raman, S.S.; Karow, D.S.; Dale, A.M. 2015: Prostate diffusion imaging with distortion correction. Magnetic Resonance Imaging 33(9): 1178-1181
Kim, C.K.; Park, J.J.; Park, B.K. 2016: Prostate diffusion-weighted imaging at 3T: effect of intravenous gadobutrol administration. European Radiology 26(5): 1450-1456
Baker, M.; Behrens, C.F. 2015: Prostate displacement during transabdominal ultrasound image-guided radiotherapy assessed by real-time four-dimensional transperineal monitoring. Acta Oncologica 54(9): 1508-1514
Boukas, A.; Sunderland, G.J.; Ross, N. 2015: Prostate dural metastasis presenting as chronic subdural hematoma. A case report and review of the literature. Surgical Neurology International 6: 30
Park, J.Wook.; Lee, J.K.; Phillips, J.W.; Huang, P.; Cheng, D.; Huang, J.; Witte, O.N. 2016: Prostate epithelial cell of origin determines cancer differentiation state in an organoid transformation assay. Proceedings of the National Academy of Sciences of the United States of America 113(16): 4482-4487
Moulton, C.R.; House, M.J.; Lye, V.; Tang, C.I.; Krawiec, M.; Joseph, D.J.; Denham, J.W.; Ebert, M.A. 2016: Prostate external beam radiotherapy combined with high-dose-rate brachytherapy: dose-volume parameters from deformably-registered plans correlate with late gastrointestinal complications. Radiation Oncology 11(1): 144
Biggs, C.N.; Siddiqui, K.M.; Al-Zahrani, A.A.; Pardhan, S.; Brett, S.I.; Guo, Q.Q.; Yang, J.; Wolf, P.; Power, N.E.; Durfee, P.N.; MacMillan, C.D.; Townson, J.L.; Brinker, J.C.; Fleshner, N.E.; Izawa, J.I.; Chambers, A.F.; Chin, J.L.; Leong, H.S. 2016: Prostate extracellular vesicles in patient plasma as a liquid biopsy platform for prostate cancer using nanoscale flow cytometry. Oncotarget 7(8): 8839-8849
Jones, A.C.; Antillon, K.S.; Jenkins, S.M.; Janos, S.N.; Overton, H.N.; Shoshan, D.S.; Fischer, E.G.; Trujillo, K.A.; Bisoffi, M. 2015: Prostate field cancerization: deregulated expression of macrophage inhibitory cytokine 1 (MIC-1) and platelet derived growth factor A (PDGF-A) in tumor adjacent tissue. Plos one 10(3): E0119314
Liss, M.A.; Xu, J.; Chen, H.; Kader, A.K. 2015: Prostate genetic score (PGS-33) is independently associated with risk of prostate cancer in the PLCO trial. Prostate 75(12): 1322-1328
Chiu, P.K.F.; Roobol, M.J.; Teoh, J.Y.; Lee, W.-M.; Yip, S.-Y.; Hou, S.-M.; Bangma, C.H.; Ng, C.-F. 2016: Prostate health index (PHI) and prostate-specific antigen (PSA) predictive models for prostate cancer in the Chinese population and the role of digital rectal examination-estimated prostate volume. International Urology and Nephrology 48(10): 1631-1637
De Luca, S.; Passera, R.; Fiori, C.; Bollito, E.; Cappia, S.; Mario Scarpa, R.; Sottile, A.; Franco Randone, D.; Porpiglia, F. 2015: Prostate health index and prostate cancer gene 3 score but not percent-free Prostate Specific Antigen have a predictive role in differentiating histological prostatitis from PCa and other nonneoplastic lesions (BPH and HG-PIN) at repeat biopsy. Urologic Oncology 33(10): 424.E17
Morton, G.; Chung, H.T.; McGuffin, M.; Helou, J.; D'Alimonte, L.; Ravi, A.; Cheung, P.; Szumacher, E.; Liu, S.; Al-Hanaqta, M.; Zhang, L.; Mamedov, A.; Loblaw, A. 2017: Prostate high dose-rate brachytherapy as monotherapy for low and intermediate risk prostate cancer: Early toxicity and quality-of life results from a randomized phase Ii clinical trial of one fraction of 19Gy or two fractions of 13.5Gy. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 122(1): 87-92
Morton, G.C. 2015: Prostate high-dose-rate brachytherapy: Transrectal ultrasound based planning, a technical note. Practical Radiation Oncology 5(4): 238-240
Sivaraman, A.; Sanchez-Salas, R.; Barret, E.; Macek, P.; Validire, P.; Galiano, M.; Rozet, F.; Cathelineau, X. 2015: Prostate histoscanning true targeting guided prostate biopsy: initial clinical experience. World Journal of Urology 33(10): 1475-1479
Silva, S.A.ân.; Gobbo, M.G.ãe.; Pinto-Fochi, M.E.; Rafacho, A.; Taboga, S.ão.R.; Almeida, E.A.; Góes, R.M.; Ribeiro, D.L. 2015: Prostate hyperplasia caused by long-term obesity is characterized by high deposition of extracellular matrix and increased content of MMP-9 and VEGF. International Journal of Experimental Pathology 96(1): 21-30
Chapet, O.; Decullier, E.; Bin, S.; Faix, A.; Ruffion, A.; Jalade, P.; Fenoglietto, P.; Udrescu, C.; Enachescu, C.; Azria, D. 2015: Prostate hypofractionated radiation therapy with injection of hyaluronic acid: acute toxicities in a phase 2 study. International Journal of Radiation Oncology Biology Physics 91(4): 730-736
Hassanzadeh, E.; Glazer, D.I.; Dunne, R.M.; Fennessy, F.M.; Harisinghani, M.G.; Tempany, C.M. 2017: Prostate imaging reporting and data system version 2 (PI-RADS v2): a pictorial review. Abdominal Radiology 42(1): 278-289
Wood, M.; Fonseca, A.; Sampson, D.; Kovendy, A.; Westhuyzen, J.; Shakespeare, T.; Turnbull, K. 2016: Prostate intensity-modulated radiotherapy planning in seven mouse clicks: Development of a class solution for cancer. Reports of Practical Oncology and Radiotherapy: Journal of Greatpoland Cancer Center in Poznan and Polish Society of Radiation Oncology 21(6): 567-570
Nagele, U.; Junker, D. 2015: Prostate interdisciplinary communication and mapping algorithm for biopsy and pathology (PIC-MABP) of multiparametric MRI findings. World Journal of Urology 33(7): 1057-1059
Bansal, N.; Duggal, L.; Jain, N.; Jain, S.; Sharma, A.; Arora, N. 2017: Prostate involvement in granulomatosis with polyangitis: a rarity. International Journal of Rheumatic Diseases 20(11): 1841-1842
Majumdar, R.; Mirheydar, H.S.; Palazzi, K.L.; Lakin, C.M.; Albo, M.E.; Parsons, J.K. 2015: Prostate laser vaporization is safe and effective in elderly men. Urology Annals 7(1): 36-40
Hashimoto, T.; Rahul, K.; Takeda, T.; Benfante, N.; Mulhall, J.P.; Hricak, H.; Eastham, J.A.; Vargas, H.A. 2016: Prostate magnetic resonance imaging findings in patients treated for testosterone deficiency while on active surveillance for low-risk prostate cancer. Urologic Oncology 34(12): 530.E9-530.E14
De Visschere, P.; Nezzo, M.; Pattyn, E.; Fonteyne, V.ér.; Van Praet, C.; Villeirs, G. 2015: Prostate magnetic resonance spectroscopic imaging at 1.5tesla with endorectal coil versus 3.0tesla without endorectal coil: comparison of spectral quality. Clinical Imaging 39(4): 636-641
Juneja, P.; Kneebone, A.; Booth, J.T.; Thwaites, D.I.; Kaur, R.; Colvill, E.; Ng, J.A.; Keall, P.J.; Eade, T. 2015: Prostate motion during radiotherapy of prostate cancer patients with and without application of a hydrogel spacer: a comparative study. Radiation Oncology 10: 215
Kulaksızoğlu, H.; Akand, M.; Kılıç, Öz.; Gül, M.; Kucur, M.; Göktaş, S. 2014: Prostate myths: what is the prostate awareness in the general male population in Turkey?. Turkish Journal of Urology 40(3): 150-155
Abele, J.T.; Moore, R.; Tymchak, W.; Owen, R.J. 2015: Prostate perfusion mapped by technetium-99m macroaggregated albumin after selective arterial injection. Journal of Vascular and Interventional Radiology: Jvir 26(3): 418-425
Stone, B.V.; Shoag, J.; Halpern, J.A.; Mittal, S.; Lewicki, P.; Golombos, D.M.; Bedretdinova, D.; Chughtai, B.; Barbieri, C.E.; Lee, R.K. 2017: Prostate size, nocturia and the digital rectal examination: a cohort study of 30 500 men. Bju International 119(2): 298-304
Youssef, R.F. 2011: Prostate sparing cystectomy: a procedure with limited indications. Arab Journal of Urology 9(2): 113-114
Aoun, F.; de Saint Aubain Somerhausen, N.; van Velthoven, R.; Peltier, A. 2014: Prostate sparing robot-assisted laparoscopic treatment of leiomyoma of the prostate. Journal of Robotic Surgery 8(4): 389-392
Cao, W.; Li, F.; Yao, J.; Yu, J. 2015: Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion. Bmc Cancer 15: 915
Rudnicka, E.; Radowicki, S.; Suchta, K. 2016: Prostate specific antigen (PSA) in diagnosis of polycystic ovarian syndrome - a new insight. Gynecological Endocrinology: the Official Journal of the International Society of Gynecological Endocrinology 32(11): 931-935
Daskivich, T.J.; Regan, M.M.; Kantoff, P.W.; Oh, W.K. 2016: Prostate specific antigen doubling time (PSA-DT) and velocity (PSA-V) provide independent prognostic information in androgen independent prostate cancer (AIPC) patients receiving chemotherapy. Journal of Clinical Oncology 24(18_Suppl): 4616-4616
Kole, T.P.; Chen, L.N.; Obayomi-Davies, O.; Kim, J.S.; Lei, S.; Suy, S.; Dritschilo, A.; Collins, S.P. 2015: Prostate specific antigen kinetics following robotic stereotactic body radiotherapy for localized prostate cancer. Acta Oncologica 54(6): 832-838
Mishra, M.V.; Shirazi, R.; Hertzfeld, K.; Barrett, W. 2016: Prostate specific antigen nadir: A prognostic marker of disease-free survival?. Journal of Clinical Oncology 23(16_Suppl): 4716-4716
Barrio, M.; Fendler, W.P.; Czernin, J.; Herrmann, K. 2016: Prostate specific membrane antigen (PSMA) ligands for diagnosis and therapy of prostate cancer. Expert Review of Molecular Diagnostics 16(11): 1177-1188
Fawzy, M.S.; Mohamed, R.H.; Elfayoumi, A.-R.R. 2015: Prostate stem cell antigen (PSCA) mRNA expression in peripheral blood in patients with benign prostatic hyperplasia and/or prostate cancer. Medical Oncology 32(3): 74
Uotani, T.; Sugimoto, M.; Ichikawa, H.; Tanaka, S.; Nagashima, H.; Uchida, T.; Graham, D.Y.; Yamaoka, Y. 2016: Prostate stem cell antigen gene TT genotype and development of intestinal metaplasia in Helicobacter pylori infection. Journal of Digestive Diseases 17(1): 20-27
Jensen, M.M.; Arvaniti, M.; Mikkelsen, J.D.; Michalski, D.; Pinborg, L.H.; Härtig, W.; Thomsen, M.S. 2015: Prostate stem cell antigen interacts with nicotinic acetylcholine receptors and is affected in Alzheimer's disease. Neurobiology of Aging 36(4): 1629-1638
Li, M.; Yu, X.; Cheng, L.; Huang, Y.; Weng, G. 2015: Prostate stem cell antigen variation rs2294008 associated with the risk of bladder cancer. International Journal of Clinical and Experimental Medicine 8(8): 13259-13266
Webber, J.P.; Spary, L.K.; Mason, M.D.; Tabi, Z.; Brewis, I.A.; Clayton, A. 2016: Prostate stromal cell proteomics analysis discriminates normal from tumour reactive stromal phenotypes. Oncotarget 7(15): 20124-20139
Heaphy, C.M.; Gaonkar, G.; Peskoe, S.B.; Joshu, C.E.; De Marzo, A.M.; Lucia, M.Scott.; Goodman, P.J.; Lippman, S.M.; Thompson, I.M.; Platz, E.A.; Meeker, A.K. 2015: Prostate stromal cell telomere shortening is associated with risk of prostate cancer in the placebo arm of the Prostate Cancer Prevention Trial. Prostate 75(11): 1160-1166
Kinoshita, H.; Matsuda, T. 2016: Prostate systematic biopsy. Nihon Rinsho. Japanese Journal of Clinical Medicine 74(Suppl 3): 346-349
Shaker, H. 2016: Prostate tissue retrieval after holmium laser enucleation of the prostate; assessment of non-morcellation approaches. Arab Journal of Urology 14(2): 156
Shui, I.M.; Wong, C.-J.; Zhao, S.; Kolb, S.; Ebot, E.M.; Geybels, M.S.; Rubicz, R.; Wright, J.L.; Lin, D.W.; Klotzle, B.; Bibikova, M.; Fan, J.-B.; Ostrander, E.A.; Feng, Z.; Stanford, J.L. 2016: Prostate tumor DNA methylation is associated with cigarette smoking and adverse prostate cancer outcomes. Cancer 122(14): 2168-2177
Steenbergen, P.; Haustermans, K.; Lerut, E.; Oyen, R.; De Wever, L.; Van den Bergh, L.; Kerkmeijer, L.G.W.; Pameijer, F.A.; Veldhuis, W.B.; van der Voort van Zyp, J.R.N.; Pos, F.J.; Heijmink, S.W.; Kalisvaart, R.; Teertstra, H.J.; Dinh, C.V.; Ghobadi, G.; van der Heide, U.A. 2015: Prostate tumor delineation using multiparametric magnetic resonance imaging: Inter-observer variability and pathology validation. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 115(2): 186-190
Rausch, S.; Hennenlotter, J.ör.; Scharpf, M.; Teepe, K.; Kühs, U.; Aufderklamm, S.; Bier, S.; Mischinger, J.; Gakis, G.; Stenzl, A.; Schwentner, C.; Todenhöfer, T. 2016: Prostate tumor overexpressed 1 expression in invasive urothelial carcinoma. Journal of Cancer Research and Clinical Oncology 142(5): 937-947
Chen, S.-P.; Zhang, L.-S.; Fu, B.-S.; Zeng, X.-C.; Yi, H.-M.; Jiang, N. 2015: Prostate tumor overexpressed 1 is a novel prognostic marker for hepatocellular carcinoma progression and overall patient survival. Medicine 94(4): E423
Yang, L.; Wang, H.; Wang, Y.; He, Z.; Chen, H.; Liang, S.; He, S.; Wu, S.; Song, L.; Chen, Y. 2016: Prostate tumor overexpressed-1, in conjunction with human papillomavirus status, predicts outcome in early-stage human laryngeal squamous cell carcinoma. Oncotarget 7(22): 31878-31891
Lee, J.; Huang, W.; Broering, J.M.; Barron, A.E.; Seo, J. 2015: Prostate tumor specific peptide-peptoid hybrid prodrugs. Bioorganic and Medicinal Chemistry Letters 25(14): 2849-2852
Alcayaga-Miranda, F.; González, P.L.; Lopez-Verrilli, A.; Varas-Godoy, M.; Aguila-Díaz, C.; Contreras, L.; Khoury, M. 2016: Prostate tumor-induced angiogenesis is blocked by exosomes derived from menstrual stem cells through the inhibition of reactive oxygen species. Oncotarget 7(28): 44462-44477
Mak, P.; Li, J.; Samanta, S.; Chang, C.; Jerry, D.J.; Davis, R.J.; Leav, I.; Mercurio, A.M. 2015: Prostate tumorigenesis induced by PTEN deletion involves estrogen receptor β repression. Cell Reports 10(12): 1982-1991
Cui, Y.; Ma, W.; Lei, F.; Li, Q.; Su, Y.; Lin, X.; Lin, C.; Zhang, X.; Ye, L.; Wu, S.; Li, J.; Yuan, Z.; Song, L. 2016: Prostate tumour overexpressed-1 promotes tumourigenicity in human breast cancer via activation of Wnt/β-catenin signalling. Journal of Pathology 239(3): 297-308
Dinkla, A.M.; Pieters, B.R.; Koedooder, K.; van Wieringen, N.; van der Laarse, R.; Bel, A. 2014: Prostate volume and implant configuration during 48 hours of temporary prostate brachytherapy: limited effect of oedema. Radiation Oncology 9: 272
Shin, Y.S.; Choi, H.; Cheon, M.W.; Park, S.C.; Park, J.K.; Kim, H.J.; Jeong, Y.B. 2015: Prostate volume and prostate-specific antigen in men with Parkinson's disease are not different compared to age-matched control group: a prospective, case-controlled multicenter study. Prostate International 3(2): 62-64
Tadin, T.; Spanjol, J.; Muskardin, I.; Fuckar, Z. 2014: Prostate volume and urinary discomforts in elderly. Collegium Antropologicum 38(4): 1119-1122
Woodruff, A.J.; Morgan, T.M.; Wright, J.L.; Porter, C.R. 2016: Prostate volume as an independent predictor of prostate cancer and high-grade disease on prostate needle biopsy. Journal of Clinical Oncology 26(15_Suppl): 5165-5165
Paterson, N.R.; Lavallée, L.T.; Nguyen, L.N.; Witiuk, K.; Ross, J.; Mallick, R.; Shabana, W.; MacDonald, B.; Scheida, N.; Fergusson, D.; Momoli, F.; Cnossen, S.; Morash, C.; Cagiannos, I.; Breau, R.H. 2016: Prostate volume estimations using magnetic resonance imaging and transrectal ultrasound compared to radical prostatectomy specimens. Canadian Urological Association Journal 10(7-8): 264-268
Li, S-Hui.; Yang, Q-Fang.; Zuo, P-Yuan.; Liu, Y-Wei.; Liao, Y-Hua.; Liu, C-Yun. 2016: Prostate volume growth rate changes over time: Results from men 18 to 92 years old in a longitudinal community-based study. Journal of Huazhong University of Science and Technology. Medical Sciences 36(6): 796-800
Yilmaz, H.; Ustuner, M.; Ciftci, S.; Yavuz, U.; Ozkan, T.A.; Dillioglugil, O. 2014: Prostate volume predicts high grade prostate cancer both in digital rectal examination negative (ct1c) and positive (≥ct2) patients. International Braz J Urol: Official Journal of the Brazilian Society of Urology 40(5): 613-619
Kranzbühler, B.; Gross, O.; Fankhauser, C.D.; Wettstein, M.S.; Grossmann, N.C.; Hefermehl, L.J.; Zimmermann, M.; Müller, A.; Eberli, D.; Sulser, T.; Poyet, Cédric.; Hermanns, T. 2017: Prostate volume reduction following pure transurethral bipolar plasma vaporization and conventional transurethral resection of the prostate: a prospective investigation using transrectal 3D ultrasound volumetry. World Journal of Urology 35(3): 429-435
Commandeur, F.; Acosta, O.; Simon, A.; Mathieu, R.; Fautrel, A.; Gnep, K.; Haigron, P.; de Crevoisier, R. 2015: Prostate whole-mount histology reconstruction and registration to MRi for correlating in-vivo observations with biological findings. Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference 2015: 2399-2402
Gomella, L.G. 2016: Prostate, Breast and Ovarian Cancer Genetic Risk Assessment: Connecting the Dots. Canadian Journal of Urology 23(5): 8429
Stephan, C.; Rittenhouse, H.; Hu, X.; Cammann, H.; Jung, K. 2014: Prostate-Specific Antigen (PSA) Screening and new Biomarkers for Prostate Cancer (PCa). Ejifcc 25(1): 55-78
Coric, J.; Mujic, J.; Kucukalic, E.; Ler, D. 2015: Prostate-Specific Antigen (PSA) and Prostate Volume: Better Predictor of Prostate Cancer for Bosnian and Herzegovina Men. Open Biochemistry Journal 9: 34-36
Tawfik, A. 2015: Prostate-Specific Antigen (PSA)-Based Population Screening for Prostate Cancer: An Economic Analysis. Ontario Health Technology Assessment Series 15(11): 1-37
Nowroozi, M.Reza.; Momeni, S.Ali.; Ohadian Moghadam, S.; Ayati, E.; Mortazavi, A.; Arfae, S.; Jamshidian, H.; Taherimahmoudi, M.; Ayati, M. 2016: Prostate-Specific Antigen Density and Gleason Score Predict Adverse Pathologic Features in Patients with Clinically Localized Prostate Cancer. Nephro-Urology Monthly 8(6): E39984
Giacalone, N.J.; Wu, J.; Chen, M.-H.; Renshaw, A.; Loffredo, M.; Kantoff, P.W.; D'Amico, A.V. 2016: Prostate-Specific Antigen Failure and Risk of Death Within Comorbidity Subgroups Among Men with Unfavorable-Risk Prostate Cancer Treated in a Randomized Trial. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 34(31): 3781-3786
De Vincentis, G.; Follacchio, G.Anna.; Frantellizzi, V.; Liberatore, M.; Monteleone, F.; Cortesi, E. 2016: Prostate-Specific Antigen Flare Phenomenon During 223 Ra-Dichloride Treatment for Bone Metastatic Castration-Resistant Prostate Cancer: A Case Report. Clinical Genitourinary Cancer 14(5): E529-E533
Ueda, Y.; Matsubara, N.; Tabata, K-Ichi.; Satoh, T.; Kamiya, N.; Suzuki, H.; Kawahara, T.; Uemura, H. 2017: Prostate-Specific Antigen Flare Phenomenon Induced by Abiraterone Acetate in Chemotherapy-Naive Patients With Metastatic Castration-Resistant Prostate Cancer. Clinical Genitourinary Cancer 15(2): 320-325
Conrad, T.; Paxton, R.J.; Assum, G.ün.; Ayasse, M. 2018: Divergence in male sexual odor signal and genetics across populations of the red mason bee, Osmia bicornis, in Europe. Plos one 13(2): E0193153
Shoag, J.E.; Schlegel, P.N.; Hu, J.C. 2016: Prostate-Specific Antigen Screening: time to Change the Dominant Forces on the Pendulum. Journal of Clinical Oncology: Official Journal of the American Society of Clinical Oncology 34(29): 3499-3501
Musrap, N.; Diamandis, E.P. 2016: Prostate-Specific Antigen as a Marker of Hyperandrogenism in Women and its Implications for Antidoping. Clinical Chemistry 62(8): 1066-1074
Kim, J.S.; Ryu, J.-G.; Kim, J.W.; Hwang, E.C.; Jung, S.I.; Kang, T.W.; Kwon, D.; Park, K. 2015: Prostate-Specific Antigen fluctuation: what does it mean in diagnosis of prostate cancer?. International Braz J Urol: Official Journal of the Brazilian Society of Urology 41(2): 258-264
Pabisiak, K.; Ostrowski, M.; Kram, A.; Safranow, K.; Myślak, M.; Sieńko, J.; Sulikowski, T.; Ciechanowski, K. 2016: Prostate-Specific Antigen: Nonspecific in Deceased Organ Donors. Transplantation Proceedings 48(5): 1374-1377
Rodriguez, M.; Siwko, S.; Liu, M. 2016: Prostate-Specific G-Protein Coupled Receptor, an Emerging Biomarker Regulating Inflammation and Prostate Cancer Invasion. Current Molecular Medicine 16(6): 526-532
Vamadevan, S.; Shetty, D.; Le, K.; Bui, C.; Mansberg, R.; Loh, H. 2016: Prostate-Specific Membrane Antigen (PSMA) Avid Pancreatic Neuroendocrine Tumor. Clinical Nuclear Medicine 41(10): 804-806
Crowley, M.J.P.; Scognamiglio, T.; Liu, Y.-F.; Kleiman, D.A.; Beninato, T.; Aronova, A.; Liu, H.; Jhanwar, Y.S.; Molina, A.; Tagawa, S.T.; Bander, N.H.; Zarnegar, R.; Elemento, O.; Fahey, T.J. 2016: Prostate-Specific Membrane Antigen Is a Potential Antiangiogenic Target in Adrenocortical Carcinoma. Journal of Clinical Endocrinology and Metabolism 101(3): 981-987
Bhardwaj, H.; Stephens, M.; Bhatt, M.; Thomas, P.A. 2016: Prostate-Specific Membrane Antigen PET/CT Findings for Hepatic Hemangioma. Clinical Nuclear Medicine 41(12): 968-969
Kobe, C.; Maintz, D.; Fischer, T.; Drzezga, A.; Chang, D.-H. 2015: Prostate-Specific Membrane Antigen PET/CT in Splenic Sarcoidosis. Clinical Nuclear Medicine 40(11): 897-898
Hermann, R.M.; Djannatian, M.; Czech, N.; Nitsche, M. 2016: Prostate-Specific Membrane Antigen PET/CT: False-Positive Results due to Sarcoidosis?. Case Reports in Oncology 9(2): 457-463
Karandish, F.; Haldar, M.K.; You, S.; Brooks, A.E.; Brooks, B.D.; Guo, B.; Choi, Y.; Mallik, S. 2016: Prostate-Specific Membrane Antigen Targeted Polymersomes for Delivering Mocetinostat and Docetaxel to Prostate Cancer Cell Spheroids. Acs Omega 1(5): 952-962
Vamadevan, S.; Le, K.; Bui, C.; Mansberg, R. 2016: Prostate-Specific Membrane Antigen Uptake in Small Cleaved B-Cell Follicular Non-Hodgkin Lymphoma. Clinical Nuclear Medicine 41(12): 980-981
Teo, M.Y.; Morris, M.J. 2016: Prostate-Specific Membrane Antigen-Directed Therapy for Metastatic Castration-Resistant Prostate Cancer. Cancer Journal 22(5): 347-352
Rowe, S.P.; Drzezga, A.; Neumaier, B.; Dietlein, M.; Gorin, M.A.; Zalutsky, M.R.; Pomper, M.G. 2016: Prostate-Specific Membrane Antigen-Targeted Radiohalogenated PET and Therapeutic Agents for Prostate Cancer. Journal of Nuclear Medicine: Official Publication Society of Nuclear Medicine 57(Suppl 3): 90s-96s
Stanhiser, J.; Mahdi, H.; Rosa, G.; Harper, H.; Shepard, D.; Rose, P.G.; Roma, A.A. 2016: Prostate-Type Adenocarcinoma in Mature Cystic Ovarian Teratoma. International Journal of Gynecological Pathology: Official Journal of the International Society of Gynecological Pathologists 35(2): 185-190
Kulkarni, P.; Dunker, A.K.; Weninger, K.; Orban, J. 2016: Prostate-associated gene 4 (PAGE4), an intrinsically disordered cancer/testis antigen, is a novel therapeutic target for prostate cancer. Asian Journal of Andrology 18(5): 695-703
Roberts, M.J.; Richards, R.S.; Chow, C.W.K.; Doi, S.A.R.; Schirra, H.J.; Buck, M.; Samaratunga, H.; Perry-Keene, J.; Payton, D.; Yaxley, J.; Lavin, M.F.; Gardiner, R.A. 2016: Prostate-based biofluids for the detection of prostate cancer: a comparative study of the diagnostic performance of cell-sourced RNA biomarkers. Prostate International 4(3): 97-102
Gilligan, T.D.; Kennedy, M.W.; Olson, E.; Gerberick, A.; Wilson-Glover, A.; Allen, J.D. 2016: Prostate-cancer (CaP) screening decision aid for black men designed to enhance shared decision-making. Journal of Clinical Oncology 24(18_Suppl): 6059-6059
Tsui, K.-H.; Lin, Y.-H.; Chung, L.-C.; Chuang, S.-T.; Feng, T.-H.; Chiang, K.-C.; Chang, P.-L.; Yeh, C.-J.; Juang, H.-H. 2016: Prostate-derived ets factor represses tumorigenesis and modulates epithelial-to-mesenchymal transition in bladder carcinoma cells. Cancer Letters 375(1): 142-151
Nour, H.; Abdelrazak, O.; Wishahy, M.; Elkatib, S.; Botto, H. 2011: Prostate-sparing cystectomy: Potential functional advantages and objective oncological risks; a case series and review. Arab Journal of Urology 9(2): 107-112
Liu, X.; Tang, J.; Fei, X.; Li, Q.-Y. 2015: Prostate-specific Antigen (PSA) Density and Free to Total PSA Ratio in Diagnosing Prostate Cancer with Prostate-Specific Antigen Levels of 4.0 ng/ml or Less. Iranian Journal of Public Health 44(11): 1466-1472
Rescigno, P.; Lorente, D.; Bianchini, D.; Ferraldeschi, R.; Kolinsky, M.P.; Sideris, S.; Zafeiriou, Z.; Sumanasuriya, S.; Smith, A.D.; Mehra, N.; Jayaram, A.; Perez-Lopez, R.; Mateo, J.; Parker, C.; Dearnaley, D.P.; Tunariu, N.; Reid, A.; Attard, G.; de Bono, J.S. 2016: Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. European Urology 70(5): 724-731
Xie, G.-S.; Lyv, J.-X.; Li, G.; Yan, C.-Y.; Hou, J.-Q.; Pu, J.-X.; Ding, X.; Huang, Y.-H. 2016: Prostate-specific Antigen Density Variation Rate as a Potential Guideline Parameter for Second Prostate Cancer Detection Biopsy. Chinese Medical Journal 129(15): 1800-1804
Kryvenko, O.N.; Diaz, M.; Matoso, A.; Kates, M.; Cohen, J.; Swanson, G.P.; Epstein, J.I. 2016: Prostate-specific Antigen Mass Density--A Measure Predicting Prostate Cancer Volume and Accounting for Overweight and Obesity-related Prostate-specific Antigen Hemodilution. Urology 90: 141-147
Wernicke, A.G.; Kim, S.; Liu, H.; Bander, N.H.; Pirog, E.C. 2017: Prostate-specific Membrane Antigen (PSMA) Expression in the Neovasculature of Gynecologic Malignancies: Implications for PSMA-targeted Therapy. Applied Immunohistochemistry and Molecular Morphology: Aimm 25(4): 271-276
Roessner, M.; de Wit, R.; Tannock, I.F.; Yateman, N.; Yao, S-L.; Yver, A.; Eisenberger, M.A. 2016: Prostate-specific antigen (PSA) response as a surrogate endpoint for overall survival (OS): Analysis of the TAX 327 Study comparing docetaxel plus prednisone with mitoxantrone plus prednisone in advanced prostate cancer. Journal of Clinical Oncology 23(16_Suppl): 4554-4554
Ewenighi, C.O.; Dimkpa, U.; Onyeanusi, J.C.; Babtunde, A.; Onoh, L.U.M.; Onoh, G.O.; Ezeugwu, U. 2017: Prostate-specific antigen and its derivatives in young adults occupationally exposed to quarry pollutants in southeastern Nigeria. Archives of Environmental and Occupational Health 72(5): 258-263
Ducatman, A.; Zhang, J.; Fan, H. 2015: Prostate-specific antigen and perfluoroalkyl acids in the C8 health study population. Journal of Occupational and Environmental Medicine 57(1): 111-114
Mazer, S.J.; Hendrickson, B.T.; Chellew, J.P.; Kim, L.J.; Liu, J.W.; Shu, J.; Sharma, M.V. 2018: Divergence in pollen performance between Clarkia sister species with contrasting mating systems supports predictions of sexual selection. Evolution; International Journal of Organic Evolution 72(3): 453-472
Leduc, N.; Atallah, V.; Creoff, M.; Rabia, N.; Taouil, T.; Escarmant, P.; Vinh-Hung, V. 2015: Prostate-specific antigen bounce after curative brachytherapy for early-stage prostate cancer: a study of 274 African-Caribbean patients. BrachyTherapy 14(6): 826-833
Yiakoumos, T.; Kälble, T.; Rausch, S. 2015: Prostate-specific antigen density as a parameter for the prediction of positive lymph nodes at radical prostatectomy. Urology Annals 7(4): 433-437
Kang, H.W.; Jung, H.D.; Lee, J.Y.; Kwon, J.K.; Jeh, S.U.; Cho, K.S.; Ham, W.S.; Choi, Y.D. 2016: Prostate-specific antigen density predicts favorable pathology and biochemical recurrence in patients with intermediate-risk prostate cancer. Asian Journal of Andrology 18(3): 480-484
Udeh, E.I.; Nnabugwu, I.I.; Ozoemena, F.O.; Ugwumba, F.O.; Aderibigbe, A.S.O.; Ohayi, S.R.; Echetabu, K.N. 2016: Prostate-specific antigen density values among patients with symptomatic prostatic enlargement in Nigeria. World Journal of Surgical Oncology 14(1): 174
Ghosn, M.; Dagher, A.; El-Karak, F. 2015: Prostate-specific antigen doubling time and response to cabazitaxel in a hormone-resistant metastatic prostate cancer patient. Journal of Biomedical Research 29(5): 420-422
Servoll, E.; Sæter, T.; Vlatkovic, L.; Nesland, J.M.; Waaler, G.; Axcrona, K. 2015: Prostate-specific antigen doubling time subsequent to radical prostatectomy is a predictor of outcome following salvage external beam radiation therapy: a single-centre experience. Scandinavian Journal of Urology 49(3): 218-223
Scotte, F.; Banu, E.; Oudard, S.; Banu, A.; Medioni, J.; Fabre Guillevin, E.; Mejean, A.; Fontaine, E.; Thiounn, N.; Andrieu, J.M. 2016: Prostate-specific antigen doubling-time (PSA DT) before onset of chemotherapy as survival predictor for hormone refractory prostate cancer (HRPC) patients. Journal of Clinical Oncology 23(16_Suppl): 4551-4551
Kim, M.; Lee, J.; Jeong, C.W.; Ku, J.H.; Kim, H.H.; Kwak, C. 2015: Prostate-specific antigen kinetic profiles during androgen deprivation therapy as prognostic factors in castration-resistant prostate cancer. Urologic Oncology 33(5): 203.E1-9
Park, Y.H.; Choi, I.Y.; Yoon, S.C.; Jang, H.S.; Moon, H.W.; Hong, S.-H.; Kim, S.W.; Hwang, T.-K.; Lee, J.Y. 2015: Prostate-specific antigen kinetics after primary stereotactic body radiation therapy using CyberKnife for localized prostate cancer. Prostate International 3(1): 6-9
Kim, H.J.; Phak, J.H.; Kim, W.C. 2015: Prostate-specific antigen kinetics after stereotactic body radiotherapy as monotherapy or boost after whole pelvic radiotherapy for localized prostate cancer. Prostate International 3(4): 118-122
Kim, H.J.; Phak, J.H.; Kim, W.C. 2017: Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost and whole pelvic radiotherapy for intermediate- and high-risk prostate cancer. Asia-Pacific Journal of Clinical Oncology 13(1): 21-27
Phak, J.Hoon.; Kim, H.Jung.; Kim, W.Chul. 2016: Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy boost as post-external beam radiotherapy versus conventionally fractionated external beam radiotherapy for localized prostate cancer. Prostate International 4(1): 25-29
Lee, S.Ho.; Kim, H.Jung.; Kim, W.Chul. 2016: Prostate-specific antigen kinetics following hypofractionated stereotactic body radiotherapy versus conventionally fractionated external beam radiotherapy for low- and intermediate-risk prostate cancer. Asia-Pacific Journal of Clinical Oncology 12(4): 388-395
Mithal, P.; Howard, L.E.; Aronson, W.J.; Kane, C.J.; Cooperberg, M.R.; Terris, M.K.; Amling, C.L.; Freedland, S.J. 2015: Prostate-specific antigen level, stage or Gleason score: which is best for predicting outcomes after radical prostatectomy, and does it vary by the outcome being measured? Results from Shared Equal Access Regional Cancer Hospital database. International Journal of Urology: Official Journal of the Japanese Urological Association 22(4): 362-366
Choi, W.S.; Heo, N.J.; Paick, J.-S.; Son, H. 2016: Prostate-specific antigen lowering effect of metabolic syndrome is influenced by prostate volume. International Journal of Urology: Official Journal of the Japanese Urological Association 23(4): 299-304
Tsumura, H.; Satoh, T.; Ishiyama, H.; Tabata, K.-I.; Komori, S.; Sekiguchi, A.; Ikeda, M.; Kurosaka, S.; Fujita, T.; Kitano, M.; Hayakawa, K.; Iwamura, M. 2016: Prostate-specific antigen nadir after high-dose-rate brachytherapy predicts long-term survival outcomes in high-risk prostate cancer. Journal of Contemporary BrachyTherapy 8(2): 95-103
Kovalainen, E.; Vaarala, M.H. 2016: Prostate-specific antigen nadir concentration, hypertension and diabetes as risk factors for biochemical failure after permanent 125i seed brachytherapy for prostate cancer. Molecular and Clinical Oncology 5(5): 647-650
Joob, B.; Wiwanitkit, V. 2015: Prostate-specific antigen obtained from fresh and dried urine. Urology Annals 7(1): 128
Simpkin, A.J.; Donovan, J.L.; Tilling, K.; Athene Lane, J.; Martin, R.M.; Albertsen, P.C.; Bill-Axelson, A.; Ballentine Carter, H.; Bosch, J.L.H.R.; Ferrucci, L.; Hamdy, F.C.; Holmberg, L.; Jeffrey Metter, E.; Neal, D.E.; Parker, C.C.; Metcalfe, C. 2016: Prostate-specific antigen patterns in US and European populations: comparison of six diverse cohorts. Bju International 118(6): 911-918
Wiegel, T.; Bartkowiak, D.; Bottke, D.; Thamm, R.; Hinke, A.; Stöckle, M.; Rübe, C.; Semjonow, A.; Wirth, M.; Störkel, S.; Golz, R.; Engenhart-Cabillic, R.; Hofmann, R.; Feldmann, H.-J.ür.; Kälble, T.; Siegmann, A.; Hinkelbein, W.; Steiner, U.; Miller, K. 2015: Prostate-specific antigen persistence after radical prostatectomy as a predictive factor of clinical relapse-free survival and overall survival: 10-year data of the ARO 96-02 trial. International Journal of Radiation Oncology Biology Physics 91(2): 288-294
Wirth, M.P.; Froehner, M. 2015: Prostate-specific antigen pox virus vaccination for recurrent prostate cancer. European Urology 68(3): 372-373
Arab, D.; Ardestani Zadeh, A.; Mirmohammadkhani, M.; Beiglarzadeh, A. 2016: Prostate-specific antigen rising in Iranian men in correlation with body mass index, fasting blood sugar and blood lipid profile. Journal of Nephropathology 5(4): 134-138
Gin, G.E.; Pereira, J.F.; Weinberg, A.D.; Mehrazin, R.; Lerner, S.M.; Sfakianos, J.P.; Phillips, C.K. 2016: Prostate-specific antigen screening and prostate cancer treatment in renal transplantation candidates: a survey of U.S. transplantation centers. Urologic Oncology 34(2): 57.E9
Valberg, M.; Grotmol, T.; Tretli, S.; Veierød, M.B.; Moger, T.A.; Devesa, S.S.; Aalen, O.O. 2017: Prostate-specific antigen testing for prostate cancer: Depleting a limited pool of susceptible individuals?. European Journal of Epidemiology 32(6): 511-520
Nderitu, P.; Van Hemelrijck, M.; Ashworth, M.; Mathur, R.; Hull, S.; Dudek, A.; Chowdhury, S. 2016: Prostate-specific antigen testing in inner London general practices: are those at higher risk most likely to get tested?. Bmj Open 6(7): E011356
Zambon, Jão.Paulo.; Almeida, F.G.; Conceição, R.Dilguerian.O.; Tabone, V.Arevalo.; Kashiwagi, N.Miwa.; Ross, C.L.; Carvalho, Jé.Antônio.Maluf.de. 2014: Prostate-specific antigen testing in men between 40 and 70 years in Brazil: database from a check-up program. International Braz J Urol: Official Journal of the Brazilian Society of Urology 40(6): 745-752
Moss, S.; Melia, J.; Sutton, J.; Mathews, C.; Kirby, M. 2016: Prostate-specific antigen testing rates and referral patterns from general practice data in England. International Journal of Clinical Practice 70(4): 312-318
Albertsen, P.C. 2015: Prostate-specific antigen testing: good or bad?. Oncologist 20(3): 233-235
D'Amico, A.V.; Cullen, J.; Chen, Y.; McLeod, D.G. 2016: Prostate-specific antigen velocity and the odds of detecting gleason 8 to 10 prostate cancer at biopsy. Journal of Clinical Oncology 24(18_Suppl): 4567-4567
Gorday, W.; Sadrzadeh, H.; de Koning, L.; Naugler, C.T. 2015: Prostate-specific antigen velocity is not better than total prostate-specific antigen in predicting prostate biopsy diagnosis. Clinical Biochemistry 48(18): 1230-1234
Dickinson, L.; Ahmed, H.U.; Hindley, R.G.; McCartan, N.; Freeman, A.; Allen, C.; Emberton, M.; Kirkham, A.P. 2017: Prostate-specific antigen vs. magnetic resonance imaging parameters for assessing oncological outcomes after high intensity-focused ultrasound focal therapy for localized prostate cancer. Urologic Oncology 35(1): 30.E9-30.E15
Kitagawa, Y.; Namiki, M. 2015: Prostate-specific antigen-based population screening for prostate cancer: current status in Japan and future perspective in Asia. Asian Journal of Andrology 17(3): 475-480
Alberts, A.R.; Schoots, I.G.; Roobol, M.J. 2015: Prostate-specific antigen-based prostate cancer screening: past and future. International Journal of Urology: Official Journal of the Japanese Urological Association 22(6): 524-532
Kim, E.H.; Andriole, G.L. 2015: Prostate-specific antigen-based screening: controversy and guidelines. Bmc Medicine 13: 61
Perico, M.E.; Grasso, S.; Brunelli, M.; Martignoni, G.; Munari, E.; Moiso, E.; Fracasso, G.; Cestari, T.; Naim, H.Y.; Bronte, V.; Colombatti, M.; Ramarli, D. 2016: Prostate-specific membrane antigen (PSMA) assembles a macromolecular complex regulating growth and survival of prostate cancer cells "in vitro" and correlating with progression "in vivo". Oncotarget 7(45): 74189-74202
Conway, R.E.; Rojas, C.; Alt, J.; Nováková, Z.; Richardson, S.M.; Rodrick, T.C.; Fuentes, J.L.; Richardson, N.H.; Attalla, J.; Stewart, S.; Fahmy, B.; Barinka, C.; Ghosh, M.; Shapiro, L.H.; Slusher, B.S. 2016: Prostate-specific membrane antigen (PSMA)-mediated laminin proteolysis generates a pro-angiogenic peptide. Angiogenesis 19(4): 487-500
Kiess, A.P.; Banerjee, S.R.; Mease, R.C.; Rowe, S.P.; Rao, A.; Foss, C.A.; Chen, Y.; Yang, X.; Cho, S.Y.; Nimmagadda, S.; Pomper, M.G. 2015: Prostate-specific membrane antigen as a target for cancer imaging and therapy. Quarterly Journal of Nuclear Medicine and Molecular Imaging: Official Publication of the Italian Association of Nuclear Medicine and the International Association of Radiopharmacology and Section of the Society Of. 59(3): 241-268
Bouchelouche, K.; Choyke, P.L. 2016: Prostate-specific membrane antigen positron emission tomography in prostate cancer: a step toward personalized medicine. Current Opinion in Oncology 28(3): 216-221
Pu, F.; Salarian, M.; Xue, S.; Qiao, J.; Feng, J.; Tan, S.; Patel, A.; Li, X.; Mamouni, K.; Hekmatyar, K.; Zou, J.; Wu, D.; Yang, J.J. 2016: Prostate-specific membrane antigen targeted protein contrast agents for molecular imaging of prostate cancer by MRi. Nanoscale 8(25): 12668-12682
Demirkol, M.O.; Acar, Öm.; Uçar, B.; Ramazanoğlu, S.R.; Sağlıcan, Y.şi.; Esen, T.ık. 2015: Prostate-specific membrane antigen-based imaging in prostate cancer: impact on clinical decision making process. Prostate 75(7): 748-757
Maurer, T.; Weirich, G.; Schottelius, M.; Weineisen, M.; Frisch, B.; Okur, A.; Kübler, H.; Thalgott, M.; Navab, N.; Schwaiger, M.; Wester, H.-J.ür.; Gschwend, J.ür.E.; Eiber, M. 2015: Prostate-specific membrane antigen-radioguided surgery for metastatic lymph nodes in prostate cancer. European Urology 68(3): 530-534
Stuart, C.H.; Singh, R.; Smith, T.L.; D'Agostino, R.; Caudell, D.; Balaji, K.C.; Gmeiner, W.H. 2016: Prostate-specific membrane antigen-targeted liposomes specifically deliver the Zn(2+) chelator TPEN inducing oxidative stress in prostate cancer cells. Nanomedicine 11(10): 1207-1222
Mata, C.; Walker, P.M.; Oliver, A.; Brunotte, F.ço.; Martí, J.; Lalande, A. 2016: ProstateAnalyzer: Web-based medical application for the management of prostate cancer using multiparametric MR imaging. Informatics for Health and Social Care 41(3): 286-306
Ferretti, M.; Phillips, J. 2015: Prostatectomy for benign prostate disease: open, laparoscopic and robotic techniques. Canadian Journal of Urology 22(Suppl 1): 60-66
De Bari, B.; Zietman, A.L.; Poortmans, P. 2016: Prostatectomy vs radiation therapy for prostate cancer: the (still) unsolved dilemma. RadioTherapy and Oncology: Journal of the European Society for Therapeutic Radiology and Oncology 119(2): 368
Franchini, F.; Borsari, M.; Frigieri, F.; Castanò, C.; Voci, C. 2015: Prostatectomy: a Comparison of Cost-Benefit Analysis Between Open Surgery and Robotic Techniques. Value in Health 18(7): A452
Simpson, P. 2015: Prostatectomy: information provision and education for patients. British Journal of Nursing 24(9): S24-S28
Kirschenbaum, A.; Izadmehr, S.; Yao, S.; O'Connor-Chapman, K.L.; Huang, A.; Gregoriades, E.M.; Yakar, S.; Levine, A.C. 2016: Prostatic Acid Phosphatase Alters the RANKL/OPG System and Induces Osteoblastic Prostate Cancer Bone Metastases. Endocrinology 157(12): 4526-4533
Skala, S.L.; Owens, S.R.; Xiao, H.; Bauman, K.A.; Tomlins, S.A.; Chinnaiyan, A.M.; Shao, L.; Jentzen, J.M.; Gordon, D.; Mehra, R. 2016: Prostatic Adenocarcinoma With Hormone Exposure Related Changes in a Patient With Hepatic Cirrhosis - Value of Autopsy in a Case Report. Urology Case Reports 9: 37-40
Zhou, M.; Magi-Galluzzi, C. 2008: Prostatic Adenocarcinoma, Prostatic Intraepithelial Neoplasia, and Intraductal Carcinoma. Surgical Pathology Clinics 1(1): 43-75
Feng, S.; Tian, Y.; Liu, W.; Li, Z.; Deng, T.; Li, H.; Wang, K. 2017: Prostatic Arterial Embolization Treating Moderate-to-Severe Lower Urinary Tract Symptoms Related to Benign Prostate Hyperplasia: a Meta-Analysis. Cardiovascular and Interventional Radiology 40(1): 22-32
Bilhim, T.; Bagla, S.; Sapoval, M.; Carnevale, F.Cesar.; Salem, R.; Golzarian, J. 2015: Prostatic Arterial Embolization versus Transurethral Resection of the Prostate for Benign Prostatic Hyperplasia. Radiology 276(1): 310-311
Russo, G.I.; Kurbatov, D.; Sansalone, S.; Lepetukhin, A.; Dubsky, S.; Sitkin, I.; Salamone, C.; Fiorino, L.; Rozhivanov, R.; Cimino, S.; Morgia, G. 2015: Prostatic Arterial Embolization vs Open Prostatectomy: a 1-Year Matched-pair Analysis of Functional Outcomes and Morbidities. Urology 86(2): 343-348
Li, Q.; Duan, F.; Wang, M-Qiang.; Zhang, G-Dong.; Yuan, K. 2015: Prostatic Arterial Embolization with Small Sized Particles for the Treatment of Lower Urinary Tract Symptoms Due to Large Benign Prostatic Hyperplasia: Preliminary Results. Chinese Medical Journal 128(15): 2072-2077
Sun, F.; Crisóstomo, V.ón.; Báez-Díaz, C.; Sánchez, F.M. 2016: Prostatic Artery Embolization (PAE) for Symptomatic Benign Prostatic Hyperplasia (BPH): Part 1, Pathological Background and Clinical Implications. Cardiovascular and Interventional Radiology 39(1): 1-7
Sun, F.; Crisóstomo, V.ón.; Báez-Díaz, C.; Sánchez, F.M. 2016: Prostatic Artery Embolization (PAE) for Symptomatic Benign Prostatic Hyperplasia (BPH): Part 2, Insights into the Technical Rationale. Cardiovascular and Interventional Radiology 39(2): 161-169
Bhatia, S.S.; Dalal, R.; Gomez, C.; Narayanan, G. 2016: Prostatic Artery Embolization After Failed Urological Interventions for Benign Prostatic Obstruction: a Case Series of Three Patients. Cardiovascular and Interventional Radiology 39(8): 1203-1208
Isaacson, A.J.; Raynor, M.C.; Yu, H.; Burke, C.T. 2016: Prostatic Artery Embolization Using Embosphere Microspheres for Prostates Measuring 80-150 cm(3): Early Results from a US Trial. Journal of Vascular and Interventional Radiology: Jvir 27(5): 709-714
Kably, I.; Dupaix, R. 2016: Prostatic Artery Embolization and the Accessory Pudendal Artery. Journal of Vascular and Interventional Radiology: Jvir 27(8): 1266-1268
Gabr, A.H.; Gabr, M.F.; Elmohamady, B.N.; Ahmed, A.-F. 2016: Prostatic Artery Embolization: a Promising Technique in the Treatment of High-Risk Patients with Benign Prostatic Hyperplasia. Urologia Internationalis 97(3): 320-324
Takai, T.; Inamoto, T.; Komura, K.; Tsujino, T.; Matsunaga, T.; Yoshikawa, Y.; Uchimoto, T.; Saito, K.; Tanda, N.; Minami, K.; Uehara, H.; Ibuki, N.; Takahara, K.; Nomi, H.; Kiyama, S.; Azuma, H. 2016: Prostatic Bleeding after Prostatic Biopsy Effects Oncological Outcomes with Laparoscopic Radical Prostatectomy. Asian Pacific Journal of Cancer Prevention: Apjcp 17(3): 1373-1377
Hooda, A.K.; Sanga, S.; Raychaudhury, N.; Narula, A.S. 2006: Prostatic Cyst : Association with Autosomal Dominant Polycystic Kidney Disease. Medical Journal Armed Forces India 62(3): 273-274
Ringoir, A.; Rappe, B.; Dhaene, K.; Schallier, D. 2016: Prostatic Leiomyoma: A Case Report. Urology Case Reports 9: 45-47
Matsuyama, S.; Nohara, T.; Kawaguchi, S.; Seto, C.; Nakanishi, Y.; Uchiyama, A.; Ishizawa, S. 2015: Prostatic Stromal Tumor of Uncertain Malignant Potential which Was Difficult to Diagnose. Case Reports in Urology 2015: 879584
Costa, N.V.; Pereira, J.é; Fernandes, L.úc.; Bilhim, T.; Pisco, J.ão.M. 2016: Prostatic Tissue Expulsion after Prostatic Artery Embolization. Journal of Vascular and Interventional Radiology: Jvir 27(4): 601-603
Gratzke, C.; Barber, N.; Speakman, M.J.; Berges, R.; Wetterauer, U.; Greene, D.; Sievert, K-Dietrich.; Chapple, C.R.; Patterson, J.M.; Fahrenkrug, L.; Schoenthaler, M.; Sonksen, J. 2017: Prostatic urethral lift vs transurethral resection of the prostate: 2-year results of the BPH6 prospective, multicentre, randomized study. Bju International 119(5): 767-775
Jones, P.; Rai, B.P.; Aboumarzouk, O.M.; Somani, B.K. 2016: Prostatic Urethral Lift Vs Prostate Arterial Embolization: Novel Nonablative Strategies in the Management of Lower Urinary Tract Symptoms Secondary to Benign Prostate Hyperplasia. Urology 87: 11-17
Bozkurt, A.; Karabakan, M.; Keskin, E.; Hirik, E.; Balci, M.B.C.; Nuhoglu, B. 2016: Prostatic Urethral Lift: a new Minimally Invasive Treatment for Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Urologia Internationalis 96(2): 202-206
Roehrborn, C.G. 2016: Prostatic Urethral Lift: a Unique Minimally Invasive Surgical Treatment of Male Lower Urinary Tract Symptoms Secondary to Benign Prostatic Hyperplasia. Urologic Clinics of North America 43(3): 357-369
Liang, K.; Guo, W. 2015: Prostatic abscess caused by Mycobacterium tuberculosis and Escherichia coli in a patient with acquired immunodeficiency syndrome. American Journal of the Medical Sciences 350(2): 153-154
Kadoya, Y.; Kenzaka, T. 2016: Prostatic abscess in a patient with ST-elevation myocardial infarction: a case report. Bmc Cardiovascular Disorders 16: 48
Tolosa-Alvarez, A.B.; Romero-Requena, J.M.; Merchan-Cuenda, M. 2016: Prostatic abscess: Clinical case and a literature review. Semergen 42(4): 280-282
Elshal, A.M.; Abdelhalim, A.; Barakat, T.S.; Shaaban, A.A.; Nabeeh, A.; Ibrahiem, E-Housseiny. 2014: Prostatic abscess: Objective assessment of the treatment approach in the absence of guidelines. Arab Journal of Urology 12(4): 262-268
Doreswamy, K.; Karthikeyan, V.S.; Nagabhushana, M.; Shankaranand, B. 2015: Prostatic adenocarcinoma presenting as isolated inguinal lymphadenopathy. BMJ Case Reports
Zhang, J.; Dong, M.; Hu, X.; Liu, L.; Li, S.; Li, C.; Yang, L.; Xiao, Y.; Pang, S.; Wang, C. 2016: Prostatic adenocarcinoma presenting with metastases to the testis and epididymis: A case report. Oncology Letters 11(1): 792-794
Çakmak, Öz.ür.; Tarhan, H.üs.; Küçük, Ül.ü; İlbey, Y.Öz. 2015: Prostatic adenocarcinoma with initial metastatic spread to the mandible. Turkish Journal of Urology 41(3): 149-151
Zhao, M.; Teng, X.D.; He, X.L.; Cao, D.F. 2016: Prostatic adenocarcinoma: update on 2014 International Society of Urological Pathology Gleason grading system and new prognostic grading groups. Zhonghua Bing Li Xue Za Zhi 45(10): 673-675
Montico, F.; Kido, L.A.; Hetzl, A.C.; Cagnon, V.ér.H.A. 2015: Prostatic angiogenic responses in late life: antiangiogenic therapy influences and relation with the glandular microenvironment in the transgenic adenocarcinoma of mouse prostate (TRAMP) model. Prostate 75(5): 484-499
Yan, W.-h.; Zhang, C.; Al, G.-p.; Shu, Y. 2015: Prostatic arterial embolization for benign prostatic hyperplasia in high-risk aged males. Zhonghua Nan Ke Xue 21(10): 900-903
Wang, M.; Guo, L.; Duan, F.; Yuan, K.; Zhang, G.; Li, K.; Yan, J.; Wang, Y.; Kang, H.; Wang, Z. 2015: Prostatic arterial embolization for the treatment of lower urinary tract symptoms as a result of large benign prostatic hyperplasia: a prospective single-center investigation. International Journal of Urology: Official Journal of the Japanese Urological Association 22(8): 766-772
Wang, M.; Guo, L.; Duan, F.; Yuan, K.; Zhang, G.; Li, K.; Yan, J.; Wang, Y.; Kang, H. 2016: Prostatic arterial embolization for the treatment of lower urinary tract symptoms caused by benign prostatic hyperplasia: a comparative study of medium- and large-volume prostates. Bju International 117(1): 155-164
Wang, M.Q.; Guo, L.P.; Zhang, G.D.; Yuan, K.; Li, K.; Duan, F.; Yan, J.Y.; Wang, Y.; Kang, H.Y.; Wang, Z.J. 2015: Prostatic arterial embolization for the treatment of lower urinary tract symptoms due to large (>80 mL) benign prostatic hyperplasia: results of midterm follow-up from Chinese population. Bmc Urology 15: 33
Wang, M.Q.; Wang, Y.; Yan, J.Y.; Yuan, K.; Zhang, G.D.; Duan, F.; Li, K. 2016: Prostatic artery embolization for the treatment of symptomatic benign prostatic hyperplasia in men ≥75 years: a prospective single-center study. World Journal of Urology 34(9): 1275-1283
De Assis, A.é M.; Moreira, A.M.; de Paula Rodrigues, V.C.; Yoshinaga, E.M.; Antunes, A.A.; Harward, S.H.; Srougi, M.; Carnevale, F.C. 2015: Prostatic artery embolization for treatment of benign prostatic hyperplasia in patients with prostates > 90 g: a prospective single-center study. Journal of Vascular and Interventional Radiology: Jvir 26(1): 87-93
Teoh, J.Y.C.; Chiu, P.K.F.; Yee, C.-H.; Wong, H.-M.; Chan, C.-K.; Chan, E.S.Y.; Hou, S.S.M.; Ng, C.-F. 2017: Prostatic artery embolization in treating benign prostatic hyperplasia: a systematic review. International Urology and Nephrology 49(2): 197-203
Garzón, W.J.; Andrade, G.; Dubourcq, F.; Abud, D.G.; Bredow, M.; Khoury, H.J.; Kramer, R. 2016: Prostatic artery embolization: radiation exposure to patients and staff. Journal of Radiological Protection: Official Journal of the Society for Radiological Protection 36(2): 246-254
De Beule, T.; Carels, K.; Tejpar, S.; Van Cleynenbreugel, B.; Oyen, R.; Maleux, G. 2015: Prostatic biopsy-related rectal bleeding refractory to medical and endoscopic therapy definitively managed by catheter-directed embolotherapy: a case report. Journal of Medical Case Reports 9: 242
Rodríguez-Patrón, R.; González Gordaliza, C.; Sanz-Mayayo, E.; Burgos Revilla, F.J. 2016: Prostatic biopsy: from organ biopsy to lesion biopsy. the role of MRi and MRi based biopsy systems. Archivos Espanoles de Urologia 69(3): 101-116
Lechien, Jérôme.Rene.; Doyen, J.; Khalife, M.; Saussez, S. 2020: Prostatic carcinoma metastatic to frontal and cavernous sinuses: a case report. Brazilian Journal of Otorhinolaryngology 86(3): 383-385
Al Nemer, A.M.; Aldamanhori, R.B. 2015: Prostatic diseases under focus in a university hospital in Eastern Saudi Arabia. A 15-year experience. Saudi Medical Journal 36(11): 1319-1323
Gladwish, A.; Pang, G.; Cheung, P.; D'Alimonte, L.; Deabreu, A.; Loblaw, A. 2014: Prostatic displacement during extreme hypofractionated radiotherapy using volumetric modulated arc therapy (VMAT). Radiation Oncology 9: 262
Gulavita, P.; Hakim, S.W.; Schieda, N.; Breau, R.H.; Morash, C.; Keefe, D.T.; Robertson, S.J.; Mai, K.T.; Belanger, E.C.; Flood, T.A. 2015: Prostatic ductal adenocarcinoma: An aggressive variant that is underdiagnosed and undersampled on transrectal ultrasound (TRUS)-guided needle biopsy. Canadian Urological Association Journal 9(9-10): 302-306
Lacetera, V.; Cardinali, M.; Mantello, G.; Fenu, F.; Sbrollini, G.; Tombolini, F.; Conti, A.; Maggi, S.; Muzzonigro, G.; Galosi, A.B. 2014: Prostatic fiducial markers implantation by transrectal ultrasound for adaptive image guided radiotherapy in localized cancer: 7-years experience. Archivio Italiano di Urologia Andrologia: Organo Ufficiale di Societa Italiana di Ecografia Urologica e Nefrologica 86(4): 349-352
El Abiad, Y.; Alami, M. 2015: Prostatic fossa calculus. Pan African Medical Journal 21: 236
Kumar, S.; Yadav, R.Niwas.; Gupta, P.; Gaspar, B.Louis.; Kakkar, N.; Verma, A.; Parthan, G.; Bhansali, A.; Mukherjee, K.K.; Korbonits, Márta.; Dutta, P. 2015: Prostatic hyperplasia in acromegaly, a myth or reality: a case-control study. European Journal of Endocrinology 173(2): X1
Lee, S.; Yang, G.; Bushman, W. 2015: Prostatic inflammation induces urinary frequency in adult mice. Plos one 10(2): E0116827
Liu, Y.-j.; Song, G.-h.; Zhang, C. 2015: Prostatic inflammation-induced chronic pelvic pain: Roles of substance P and c-fos in the spinal cord. Zhonghua Nan Ke Xue 21(8): 681-686
Tan, G.; Li, J.; Chen, L.; Chen, X.; Zhang, S.; Ke, L.; Liu, J. 2015: Prostatic melioidosis rarely reported in China: two cases report and literatures review. International Journal of Clinical and Experimental Medicine 8(11): 21830-21832
Li, Y.; An, W.; Wei, W.; Liu, M.; Wang, G.; Wang, X. 2015: Prostatic metastases and polycythemia vera on bone magnetic resonance imaging: A case report. Oncology Letters 9(3): 1317-1320
Janowitz, T.; Welsh, S.; Warren, A.Y.; Robson, J.; Thomas, B.; Shaw, A.; Ainsworth, N.L.; Neal, D.E.; Mazhar, D. 2015: Prostatic relapse of an undifferentiated teratoma 24 years after orchidectomy. Bmc Research Notes 8: 524
Dellavedova, T. 2016: Prostatic specific antigen. from its early days until becoming a prostate cancer biomarker. Archivos Espanoles de Urologia 69(1): 19-23
Cavaliere, E.; Alaggio, R.; Castagnetti, M.; Scarzello, G.; Bisogno, G. 2014: Prostatic stromal sarcoma in an adolescent: the role of chemotherapy. Rare Tumors 6(4): 5607
Perera, M.; Roberts, M.J.; Doi, S.A.R.; Bolton, D. 2015: Prostatic urethral lift improves urinary symptoms and flow while preserving sexual function for men with benign prostatic hyperplasia: a systematic review and meta-analysis. European Urology 67(4): 704-713
Garcia, C.; Chin, P.; Rashid, P.; Woo, H.H. 2015: Prostatic urethral lift: a minimally invasive treatment for benign prostatic hyperplasia. Prostate International 3(1): 1-5
Rukstalis, D.B. 2015: Prostatic urethral lift: a novel approach for managing symptomatic BPH in the aging man. Canadian Journal of Urology 22(Suppl 1): 67-74
Xu, H.; Liu, C.; Gu, M.; Chen, Y.; Cai, Z.; Chen, Q.; Wang, Z. 2017: Prostatic vascular damage induced by cigarette smoking as a risk factor for recovery after holmium laser enucleation of the prostate (HoLEP). Oncotarget 8(8): 14039-14049
Humphrey, P.A. 2015: Prostatic-type epithelial polyp of the urethra. Journal of Urology 193(6): 2095-2096
Boehm, K.; Valdivieso, R.; Meskawi, M.; Larcher, A.; Schiffmann, J.; Sun, M.; Graefen, M.; Saad, F.; Parent, M.-Él.; Karakiewicz, P.I. 2016: Prostatitis, other genitourinary infections and prostate cancer: results from a population-based case-control study. World Journal of Urology 34(3): 425-430
Patodia, M.; Kumar, M.; Sankhwar, S.; Goel, A.; Singh, S.; Purkait, B. 2015: Prostato-inguinal fistula: An unusual site of voiding. Canadian Urological Association Journal 9(11-12): E821-E822
Sanchez, A.; Rodríguez, D.; Cheng, J-Sian.; McGovern, F.J.; Tabatabaei, S. 2015: Prostato-symphyseal fistula after photoselective vaporization of the prostate: case series and literature review of a rare complication. Urology 85(1): 172-177
Whelan, L.; Mullarkey, E.; Woo, H.H. 2015: Prostatosymphyseal Fistula Treated by Robotic Assisted Radical Prostatectomy. Case Reports in Urology 2015: 582705
Plateau, B.; Ruivard, M.; Montoriol, P-François. 2015: Prostatosymphyseal fistula and osteomyelitis pubis following transurethral resection of the prostate: CT and MRI findings. Journal of Medical Imaging and Radiation Oncology 59(6): 713-715
Geng, T.; Xia, L.; Russo, S.; Kamara, D.; Cowart, L.A. 2015: Prosteatotic genes are associated with unsaturated fat suppression of saturated fat-induced hepatic steatosis in C57BL/6 mice. Nutrition Research 35(9): 812-822
Tkach, V.V.; Curran, S.S. 2015: Prosthenystera oonastica n. sp. (Digenea: Callodistomidae) from ictalurid catfishes in southeastern United States and molecular evidence differentiating species in the genus across Americas. Systematic Parasitology 90(1): 39-51
Simón-Allué, R.; Hernández-Gascón, B.; Lèoty, L.; Bellón, J.M.; Peña, E.; Calvo, B. 2016: Prostheses size dependency of the mechanical response of the herniated human abdomen. Hernia: the Journal of Hernias and Abdominal Wall Surgery 20(6): 839-848
Bergmeister, K.D.; Hader, M.; Lewis, S.; Russold, M.-F.; Schiestl, M.; Manzano-Szalai, K.; Roche, A.D.; Salminger, S.; Dietl, H.; Aszmann, O.C. 2016: Prosthesis Control with an Implantable Multichannel Wireless Electromyography System for High-Level Amputees: a Large-Animal Study. Plastic and Reconstructive Surgery 137(1): 153-162
Tomšič, A.; Palmen, M.; Versteegh, M.I.M.; van der Kley, F.; Siebelink, H.-M.J.; Berendsen, R.R.; Schalij, M.J. 2016: Prosthesis Dislocation After Transapical Valve-In-Valve Mitral Valve Implantation. Canadian Journal of Cardiology 32(12): 1576.E7-1576.E9
Barbanti, M.; Immè, S.; Ohno, Y.; Gulino, S.; Todaro, D.; Sgroi, C.; Tamburino, C.; Patanè, M.; Pilato, G.; Capodanno, D.; Tamburino, C. 2016: Prosthesis choice for transcatheter aortic valve replacement: Improved outcomes with the adoption of a patient-specific transcatheter heart valve selection algorithm. International Journal of Cardiology 203: 1009-1010
Ackland, D.C.; Patel, M.; Knox, D. 2015: Prosthesis design and placement in reverse total shoulder arthroplasty. Journal of Orthopaedic Surgery and Research 10: 101
Follis, F.; Gandolfo, C.; Santise, G.; Stabile, A.; Benedetto, M.; Cirrincione, G.; Arcadipane, A.; Centineo, L.; Follis, M. 2016: Prosthesis embolization into the left ventricle during transcatheter aortic valve implantation. Journal of Cardiovascular Medicine 17(Suppl 2): E191-E192
Ackland, D.C.; Moskaljuk, A.; Hart, C.; Vee Sin Lee, P.; Dimitroulis, G. 2015: Prosthesis loading after temporomandibular joint replacement surgery: a musculoskeletal modeling study. Journal of Biomechanical Engineering 137(4): 041001
Dou, Q.; Yin, Z.; Sun, L.; Feng, X. 2015: Prosthesis replacement in Mason IIi radial head fractures: a meta-analysis. Orthopaedics and Traumatology Surgery and Research: Otsr 101(6): 729-734
Dahou, A.; Mahjoub, H.ïf.; Pibarot, P. 2016: Prosthesis-Patient Mismatch After Aortic Valve Replacement. Current Treatment Options in Cardiovascular Medicine 18(11): 67
Swinkels, B.M.; de Mol, B.A.; Kelder, J.C.; Vermeulen, F.E.; ten Berg, J.ën.M. 2016: Prosthesis-Patient Mismatch After Aortic Valve Replacement: Effect on Long-Term Survival. Annals of Thoracic Surgery 101(4): 1388-1394
Takagi, H.; Umemoto, T. 2016: Prosthesis-Patient Mismatch After Transcatheter Aortic Valve Implantation. Annals of Thoracic Surgery 101(3): 872-880
Cho, I.J.; Hong, G.R.; Lee, S.H.; Lee, S.; Chang, B.C.; Shim, C.Y.; Chang, H.J.; Ha, J.W.; Chung, N. 2016: Prosthesis-Patient Mismatch after Mitral Valve Replacement: Comparison of Different Methods of Effective Orifice Area Calculation. Yonsei Medical Journal 57(2): 328-336
Oh, J.K.; Zorn, G.L. 2016: Prosthesis-Patient Mismatch: Another Reason for TAVR?. JACC. Cardiovascular Imaging 9(8): 934-936
Stähli, B.E.; Nguyen-Kim, T.D.L.; Gebhard, C.ér.; Erhart, L.; Frauenfelder, T.; Tanner, F.C.; Falk, V.; Landmesser, U.; Nietlispach, F.; Lüscher, T.F.; Maier, W.; Binder, R.K. 2015: Prosthesis-Specific Predictors of Paravalvular Regurgitation after Transcatheter Aortic Valve Replacement: Impact of Calcification and Sizing on Balloon-Expandable versus Self-Expandable Transcatheter Heart Valves. Journal of Heart Valve Disease 24(1): 10-21
Wang, S.; Leng, X.; Zheng, Y.; Zhang, D.; Wu, G. 2015: Prosthesis-guided implant restoration of an auricular defect using computed tomography and 3-dimensional photographic imaging technologies: a clinical report. Journal of Prosthetic Dentistry 113(2): 152-156
Mizia-Stec, K.; Mizia, M.; Sikora-Puz, A.; Gieszczyk-Strózik, K.; Bochenek, T.; Lasota, B.; Chmiel, A.; Chudek, J.; Deja, M.; Płońska-Gościniak, E. 2016: Prosthesis-patient mismatch and left ventricle systolic strain in patients with severe degenerative aortic stenosis, who are undergoing surgical valve replacement. Kardiologia Polska 74(6): 537-546
Kawamoto, N.; Fujita, T.; Hata, H.; Shimahara, Y.; Sato, S.; Kobayashi, J. 2016: Prosthesis-patient mismatch due to small ring annuloplasty in patients with degenerative mitral insufficiency. Journal of Cardiology 68(2): 141-147
Zorn, G.L.; Little, S.H.; Tadros, P.; Deeb, G.M.; Gleason, T.G.; Heiser, J.; Kleiman, N.S.; Oh, J.K.; Popma, J.J.; Adams, D.; Huang, J.; Reardon, M.J. 2016: Prosthesis-patient mismatch in high-risk patients with severe aortic stenosis: a randomized trial of a self-expanding prosthesis. Journal of Thoracic and Cardiovascular Surgery 151(4): 1014-1022; 1023.E1-3
Shen, J.; Vallera, D.A.; Wagner, C.R. 2015: Prosthetic Antigen Receptors. Journal of the American Chemical Society 137(32): 10108-10111
Virk, H.Ul.Hassan.; Inayat, F.; Farooq, S.; Ghani, A.Raza.; Mirrani, G.A.; Athar, M.Waqas. 2016: Prosthetic Aortic Valve Endocarditis with Left Main Coronary Artery Embolism: A Case Report and Review of the Literature. North American Journal of Medical Sciences 8(6): 259-262
Lee, C.Y.; Wong, J.K.; Ross, R.E.; Liu, D.C.; Khabbaz, K.R.; Martellaro, A.J.; Gorea, H.R.; Sauer, J.S.; Knight, P.A. 2016: Prosthetic Aortic Valve Fixation Study: 48 Replacement Valves Analyzed Using Digital Pressure Mapping. Innovations 11(5): 327-336
Ramagiri-Vinod, N.; Tahir, H.; Narukonda, S.; Joshi, M. 2016: Prosthetic Arteriovenous Graft Contact Dermatitis Masquerading as an Arteriovenous Graft Infection in a Hemodialysis Patient. Journal of Investigative Medicine High Impact Case Reports 4(3): 2324709616658311
Vitale, M.A.; Fruth, K.M.; Rizzo, M.; Moran, S.L.; Kakar, S. 2015: Prosthetic Arthroplasty Versus Arthrodesis for Osteoarthritis and Posttraumatic Arthritis of the Index Finger Proximal Interphalangeal Joint. Journal of Hand Surgery 40(10): 1937-1948
Nahabedian, M.Y. 2016: Prosthetic Breast Reconstruction with Acellular Dermal Matrices: Achieving Predictability and Reproducibility. Plastic and Reconstructive Surgery. Global Open 4(5): E698
Engelhardt, F.; Zeman, F.; Behr, M.; Hahmel, S. 2016: Prosthetic Complications and Maintenance Requirements in Locator-attached Implant-Supported Overdentures: A Retrospective Study. European Journal of Prosthodontics and Restorative Dentistry 24(1): 31-35
Kamble, V.B. 2014: Prosthetic Correction of Postenucleation Socket Syndrome: A Case Report. Journal of Indian Prosthodontic Society 14(Suppl. 1): 172-176
Kennedy, C.D.; Huang, J.I. 2016: Prosthetic Design in Total Wrist Arthroplasty. Orthopedic Clinics of North America 47(1): 207-218
Martinez, R.M.; Bowen, T.R.; Foltzer, M.A. 2016: Prosthetic Device Infections. Microbiology Spectrum 4(4)
García-País, Mía.José.; Rabuñal, Rón.; Alonso, Mía.Pilar.; Corredoira, J. 2015: Prosthetic Endocarditis Caused by Streptococcus bovis Group. Clinical infectious diseases: an official publication of the Infectious Diseases Society of America 61(7): 1204-1206
Stull, M.C.; Clemens, M.S.; Heafner, T.A.; Watson, J.D.B.; Arthurs, Z.M.; Propper, B.W. 2016: Prosthetic Graft Patency in the Setting of a Polymicrobial Infection in Swine (Sus scrofa). Annals of Vascular Surgery 36: 265-272
Kao, F.-C.; Hsu, Y.-C.; Chen, W.-H.; Lin, J.-N.; Lo, Y.-Y.; Tu, Y.-K. 2017: Prosthetic Joint Infection Following Invasive Dental Procedures and Antibiotic Prophylaxis in Patients with Hip or Knee Arthroplasty. Infection Control and Hospital Epidemiology 38(2): 154-161
Gregg, R.D.; Martin, A.E. 2016: Prosthetic Leg Control in the Nullspace of Human Interaction. Proceedings of the . American Control Conference. American Control Conference 2016: 4814-4821
Abdulhadi, L.Mahmoud. 2014: Prosthetic Management and Analysis of Combined Extraoral-Intraoral Maxillofacial Defects Complicated with Microstomia. A Report of Three Cases. European Journal of Prosthodontics and Restorative Dentistry 22(4): 167-173
Rilo, B.; Fernández-Formoso, N.; DaSilva, L.; Pinho, J.âo.C.; Lago, L. 2015: Prosthetic Management for a Palatal Perforation from Cocaine Abuse. Journal of Prosthodontics: Official Journal of the American College of Prosthodontists 24(7): 586-588
Pinto, A.S.B.; Conceição Pinto, M.E.S.; Melo do Val, C.; Costa Oliveira, L.; Costa de Aquino, C.; Vasconcelos, D.F.P. 2016: Prosthetic Management of a Child with Hypohidrotic Ectodermal Dysplasia: 6-Year Follow-Up. Case Reports in Dentistry 2016: 2164340
Fernandez, T.; Karunakaran, H.; Rodrigues, S.Virginia. 2016: Prosthetic Management of a Nasal Septal Defect using a Custom Made Unilateral Intranasal Stent: A Case Report. Journal of Clinical and Diagnostic Research: Jcdr 10(8): Zd33-Zd34
Bernstein, F. 2015: Prosthetic Manhood in the Soviet Union at the End of World War Ii. Osiris 30: 113-133
Tatar, C.; Tüzün, İs.S.; Karşıdağ, T.; Kızılkaya, M.C.; Yılmaz, E. 2016: Prosthetic Mesh Repair for Incarcerated Inguinal Hernia. Balkan Medical Journal 33(4): 434-440
Burke, M.J.; Parente, E.J. 2016: Prosthetic Mesh for Obliteration of the Nephrosplenic Space in Horses: 26 Clinical Cases. Veterinary Surgery: Vs 45(2): 201-207
Essandoh, M.; Humeidan, M.; Castellon-Larios, K.; George, B.; Zuleta-Alarcon, A.; Daoud, E.G. 2015: Prosthetic Mitral Perivalvular Defect Occlusion with Multiple Amplatzer Devices Using 3D Transesophageal Echocardiography and Fluoroscopic Guidance. Journal of Cardiothoracic and Vascular Anesthesia 29(4): 1029-1032
Maragiannis, D.; Gramze, N.; Ramlawi, B.; Little, S.H. 2015: Prosthetic Mitral Valve Thrombosis. Methodist Debakey Cardiovascular Journal 11(3): 195
Tannure, P.N.; Moraes, G.G.; Borba, M.; Abrahão, A.; Andrade, M.; Fidalgo, T. 2015: Prosthetic Oral Rehabilitation of a Child With S-ECC: A Case Report with Histopathologic Analysis. Journal of Clinical Pediatric Dentistry 39(5): 410-414
Schroeter, T.; Lurz, P.; Kiefer, P.; Wehbe, M.; Dähnert, I. 2015: Prosthetic Pulmonary Valve Stenosis: a Different way to Solve the Problem. Annals of Thoracic Surgery 100(3): 1103-1105
Yoon, H.-I. 2016: Prosthetic Rehabilitation After Fibular Free Flap Surgery of Mandibular Defects in a Patient with Oral Squamous Cell Carcinoma. Journal of Craniofacial Surgery 27(7): E685-E688
Kralovec, M.E.; Houdek, M.T.; Andrews, K.L.; Shives, T.C.; Rose, P.S.; Sim, F.H. 2015: Prosthetic Rehabilitation After Hip Disarticulation or Hemipelvectomy. American Journal of Physical Medicine and Rehabilitation 94(12): 1035-1040
Rehani, U.; Adlakha, V.K.; Chandna, P.; Agarwal, A.; Rana, V.; Malik, P. 2010: Prosthetic Rehabilitation in Marble Bone Disease. International Journal of Clinical Pediatric Dentistry 3(3): 207-210
Picos, A.Monica.; Donca, V.; Picos, A. 2014: Prosthetic Rehabilitation in Partially Edentulous Elders - A Case Report. Clujul Medical 87(3): 203-206
Agrawal, K.K.; Aggarawal, H.; Singh, K. 2014: Prosthetic Rehabilitation of Amputated Thumb: a Simplified Approach. Journal of Indian Prosthodontic Society 14(Suppl 1): 260-263
Chander, K.Subash.; Komala, J.; Reddy, R.; Umair, M.; Rajender, K.; Venkatesh, K. 2015: Prosthetic Rehabilitation of Bilateral External Nasal Valve Area after Nasal Reconstruction for a Congenitally Missing Nose: A Clinical Report. Journal of International Oral Health: Jioh 7(Suppl. 1): 80-82
Dathan, P.C.; Kumar, T.Mohan.; Ravindran, S.; Nair, K.Chandrasekharan.; Kumar, A. 2016: Prosthetic Rehabilitation of Lower Limb with RTV Siliconee Using Prosthodontic Clinical and Laboratory Techniques - A Case Report. Journal of Clinical and Diagnostic Research: Jcdr 10(8): Zd35-Zd37
Janya, S.; Gubrellay, P.; Purwar, A.; Khanna, S. 2014: Prosthetic Rehabilitation of Ocular Defect resulting from Pediatric Retinoblastoma. International Journal of Clinical Pediatric Dentistry 7(3): 209-212
Rolski, D.; Kostrzewa-Janicka, J.; Nieborak, R.; Przybyłowska, D.; Stopa, Z.; Mierzwińska-Nastalska, E. 2016: Prosthetic Rehabilitation of Patients After Surgical Treatment of Maxillary Tumors with Respect to Upper Airway Protection. Advances in Experimental Medicine and Biology 885: 83-88
Shakya, P.; Chotprasert, N.; Srithavaj, T. 2016: Prosthetic Rehabilitation of Squamous Cell Carcinoma of Orbit: A Clinical Report. Journal of Clinical and Diagnostic Research: Jcdr 10(8): Zj16-Zj17
Artopoulou, I.Ioanna.; Lemon, J.C. 2016: Prosthetic Rehabilitation of a Complex Maxillofacial Defect as an Alternative to Surgical Reconstruction: A Case History Report. International Journal of Prosthodontics 29(3): 227-229
Moretto, G.; Pupo, Y.M.; Bueno, A.L.N.; Araujo, F.O. 2016: Prosthetic Rehabilitation of a Patient with Gastroesophageal Reflux Disease: Five-Year Follow-up. Operative Dentistry 41(2): 132-137
Raju, M.; Shetty, M.; Prasad D, K. 2014: Prosthetic Rehabilitation of a Patient with Congenitally Deformed Ears. Journal of Indian Prosthodontic Society 14(Suppl 1): 264-267
Putanikar, N.Y.; Patil, A.G.; Shetty, P.K.; Nagaral, S.; Mithaiwala, H.I. 2015: Prosthetic Rehabilitation of a Patient with Ocular Defect using Semi-customized Prosthesis: A Case Report. Journal of International Oral Health: Jioh 7(4): 81-84
Mian, S.Z.; Agranat, J.S.; Jacobs, D.S. 2016: Prosthetic Replacement of the Ocular Surface Ecosystem (PROSE) Treatment for Complications After LASIK. Eye and Contact Lens 42(6): 371-373
Chahal, J.S.; Heur, M.; Chiu, G.B. 2017: Prosthetic Replacement of the Ocular Surface Ecosystem Scleral Lens Therapy for Exposure Keratopathy. Eye and Contact Lens 43(4): 240-244
Refatllari, A.; Likaj, E.; Dumani, S. 2016: Prosthetic Subclavian-Aortic Bypass as a Safe Surgical Technique for the Coarctation of the Aorta in Adults. Open Access Macedonian Journal of Medical Sciences 4(1): 47-49
Passia, N.; Kern, M. 2015: Prosthetic Treatment Concepts for the Reduced Dentition in German Dental Schools. International Journal of Prosthodontics 28(4): 425-431
Yokokawa, T.; Ohara, T.; Takashio, S.; Sakamoto, M.; Wada, Y.; Nakamura, K.; Takahama, H.; Amaki, M.; Hasegawa, T.; Sugano, Y.; Kanzaki, H.; Yasuda, S.; Ogawa, H.; Fujita, T.; Kobayashi, J.; Okamoto, Y.; Matsuyama, T.-A.; Ishibashi-Ueda, H.; Anzai, T. 2016: Prosthetic Valve Dysfunction 35 Years after Mitral Valve Replacement with a Starr-Edwards Caged-disc Valve. Internal Medicine 55(5): 479-483
Bartley, P.; Angelakis, E.; Raoult, D.; Sampath, R.; Bonomo, R.A.; Jump, R.L.P. 2016: Prosthetic Valve Endocarditis Caused by Bartonella henselae : A Case Report of Molecular Diagnostics Informing Nonsurgical Management. Open Forum Infectious Diseases 3(4): Ofw202
Stephens, J.L.; Boulemden, A.; Richens, D.; Turner, D.P.J. 2016: Prosthetic Valve Endocarditis Following Dental Extractions. Journal of Cardiac Surgery 31(5): 321-323
Tanioka, H.; Iwata, K.; Marumoto, A.; Kaneko, M. 2015: Prosthetic Valve Endocarditis using Immunosuppressive Agent for Atopic Dermatitis;Report of a Case. Kyobu Geka. Japanese Journal of Thoracic Surgery 68(5): 383-386
Furukawa, N.; Scholtz, W.; Scholtz, S.; Faber, L.; Ensminger, S.; Gummert, J.; Börgermann, J. 2015: Prosthetic Valve Escaping During Transcatheter Aortic Valve Implantation. Innovations 10(6): 425-427
Garg, J.; Palaniswamy, C.; Pinnamaneni, S.; Sarungbam, J.; Jain, D. 2016: Prosthetic Valve Thrombosis: Diagnosis and Management. American Journal of Therapeutics 23(1): E252-E255
Bonnichsen, C.R.; Pellikka, P.A. 2015: Prosthetic Valve Thrombus Versus Pannus: Progress with Imaging. CIRCULATION. Cardiovascular Imaging 8(12)
Scherrer, A.U.; Bloemberg, G.; Zbinden, R.; Zinkernagel, A.S.; Fuchs, C.; Frauenfelder, S.; Rancic, Z.; Mayer, D.; Hasse, B. 2016: Prosthetic Vascular Graft Infections: Bacterial Cultures from Negative-Pressure-Wound-Therapy Foams do not Improve Diagnostics. Journal of Clinical Microbiology 54(8): 2190-2193
Abemayor, E. 2017: Prosthetic Voice Rehabilitation Following Laryngectomy: It's the Archer Not the Arrow. JAMA Otolaryngology--Head and Neck Surgery 143(1): 72
Camargos, G.d.V.; Sotto-Maior, B.S.; Silva, W.J.é d.; Lazari, P.C.; Del Bel Cury, A.A. 2016: Prosthetic abutment influences bone biomechanical behavior of immediately loaded implants. Brazilian Oral Research 30(1)
Huijbregts, H.J.T.A.M.; Khan, R.J.K.; Fick, D.P.; Jarrett, O.M.; Haebich, S. 2016: Prosthetic alignment after total knee replacement is not associated with dissatisfaction or change in Oxford Knee Score: a multivariable regression analysis. Knee 23(3): 535-539
Nair, A.; Sajeev, C.G.; Muneer, K. 2016: Prosthetic aortic valve dehiscence: a "rocking" catastrophe. Journal of Echocardiography 14(4): 171-172
Machernis, N.P.; Jain, R.; Anigbogu, M.; Ammar, K.A.; Brauer, E.; Khandheria, B.K. 2015: Prosthetic aortic valve endocarditis with pseudoaneurysm complicated by additional rupture of mitral-aortic intervalvular fibrosa. European Heart Journal 36(40): 2741
Korteland, N.M.; Bras, F.J.; van Hout, F.M.A.; Kluin, J.; Klautz, R.J.M.; Bogers, A.J.J.C.; Takkenberg, J.J.M. 2015: Prosthetic aortic valve selection: current patient experience, preferences and knowledge. Open Heart 2(1): E000237
Pereira, V.H.; Guardado, J.; Fernandes, M.; Lourenço, M.ár.; Machado, I.ên.; Quelhas, I.; Azevedo, O.; Lourenço, A.ón. 2015: Prosthetic aortic valve: a bone in the system. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 34(2): 137.E1-4
Lee, K.-T.; Mun, G.-H. 2015: Prosthetic breast reconstruction in previously irradiated breasts: a meta-analysis. Journal of Surgical Oncology 112(5): 468-475
Quinn, T.T.; Miller, G.S.; Rostek, M.; Cabalag, M.S.; Rozen, W.M.; Hunter-Smith, D.J. 2016: Prosthetic breast reconstruction: indications and update. Gland Surgery 5(2): 174-186
Huri, G.; Familiari, F.; Salari, N.; Petersen, S.A.; Doral, M.Nedim.; McFarland, E.G. 2016: Prosthetic design of reverse shoulder arthroplasty contributes to scapular notching and instability. World Journal of Orthopedics 7(11): 738-745
Holban, A.M.; Iordanskii, A.; Grumezescu, A.M.; Bychkova, A.; Andronescu, E.; Mogoantă, L.ți.; Mogoșanu, G.D.; Iordache, F. 2015: Prosthetic devices with nanostructurated surfaces for increased resistance to microbial colonization. Current Pharmaceutical Biotechnology 16(2): 112-120
Loverix, L.; Juvonen, T.; Biancari, F. 2015: Prosthetic endocarditis after transcatheter aortic valve implantation: pooled individual patient outcome. International Journal of Cardiology 178: 67-68
Sadid-Zadeh, R.; Kutkut, A.; Kim, H. 2015: Prosthetic failure in implant dentistry. Dental Clinics of North America 59(1): 195-214
Heng, B.C.; Aubel, D.; Fussenegger, M. 2015: Prosthetic gene networks as an alternative to standard pharmacotherapies for metabolic disorders. Current Opinion in Biotechnology 35: 37-45
Lee, G.Dong.; Kim, H.Ryul.; Choi, S.Hoon.; Kim, Y-Hee.; Kim, D.Kwan.; Park, S-Il. 2016: Prosthetic graft interposition of the brachiocephalic veins or superior vena cava combined with resection of malignant tumours: graft patency and risk factors for graft occlusion. Journal of thoracic disease 8(1): 61-67
Barbarash, L.; Rutkovskaya, N.; Barbarash, O.; Odarenko, Y.; Stasev, A.; Uchasova, E. 2016: Prosthetic heart valve selection in women of childbearing age with acquired heart disease: a case report. Journal of Medical Case Reports 10: 51
Garagoli, F.; Romeo, F.J.é; Lucas, L.; Kotowicz, V.; Belziti, C.és. 2017: Prosthetic heart valve thrombosis treated with slow infusion fibrinolytic therapy in patient with acute isquemic stroke. Archivos de Cardiologia de Mexico 87(2): 175-177
Lawley, C.M.; Lain, S.J.; Algert, C.S.; Ford, J.B.; Figtree, G.A.; Roberts, C.L. 2015: Prosthetic heart valves in pregnancy, outcomes for women and their babies: a systematic review and meta-analysis. Bjog: An International Journal of Obstetrics and Gynaecology 122(11): 1446-1455
Hessler, R.; Lunebourg, A.; Fisher, J-F.; Trachsel, S.; Cometta, A. 2014: Prosthetic hip infection due to Listeria monocytogenes: review of the literature and case report. Revue Medicale Suisse 10(450): 2164-2167
Ozan, Fırat.; Öncel, Eüp.Sabri.; Duygulu, F.; Çelik, İlhami.; Altay, Tşkın. 2015: Prosthetic hip joint infection caused by Rothia dentocariosa. International Journal of Clinical and Experimental Medicine 8(7): 11628-11631
Martín-Ares, M.ía.; Barona-Dorado, C.; Guisado-Moya, B.; Martínez-Rodríguez, N.; Cortés-Bretón-Brinkmann, J.; Martínez-González, J.é M.ª 2016: Prosthetic hygiene and functional efficacy in completely edentulous patients: satisfaction and quality of life during a 5-year follow-up. Clinical Oral Implants Research 27(12): 1500-1505
Highsmith, M.Jason.; Kahle, J.T.; Miro, R.M.; Orendurff, M.S.; Lewandowski, A.L.; Orriola, J.J.; Sutton, B.; Ertl, J.P. 2016: Prosthetic interventions for people with transtibial amputation: Systematic review and meta-analysis of high-quality prospective literature and systematic reviews. Journal of Rehabilitation Research and Development 53(2): 157-184
Arnáez Solís, Rén.; Martín Salas, C.; Acha Arrieta, M.Victoria. 2017: Prosthetic joint infection by Ruminococcus gnavus in a patient without associated digestive disease. Medicina clinica 148(2): e7-e8
Honnorat, E.; Seng, P.; Savini, Hélène.; Pinelli, P-Olivier.; Simon, F.; Stein, A. 2016: Prosthetic joint infection caused by Pasteurella multocida: a case series and review of literature. Bmc Infectious Diseases 16(1): 435
Gilarranz, R.; Chamizo, F.; Horcajada, I.; Bordes-Benítez, A. 2016: Prosthetic joint infection caused by Trueperella bernardiae. Journal of infection and chemotherapy: official journal of the Japan Society of Chemotherapy 22(9): 642-644
Tornero, E.; Soriano, A. 2015: Prosthetic joint infection due to Enterococcus sp treated with debridement, antibiotics and retention of the implant (DAIR). Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 21(5): E43-E44
Dhawan, B.; Sebastian, S.; Malhotra, R.; Kapil, A.; Gautam, D. 2016: Prosthetic joint infection due to Lysobacter thermophilus diagnosed by 16S rRNA gene sequencing. Indian Journal of Medical Microbiology 34(1): 100-102
Blomfeldt, R.; Kasina, P.; Ottosson, C.; Enocson, A.; Lapidus, L.J. 2015: Prosthetic joint infection following hip fracture and degenerative hip disorder: a cohort study of three thousand, eight hundred and seven consecutive hip arthroplasties with a minimum follow-up of five years. International Orthopaedics 39(11): 2091-2096
Barbero, J.M.; Montero, E.; Vallés, A.; Plasencia, M.A.; Romanyk, J.; Gómez, J. 2016: Prosthetic joint infection in patients with hip fracture. Differences from infection of elective prosthesis. Revista Espanola de Quimioterapia: Publicacion Oficial de la Sociedad Espanola de Quimioterapia 29(5): 273-277
Roger, P.-M.; Tabutin, J.; Blanc, V.; Léotard, S.; Brofferio, P.; Léculé, F.; Redréau, B.; Bernard, E. 2015: Prosthetic joint infection: a pluridisciplinary multi-center audit bridging quality of care and outcome. Medecine et Maladies Infectieuses 45(6): 229-236
Chen, A.F.; Heller, S.; Parvizi, J. 2014: Prosthetic joint infections. Surgical Clinics of North America 94(6): 1265-1281
De Angelis, G.; Mutters, N.T.; Minkley, L.; Holderried, F.; Tacconelli, E. 2015: Prosthetic joint infections in the elderly. Infection 43(6): 629-637
Henry, M.W.; Miller, A.O.; Kahn, B.; Windsor, R.E.; Brause, B.D. 2016: Prosthetic joint infections secondary to rapidly growing mycobacteria: Two case reports and a review of the literature. Infectious Diseases 48(6): 453-460
Saeed, K.; Dryden, M.; Bassetti, M.; Bonnet, E.; Bouza, E.; Chan, M.; Cortes, N.; Davis, J.S.; Esposito, S.; Giordano, G.ér.; Gould, I.; Hartwright, D.; Lye, D.; Marin, M.; Morgan-Jones, R.; Lajara-Marco, F.; Righi, E.; Romano, C.L.; Segreti, J.; Unal, S.; Williams, R.L.; Yalcin, A.N. 2017: Prosthetic joints: shining lights on challenging blind spots. International Journal of Antimicrobial Agents 49(2): 153-161
Vasso, M.; Schiavone Panni, A.; De Martino, I.; Gasparini, G. 2016: Prosthetic knee infection by resistant bacteria: the worst-case scenario. Knee Surgery Sports Traumatology Arthroscopy: Official Journal of the Esska 24(10): 3140-3146
Seo, Y.; Noh, Y.-S.; Wie, S.-H.; Chang, U.-I. 2016: Prosthetic knee joint infection due to Listeria monocytogenes bacteremia in a diabetic female. Korean Journal of Internal Medicine 31(3): 616-619
Zhang, X.; Wang, S.; Wei, J. 2015: Prosthetic left renocaval bypass for posterior nutcracker syndrome. Indian Journal of Surgery 77(Suppl. 1): 103-105
Kim, K.; Noh, K.; Paek, J.; Kwon, K-Rock.; Pae, A. 2015: Prosthetic management of a growing patient with Russell-Silver syndrome: a clinical report. Journal of Advanced Prosthodontics 7(5): 406-410
Saadat, F.; Mosharraf, R. 2013: Prosthetic management of an extensive maxillary alveolar defect with an implant-supported restoration. Journal of Dentistry 10(3): 256-263
Marion, L.R.; Hirsh, L.S. 2015: Prosthetic management of gingival recession around implants: lessons learned from staged-approach treatment planning. Compendium of Continuing Education in Dentistry 36(3): 180-188; Quiz 189, 190
Koralakunte, P.R.; Shamnur, S.N.; Iynalli, R.V.; Shivmurthy, S. 2015: Prosthetic management of hemimandibulectomy patient with guiding plane and twin occlusion prosthesis. Journal of Natural Science Biology and Medicine 6(2): 449-453
Chatterjee, A.; Ragher, M.; Patil, S.; Chatterjee, D.; Dandekeri, S.; Prabhu, V. 2015: Prosthetic management of malpositioned implant using custom cast abutment. Journal of Pharmacy and Bioallied Sciences 7(Suppl 2): S740-S745
Adhershitha, A.R.; Anilkumar, S.; Rajesh, C.; Mohan, D.C. 2016: Prosthetic management of posttraumatic external auditory canal atresia: a rare cause of conductive hearing loss. Journal of Indian Prosthodontic Society 16(4): 390-394
Beech, A.N.; Spicer, K.A.; Hodgson, M.; Farrier, J.N. 2017: Prosthetic management of pressure necrosis of the nasal septum caused by a continuous positive airway pressure machine. British Journal of Oral and Maxillofacial Surgery 55(3): 321-323
Stadnik, H.; Kościński, T.Maciej. 2016: Prosthetic materials for treating posterior vaginal wall prolapse and rectocele - own experience. Ginekologia Polska 87(11): 729-732
Canton, S.A.; Merigliano, S.; Pasquali, C. 2016: Prosthetic mesh "slim-cigarette like" for laparoscopic repair of ventral hernias: a new technique without transabdominal fixation sutures. Updates in Surgery 68(2): 199-203
Kannan, A.; Jahan, K.; Lotun, K.; Janardhanan, R. 2015: Prosthetic mitral valve obstruction: role of real-time three-dimensional transesophageal echocardiography in diagnosis. BMJ Case Reports
Cardoso, G.ça.; Aguiar, C.; Andrade, M.J.ão.; Patrício, L.; Freire, I.; Serrano, F.át.; Anjos, R.; Mendes, M. 2015: Prosthetic mitral valve thrombosis in pregnancy: from thrombolysis to anticoagulation. Revista Portuguesa de Cardiologia: Orgao Oficial da Sociedade Portuguesa de Cardiologia 34(1): 71.E1-71.E5
Miranda, W.R.; Connolly, H.M.; Bonnichsen, C.R.; DeSimone, D.C.; Dearani, J.A.; Maleszewski, J.J.; Greason, K.L.; Wilson, W.R.; Baddour, L.M. 2016: Prosthetic pulmonary valve and pulmonary conduit endocarditis: clinical, microbiological and echocardiographic features in adults. European Heart Journal. Cardiovascular Imaging 17(8): 936-943
Salminger, S.; Sturma, A.; Herceg, M.; Riedl, O.; Bergmeister, K.; Aszmann, O.C. 2015: Prosthetic reconstruction in high amputations of the upper extremity. Der Orthopade 44(6): 413-418
Salminger, S.; Mayer, J.A.; Sturma, A.; Riedl, O.; Bergmeister, K.D.; Aszmann, O.C. 2016: Prosthetic reconstruction of the upper extremity. Der Unfallchirurg 119(5): 408-413
Salminger, S.; Roche, A.D.; Hruby, L.A.; Sturma, A.; Riedl, O.; Bergmeister, K.D.; Aszmann, O.C. 2016: Prosthetic reconstruction to restore function in transcarpal amputees. Journal of Plastic Reconstructive and Aesthetic Surgery: Jpras 69(3): 305-310
Seong, D-Jae.; Hong, S-Jin.; Ha, S-Ryong.; Hong, Y-Gi.; Kim, H-Won. 2016: Prosthetic reconstruction with an obturator using swing-lock attachment for a patient underwent maxillectomy: A clinical report. Journal of Advanced Prosthodontics 8(5): 411-416
Cumming, J.; Barr, S.; Howe, T.E. 2015: Prosthetic rehabilitation for older dysvascular people following a unilateral transfemoral amputation. Cochrane Database of Systematic Reviews 1: Cd005260
Kondaka, S.; Rao, B.L.; Reddy, J.R.; Akula, R. 2016: Prosthetic rehabilitation in patient with achalasia cardia - A rare case report. Journal of International Society of Preventive and Community Dentistry 6(4): 383-386
Sikka, N.; Jain, R.; Kaushik, A.; Rani, R. 2014: Prosthetic rehabilitation of a child with velopharyngeal dysfunction - A case report. Journal of Oral Biology and Craniofacial Research 4(2): 140-143
Shashidhar, W.C.M.P.; Mahesh Gowda, C.E. 2015: Prosthetic rehabilitation of a gunshot wound defect with combination of fixed and removable prosthesis. Medical Journal Armed Forces India 71(Suppl 2): S605-S608
Goiato, M.C.; de Medeiros, R.A.; Vechiato Filho, A.J.é; da Silva, E.V.F.; Sônego, M.V.; de Carvalho, K.H.T.; Guiotti, A.ée.M.; de Carvalho Dekon, S.F.; Pesqueira, A.ér.A.; Dos Santos, D.M. 2015: Prosthetic rehabilitation of a patient after a partial mandibulectomy. Annals of Medicine and Surgery 4(2): 200-203
Shashidhar, M.P.; Thombre, H.K. 2015: Prosthetic rehabilitation of a serving soldier with custom made ocular prosthesis. Medical Journal Armed Forces India 71(Suppl 1): S248-S250
Jain, P.; Siwach, A.; Arora, G.; Agarwal, R. 2015: Prosthetic rehabilitation of a total laryngectomy patient. Journal of Indian Prosthodontic Society 15(4): 390-394
Law, M.Y.T.; Chung, R.W.C.; Lam, O.L.T. 2015: Prosthetic rehabilitation of an edentulous patient with an oronasal fistula. Journal of Prosthetic Dentistry 113(4): 347-349
Tso, T.V.; Tso, V.J.; Stephens, W.F. 2015: Prosthetic rehabilitation of an extensive midfacial and palatal postsurgical defect with an implant-supported cross arch framework: a clinical report. Journal of Prosthetic Dentistry 113(5): 498-502
Shetty, S.; Mohammad, F.; Shetty, R.; Shenoy, K. 2016: Prosthetic rehabilitation of an orbital defect for a patient with hemifacial atrophy. Journal of Indian Prosthodontic Society 16(1): 91-95
Andrei, O.C.; Mărgărit, R.; Tănăsescu, L.A.; Dăguci, L.Ţa.; Dăguci, C. 2016: Prosthetic rehabilitation of complete edentulous patients with morphological changes induced by age and old ill fitted dentures. Romanian Journal of Morphology and Embryology 57(2 Suppl): 861-864
Andreas Zenthöfer, A.; Rammelsberg, P.; Cabrera, T.; Hassel, A. 2015: Prosthetic rehabilitation of edentulism prevents malnutrition in nursing home residents. International journal of prosthodontics 28(2): 198-200
Shrivastava, K.J.; Shrivastava, S.; Agarwal, S.; Bhoyar, A. 2015: Prosthetic rehabilitation of large mid-facial defect with magnet-retained silicone prosthesis. Journal of Indian Prosthodontic Society 15(3): 276-280
Schnabl, D. 2015: Prosthetic rehabilitation of partially edentulous patients: fixed - removable - combined? Metal - ceramics - all - ceramics? Implants? Anything goes! Part 1: two example cases of a combined fixed-removable restoration. Swiss Dental Journal 125(2): 149-154; 162-167
Schnabl, D. 2015: Prosthetic rehabilitation of partially edentulous patients: fixed - removable - combined? Metal - ceramics - all - ceramics? Implants? Anything goes! Part 2: two case studies represent the fixed, respectively the combined fixed-removable prosthetic restoration by utilization of implants. Swiss Dental Journal 125(2): 155-161
Rathee, M.; Sikka, N.; Jindal, S.; Kaushik, A. 2015: Prosthetic rehabilitation of severe Siebert's Class IIi defect with modified Andrews bridge system. Contemporary Clinical Dentistry 6(Suppl 1): S114-S116
Babu, A.S.; Manju, V.; Nair, V.P.; Thomas, C.T. 2016: Prosthetic rehabilitation of surgically treated orbital defects - evisceration, enucleation, and exenteration: a case series. Journal of Indian Prosthodontic Society 16(2): 216-220
Ali, R.; Altaie, A.; Morrow, L. 2015: Prosthetic rehabilitation of the gagging patient using acrylic training plates. Dental Update 42(1): 52
Margonar, R.ér.; Queiroz, T.P.; Saito, C.él.T.M.H.; Luvizuto, E.R.; Betoni-Júnior, W.; de Oliveira, J.úl.C.S.; Marcantonio, Él. 2015: Prosthetic rehabilitation using short dental implants associated with homogenous bone graft. Journal of Craniofacial Surgery 26(3): 946-950
Yoon, H-In.; Han, J-Suk. 2016: Prosthetic rehabilitation with an implant-supported fixed prosthesis using computer-aided design and computer-aided manufacturing dental technology for a patient with a mandibulectomy: A clinical report. Journal of Prosthetic Dentistry 115(2): 133-136
Agranat, J.S.; Kitos, N.R.; Jacobs, D.S. 2016: Prosthetic replacement of the ocular surface ecosystem: impact at 5 years. British Journal of Ophthalmology 100(9): 1171-1175
Silveira, G.S.; de Almeida, N.ál.V.; Pereira, D.M.T.; Mattos, C.áu.T.; Mucha, J.é N. 2016: Prosthetic replacement vs space closure for maxillary lateral incisor agenesis: a systematic review. American Journal of Orthodontics and Dentofacial Orthopedics: Official Publication of the American Association of Orthodontists its Constituent Societies and the American Board of Orthodontics 150(2): 228-237
Kumar, D.R.V.; Raju, D.S.; Naidu, L.; Deshpande, S.; Chadha, M.; Agarwal, A. 2015: Prosthetic status and prosthetic needs amongst geriatric fishermen population of Kutch coast, Gujarat, India. Roczniki Panstwowego Zakladu Higieny 66(2): 167-171
Vitale, S.Giovanni.; Laganà, A.Simone.; Gulino, F.Antonio.; Tropea, A.; Tarda, S. 2016: Prosthetic surgery versus native tissue repair of cystocele: literature review. Updates in Surgery 68(4): 325-329
Jones Haywood, M. 2015: Prosthetic transvalvular regurgitation diagnosed with three-dimensional transesophageal echocardiography. Anesthesia and Analgesia 121(1): 65-68
Zaoui, K.; Schneider, M.H.; Neuner, O.; Federspil, P.A. 2016: Prosthetic treatment of nasal septal perforations : Results with custom-made silicone buttons. Hno 64(12): 897-904
Filius, M.A.; Cune, M.S.; Raghoebar, G.M.; Vissink, A.; Visser, A. 2016: Prosthetic treatment outcome in patients with severe hypodontia: a systematic review. Journal of Oral Rehabilitation 43(5): 373-387
Woo, Y.Joseph.; Greene, C.L. 2016: Prosthetic valve choice in middle-aged patients: guidelines and other guiding principles. European Journal of Cardio-Thoracic Surgery: Official Journal of the European Association for Cardio-Thoracic Surgery 49(5): 1468-1469
Sarı, C.; Durmaz, T.; Karaduman, B.D.; Keleş, T.; Bayram, H.üs.; Baştuğ, S.; Özen, M.B.; Bayram, N.A.; Bilen, E.; Ayhan, H.üs.; Kasapkara, H.ı A.; Bozkurt, E. 2016: Prosthetic valve endocarditis 7 months after transcatheter aortic valve implantation diagnosed with 3D TEE. Hellenic Journal of Cardiology: Hjc 57(2): 119-123
Olsen, N.T.; De Backer, O.; Thyregod, H.G.H.; Vejlstrup, N.; Bundgaard, H.; Søndergaard, L.; Ihlemann, N. 2015: Prosthetic valve endocarditis after transcatheter aortic valve implantation. CIRCULATION. Cardiovascular Interventions 8(4)
Ahmad, K.; Klaaborg, K.E.; Hjortdal, V.; Nørgaard, B.L.; Terkelsen, C.J.; Jensen, K.; Christiansen, E.H.øj.; Terp, K.A.; Andersen, G.; Hvitfeldt, S.; Andersen, H.R. 2016: Prosthetic valve endocarditis after transcatheter aortic valve implantation-diagnostic and surgical considerations. Journal of Thoracic Disease 8(10): E1213-E1218
Amat-Santos, I.J.; Ribeiro, H.B.; Urena, M.; Allende, R.; Houde, C.; Bédard, E.; Perron, J.; DeLarochellière, R.; Paradis, J.-M.; Dumont, E.; Doyle, D.; Mohammadi, S.; Côté, M.él.; San Roman, J.é A.; Rodés-Cabau, J. 2015: Prosthetic valve endocarditis after transcatheter valve replacement: a systematic review. JACC. Cardiovascular Interventions 8(2): 334-346
Van Valen, R.; de Lind van Wijngaarden, R.A.F.; Verkaik, N.J.; Mokhles, M.M.; Bogers, A.J.J.C. 2016: Prosthetic valve endocarditis due to Propionibacterium acnes. Interactive Cardiovascular and Thoracic Surgery 23(1): 150-155
Neragi-Miandoab, S.; Westbrook, B.; Flynn, J.; Blakely, J.; Baribeau, Y. 2015: Prosthetic valve endocarditis five months following transcatheter aortic valve implantation and review of literature. Heart Surgery Forum 18(1): E20-E22
Pabilona, C.; Gitler, B.; Lederman, J.A.; Miller, D.; Keltz, T.N. 2015: Prosthetic valve endocarditis with valvular obstruction after transcatheter aortic valve replacement. Texas Heart Institute Journal 42(2): 172-174
Yousefzai, R.; Khandheria, B.K. 2015: Prosthetic valve endocarditis: multiple complications in one patient. European Heart Journal. Cardiovascular Imaging 16(8): 881
Separham, A.; Ghaffari, S.; Aslanabadi, N.; Sohrabi, B.; Ghojazadeh, M.; Anamzadeh, E.; Hajizadeh, R.; Davarmoin, G. 2015: Prosthetic valve thrombosis. Journal of Cardiac Surgery 30(3): 246-250
Bilal, M.; Khan, M.S.; Haseeb, A.; Khan, A.B. 2015: Prosthetic valve thrombosis in a patient with mitral valve replacement. JPMA. Journal of the Pakistan Medical Association 65(7): 802-803
Tarzia, V.; Guariento, A.; Bagozzi, L.; Bagno, A.; Bottio, T.; Gerosa, G. 2016: Prosthetic valve thrombosis: When prevention is better than treatment. American Heart Journal 174: E1-E2
Loureiro-Amigo, J.; Pons, S.; Sierra, M.; Meije, Y. 2017: Prosthetic valve with infective endocarditis caused by Propionibacterium avidum. A case report. Enfermedades Infecciosas y Microbiologia Clinica 35(3): 196-197
Kurlansky, P. 2015: Prosthetic valves and the unending quest for the holy grail. Journal of Thoracic and Cardiovascular Surgery 149(5): 1242-1243
Bonares, M.J.; Vaisman, A.; Sharkawy, A. 2016: Prosthetic vascular graft infection and prosthetic joint infection caused by Pseudomonas stutzeri. Idcases 6: 106-108
Oda, T.; Minatoya, K.; Kobayashi, J.; Okita, Y.; Akashi, H.; Tanaka, H.; Kawaharada, N.; Saiki, Y.; Kuniyoshi, Y.; Nishimura, K. 2015: Prosthetic vascular graft infection through a median sternotomy: a multicentre review †. Interactive Cardiovascular and Thoracic Surgery 20(6): 701
Chen, H.Y.; Berwick, Z.C.; Kemp, A.; Krieger, J.; Chambers, S.; Lurie, F.; Kassab, G.S. 2015: Prosthetic venous valve patient selection by validated physics-based computational models. Journal of Vascular Surgery. Venous and Lymphatic Disorders 3(1): 75-80
Hadjinicolaou, A.E.; Meffin, H.; Maturana, M.I.; Cloherty, S.L.; Ibbotson, M.R. 2015: Prosthetic vision: devices, patient outcomes and retinal research. Clinical and Experimental Optometry 98(5): 395-410
Humphrey, J.M.; Lacaille, S.N.J.; Patel, K.; Thompson, E.; Tulumba, S.; Healey, J.H.; Gilhuley, K.A.; Babady, N.E.; Kamboj, M.; Mead, P.A. 2015: Prosthetic-Joint-Associated Bordetella holmesii Infection. Open Forum Infectious Diseases 2(4): Ofv169
Karrouf, G.; Zaghloul, A.; Abou-Alsaud, M.; Barbour, E.; Abouelnasr, K. 2016: Prosthetics and Techniques in Repair of Animal's Abdominal Wall. Scientifica 2016: 9463186
Taylor, R.J.; Sherris, D.A. 2015: Prosthetics for nasal perforations: a systematic review and meta-analysis. Otolaryngology--Head and Neck Surgery: Official Journal of American Academy of Otolaryngology-Head and Neck Surgery 152(5): 803-810
Anderson, S.; Stuckey, R.; Oakman, J.R. 2016: Prosthetists' and Orthotists' experience of their work and workspace - characterising the physical and organisational environment: Focus group findings. Prosthetics and Orthotics International 40(6): 703-712
Hafner, B.J.; Spaulding, S.E.; Salem, R.; Morgan, S.J.; Gaunaurd, I.; Gailey, R. 2017: Prosthetists' perceptions and use of outcome measures in clinical practice: Long-term effects of focused continuing education. Prosthetics and Orthotics International 41(3): 266-273
Bilton, D.T. 2013: Prosthetops wolybergensis sp. nov.--a giant amongst the 'minute moss beetles', with new data on other members of the genus (Coleoptera, Hydraenidae). Zootaxa 3666: 345-357
Boonsiriphant, P.; Hirsch, J.A.; Greenberg, A.M.; Genden, E.M. 2015: Prosthodontic Considerations in Post-cancer Reconstructions. Oral and Maxillofacial Surgery Clinics of North America 27(2): 255-263
Rynn, M.Howard.; Afshari, F.S.; Schneider, J.; Yuan, J.Chia-Chun.; Harlow, R.; Knoernschild, K.L.; Campbell, S.D.; Sukotjo, C. 2015: Prosthodontic Implant Club at UIC, Program Description and Survey Analysis. Journal of Prosthodontics: Official Journal of the American College of Prosthodontists 24(8): 665-671
Artopoulou, I.Ioanna.; Martin, J.W.; Chambers, M.S. 2016: Prosthodontic Management and Treatment Considerations for an HIV-Positive Patient with a Nonhealing Lesion of the Maxilla: A Clinical Case History Report. International Journal of Prosthodontics 29(4): 354-356
Dhakshaini, M.R.; Pushpavathi, M.; Garhnayak, M.; Dhal, A. 2015: Prosthodontic Management in Conjunction with Speech Therapy in Cleft Lip and Palate: A Review and Case Report. Journal of International Oral Health: Jioh 7(Suppl. 2): 106-111
Gurkar, H.; Venkatesh, O.Y.; Somashekar, J.M.; Gowda, M.H.L.; Dwivedi, M.; Ningthoujam, I. 2016: Prosthodontic Management of Xerostomic Patient: a Technical Modification. Case Reports in Dentistry 2016: 8905891
Siddiqui, M.Musaab.; Taylor, P.D. 2016: Prosthodontic Rehabilitation for a Patient with Ellis-Van Creveld Syndrome: A Case Report. European Journal of Prosthodontics and Restorative Dentistry 24(1): 36-39
Rajapur, A.; Mitra, N.; Prakash, V.J.; Rah, S.A.; Thumar, S. 2015: Prosthodontic Rehabilitation of Patients with Bell's Palsy: our Experience. Journal of International Oral Health: Jioh 7(Suppl 2): 77-81
Sethuram, A.K.; Arora, V.; Kumar Pal, A.; Singh Sandhu, H.; Sahoo, N.K.; Guruprasada, B.S. 2016: Prosthodontic Rehabilitation with a Telescopic Prosthesis of a Nonsyndromic Oligodontia Patient. Journal of Prosthodontics: Official Journal of the American College of Prosthodontists 25(3): 247-251
Zhang, X.X.; Peng, D.; Feng, H.L. 2015: Prosthodontic Treatment for Severe Oligodontia with Long-term Follow-up. Chinese Journal of Dental Research: the Official Journal of the Scientific Section of the Chinese Stomatological Association 18(3): 163-169
Hutten, M.C. 2016: Prosthodontic considerations for managing the older adult patient. General Dentistry 64(6): 18-22
Korduner, E.-K.; Collin Bagewitz, I.; Vult von Steyern, P.; Wolf, E. 2016: Prosthodontic decision-making relating to dentitions with compromised molars: the perspective of Swedish General Dental Practitioners. Journal of Oral Rehabilitation 43(12): 967-976
Păuna, M.Rodica.; Babiuc, I.; Farcaşiu, A.Titus. 2015: Prosthodontic management of an extreme atrophy of the mandible correlated with a prominent genial tubercle - a clinical report. Romanian Journal of Morphology and Embryology 56(2 Suppl): 867-870
Taruna, M.; Chittaranjan, B.; Sudheer, N.; Tella, S.; Abusaad, M. 2014: Prosthodontic perspective to all-on-4® concept for dental implants. Journal of Clinical and Diagnostic Research: Jcdr 8(10): Ze16-Ze19
Manfredini, D.; Poggio, C.E. 2017: Prosthodontic planning in patients with temporomandibular disorders and/or bruxism: a systematic review. Journal of Prosthetic Dentistry 117(5): 606-613
McKenna, G.; Hayes, M.; Burke, F.M. 2014: Prosthodontic rehabilitation for a patient with acromegaly. European Journal of Prosthodontics and Restorative Dentistry 22(3): 98-100
Livingstone, D.; Murthy, V.; Reddy, V.K.; Pillai, A. 2015: Prosthodontic rehabilitation of a patient with aggressive periodontitis. BMJ Case Reports
Garg, A. 2016: Prosthodontic rehabilitation of completely edentulous patient with partial glossectomy. Journal of Indian Prosthodontic Society 16(2): 204-207
Shrestha, B.; Fatmasari, F.; Thaworanunta, S.; Srithavaj, T. 2015: Prosthodontic rehabilitation of congenital auricular defect: a clinical report. Cleft Palate-Craniofacial Journal: Official Publication of the American Cleft Palate-Craniofacial Association 52(2): 229-233
Singh, N.; Dhiman, R.K.; Kumar, D. 2015: Prosthodontic rehabilitation of extraoral and intraoral maxillofacial defects. Medical Journal Armed Forces India 71(Suppl 2): S556-S559
Bansal, R.; Kumar, M.; Garg, R.; Saini, R.; Kaushala, S. 2014: Prosthodontic rehabilitation of patient with flabby ridges with different impression techniques. Indian Journal of Dentistry 5(2): 110-113
Viswambaran, M.; Thiruvalluvan, N. 2015: Prosthodontic rehabilitation protocols for immediate implants. Medical Journal Armed Forces India 71(Suppl 2): S440-S443
Károlyházy, K.; Schmidt, Péter.; Bogdán, Sándor.; Hermann, Péter.; Arányi, Z. 2014: Prosthodontic treatment of an edentulous epileptic patient with an implant-retained overdenture. A case report. Ideggyogyaszati Szemle 67(9-10): 342-346
Jackson, M. 2015: Prosthodontics rehabilitation in velopharyngeal insufficiency. Advances in Oto-Rhino-Laryngology 76: 41-49
Gantos, M.A.; Manzotti, A.; Yuan, J.C.-C.; Afshari, F.S.; Marinis, A.; Syros, G.; Rynn, M.H.; Sukotjo, C. 2015: Prosthodontics treatment considerations for methamphetamine-dependent patients. Journal of Prosthodontics: Official Journal of the American College of Prosthodontists 24(1): 64-70
Kaku, M. 2016: Prosthodontics: a multidisciplinary field in dentistry. Journal of Prosthodontic Research 60(3): 143-144
Tiosavljević, D.; Djukić-Dejanović, S.; Turza, K.; Jovanović, A.; Jeremić, V. 2016: Prostitution as a Psychiatric Situation: Ethical Aspects. Psychiatria Danubina 28(4): 349-356
Fraser, B. 1995: Prostitution is not reasonable or desirable. Nursing Standard 1987) 9(45): 40-40
Vogel, L. 2015: Prostitution laws failing sex workers: CPHA. Cmaj: Canadian Medical Association Journal 187(2): E63-E64
Miana, G.A.; Riaz, M.; Shahzad-ul-Hussan, S.; Paracha, R.Z.; Paracha, U.Z. 2015: Prostratin: An Overview. Mini Reviews in Medicinal Chemistry 15(13): 1122-1130
Strappazzon, F.; Di Rita, A.; Cianfanelli, V.; D'Orazio, M.; Nazio, F.; Fimia, G.Maria.; Cecconi, F. 2016: Prosurvival AMBRA1 turns into a proapoptotic BH3-like protein during mitochondrial apoptosis. Autophagy 12(6): 963-975
Carrington, E.M.; Zhang, J-Guo.; Sutherland, R.M.; Vikstrom, I.B.; Brady, J.L.; Soo, P.; Vremec, D.; Allison, C.; Lee, E.F.; Fairlie, W.Douglas.; Bouillet, P.; Grabow, S.; Ottina, E.; Herold, M.J.; Pellegrini, M.; Huang, D.C.S.; Tarlinton, D.M.; Strasser, A.; Lew, A.M.; Zhan, Y. 2015: Prosurvival Bcl-2 family members reveal a distinct apoptotic identity between conventional and plasmacytoid dendritic cells. Proceedings of the National Academy of Sciences of the United States of America 112(13): 4044-4049
Muir, L.A.; Murry, C.E.; Chamberlain, J.S. 2016: Prosurvival Factors Improve Functional Engraftment of Myogenically Converted Dermal Cells into Dystrophic Skeletal Muscle. Stem Cells and Development 25(20): 1559-1569
Coppola, M.; Corrado, G.; Coppola, V.; Cascone, P.; Martinelli, R.; Digilio, M.Cristina.; Pennacchio, F.; Rao, R. 2015: Prosystemin Overexpression in Tomato Enhances Resistance to Different Biotic Stresses by Activating Genes of Multiple Signaling Pathways. Plant Molecular Biology Reporter 33(5): 1270-1285
Patoleta, B.; Żabka, M. 2015: Proszynellus--a new jumping spider genus from Australia (Araneae: Salticidae). Zootaxa 3926(2): 257-267
Mall, T.; Eckstein, J.; Norris, D.; Vora, H.; Freese, N.H.; Loraine, A.E. 2016: ProtAnnot: an App for Integrated Genome Browser to display how alternative splicing and transcription affect proteins. Bioinformatics 32(16): 2499-2501
Ruiz-Blanco, Y.B.; Paz, W.; Green, J.; Marrero-Ponce, Y. 2015: ProtDCal: A program to compute general-purpose-numerical descriptors for sequences and 3D-structures of proteins. Bmc Bioinformatics 16: 162
Yap, E.-H.; Fiser, A. 2016: ProtLID, a Residue-Based Pharmacophore Approach to Identify Cognate Protein Ligands in the Immunoglobulin Superfamily. Structure 24(12): 2217-2226
Dhifli, W.; Diallo, A.B.é 2016: ProtNN: fast and accurate protein 3D-structure classification in structural and topological space. Biodata Mining 9: 30
Ngai, J.C.F.; Mak, P.-I.; Siu, S.W.I. 2016: ProtPOS: a python package for the prediction of protein preferred orientation on a surface. Bioinformatics 32(16): 2537-2538
Cheng, Y.; Perocchi, F. 2015: ProtPhylo: identification of protein-phenotype and protein-protein functional associations via phylogenetic profiling. Nucleic Acids Research 43(W1): W160-W168
Sedova, M.; Jaroszewski, L.; Godzik, A. 2016: Protael: protein data visualization library for the web. Bioinformatics 32(4): 602-604
Doweld, A.B. 2016: Protaeropsis, a new replacement generic name for fossil Sphenaster Jeffery, 1999 (Echinoidea: Spatangida) nec Wilcoxon, 1970 (Protista: Haptomonada). Zootaxa 4139(3): 421-423
Wang, C.; Wang, Z.; Che, Y. 2016: Protagonista lugubris, a cockroach species new to China and its contribution to the revision of genus Protagonista, with notes on the taxonomy of Archiblattinae (Blattodea, Blattidae). Zookeys 2016(574): 57-73
Bakchoul, T.; Jouni, R.; Warkentin, T.E. 2016: Protamine (heparin)-induced thrombocytopenia: a review of the serological and clinical features associated with anti-protamine/heparin antibodies. Journal of Thrombosis and Haemostasis: Jth 14(9): 1685-1695
Chaney, M.A.; Devin Roberts, J.; Wroblewski, K.; Shahul, S.; Gaudet, R.; Jeevanandam, V. 2016: Protamine Administration Via the Ascending Aorta May Prevent Cardiopulmonary Instability. Journal of Cardiothoracic and Vascular Anesthesia 30(3): 647-655
Kakisis, J.D.; Antonopoulos, C.N.; Moulakakis, K.G.; Schneider, F.; Geroulakos, G.; Ricco, J.B. 2016: Protamine Reduces Bleeding Complications without Increasing the Risk of Stroke after Carotid Endarterectomy: a Meta-analysis. European Journal of Vascular and Endovascular Surgery: the Official Journal of the European Society for Vascular Surgery 52(3): 296-307
Woronow, D. 2015: Protamine and Bleeding Avoidance Strategies. Journal of the American College of Cardiology 66(12): 1411-1412
Sharma, S.; Jyoti, K.; Sinha, R.; Katyal, A.; Jain, U.K.; Madan, J. 2016: Protamine coated proliposomes of recombinant human insulin encased in Eudragit S100 coated capsule offered improved peptide delivery and permeation across Caco-2 cells. Materials Science and Engineering. C Materials for Biological Applications 67: 378-385
Jiang, W.-j.; Zhang, J.; Xia, X.-y.; Xu, H.-q. 2015: Protamine gene polymorphisms and male infertility. Zhonghua Nan Ke Xue 21(12): 1134-1137
Liu, M.; Feng, B.; Shi, Y.; Su, C.; Song, H.; Cheng, W.; Zhao, L. 2015: Protamine nanoparticles for improving shRNA-mediated anti-cancer effects. Nanoscale Research Letters 10: 134
Olsson, A.; Alfredsson, J.; Håkansson, E.; Svedjeholm, R.; Berglund, J.; Berg, S.ör. 2016: Protamine reduces whole blood platelet aggregation after cardiopulmonary bypass. Scandinavian Cardiovascular Journal: Scj 50(1): 58-63
Kim, Y.J.; Wang, Y.; Gupta, R.; Kim, S.W.; Min, C.W.; Kim, Y.C.; Park, K.H.; Agrawal, G.K.; Rakwal, R.; Choung, M.-G.; Kang, K.Y.; Kim, S.T. 2015: Protamine sulfate precipitation method depletes abundant plant seed-storage proteins: a case study on legume plants. Proteomics 15(10): 1760-1764
González-Aramundiz, Jé.Vicente.; Peleteiro Olmedo, M.; González-Fernández, África.; Alonso Fernández, Mía.José.; Csaba, N.Stefánia. 2015: Protamine-based nanoparticles as new antigen delivery systems. European Journal of Pharmaceutics and Biopharmaceutics: Official Journal of Arbeitsgemeinschaft für Pharmazeutische Verfahrenstechnik E.V 97(Pt A): 51-59
Elumalai, R.; Patil, S.; Maliyakkal, N.; Rangarajan, A.; Kondaiah, P.; Raichur, A.M. 2015: Protamine-carboxymethyl cellulose magnetic nanocapsules for enhanced delivery of anticancer drugs against drug resistant cancers. Nanomedicine: Nanotechnology Biology and Medicine 11(4): 969-981
Wu, W.; Cheng, H.; Bu, R. 2015: Protamine-containing insulin allergy and renal dysfunction in a patient with type 2 diabetes. Journal of Diabetes Investigation 6(5): 591-593
Scheicher, B.; Schachner-Nedherer, A-L.; Zimmer, A. 2015: Protamine-oligonucleotide-nanoparticles: Recent advances in drug delivery and drug targeting. European Journal of Pharmaceutical Sciences: Official Journal of the European Federation for Pharmaceutical Sciences 75: 54-59
Sköld, A.E.; van Beek, J.J.P.; Sittig, S.P.; Bakdash, G.; Tel, J.; Schreibelt, G.; de Vries, I.J.M. 2015: Protamine-stabilized RNA as an ex vivo stimulant of primary human dendritic cell subsets. Cancer Immunology Immunotherapy: Cii 64(11): 1461-1473
Puras, G.; Martínez-Navarrete, G.; Mashal, M.; Zárate, J.; Agirre, M.; Ojeda, E.; Grijalvo, S.; Eritja, R.; Diaz-Tahoces, A.; Avilés-Trigueros, M.; Fernández, E.; Pedraz, J.L. 2015: Protamine/DNA/Niosome Ternary Nonviral Vectors for Gene Delivery to the Retina: the Role of Protamine. Molecular Pharmaceutics 12(10): 3658-3671
Lim, J.L.; van der Pol, S.M.A.; Baron, W.; McCord, J.M.; de Vries, H.E.; van Horssen, J. 2016: Protandim Protects Oligodendrocytes against an Oxidative Insult. Antioxidants 5(3)
Kaspric, N.; Picard, B.; Reichstadt, M.; Tournayre, J.ér.ém.; Bonnet, M. 2015: ProteINSIDE to Easily Investigate Proteomics Data from Ruminants: Application to Mine Proteome of Adipose and Muscle Tissues in Bovine Foetuses. Plos one 10(5): E0128086
Qamar, J.; Khan, M.A.M.; Nazir, Z. 2016: Protean and intangible manifestation of renal stones in children. International Journal of Surgery 36(Part D): 647-648
Ardalan, M. 2014: Protean faces of infective endocarditis in renal transplant recipients. Nephro-Urology Monthly 6(6): E18657
Bartel, B. 2015: Proteaphagy-Selective Autophagy of Inactive Proteasomes. Molecular Cell 58(6): 970-971
Shubin, A.V.; Demidyuk, I.V.; Lunina, N.A.; Komissarov, A.A.; Roschina, M.P.; Leonova, O.G.; Kostrov, S.V. 2015: Protease 3C of hepatitis a virus induces vacuolization of lysosomal/endosomal organelles and caspase-independent cell death. Bmc Cell Biology 16: 4
Lidfeldt, J.; Bendahl, P.är.-O.; Forsare, C.; Malmström, P.; Fernö, M.år.; Belting, M. 2015: Protease Activated Receptors 1 and 2 Correlate Differently with Breast Cancer Aggressiveness Depending on Tumor ER Status. Plos one 10(8): E0134932
Tamkovich, S.; Bryzgunova, O. 2016: Protease Activity and Cell-Free DNA in Blood Plasma of Healthy Donors and Breast Cancer Patients. Journal of Immunoassay and Immunochemistry 37(2): 141-153
Kan, H.; Imamura, M.; Uchida, T.; Hiraga, N.; Hayes, C.Nelson.; Tsuge, M.; Abe, H.; Aikata, H.; Makokha, G.Naswa.; Chowdhury, S.; Miki, D.; Ochi, H.; Ishida, Y.; Tateno, C.; Chayama, K. 2016: Protease Inhibitor Resistance Remains Even After Mutant Strains Become Undetectable by Deep Sequencing. Journal of Infectious Diseases 214(11): 1687-1694
Boender, T.Sonia.; Hamers, R.L.; Ondoa, P.; Wellington, M.; Chimbetete, C.; Siwale, M.; Labib Maksimos, E.E.F.; Balinda, S.N.; Kityo, C.M.; Adeyemo, T.A.; Akanmu, A.Sulaimon.; Mandaliya, K.; Botes, M.E.; Stevens, W.; Rinke de Wit, T.F.; Sigaloff, K.C.E. 2016: Protease Inhibitor Resistance in the First 3 Years of Second-Line Antiretroviral Therapy for HIV-1 in Sub-Saharan Africa. Journal of infectious diseases 214(6): 873-883
McGivern, D.R.; Masaki, T.; Lovell, W.; Hamlett, C.; Saalau-Bethell, S.; Graham, B. 2015: Protease Inhibitors Block Multiple Functions of the NS3/4A Protease-Helicase during the Hepatitis C Virus Life Cycle. Journal of Virology 89(10): 5362-5370
Voigt, J.; Woestemeyer, J. 2015: Protease Inhibitors Cause Necrotic Cell Death in Chlamydomonas reinhardtii by Inducing the Generation of Reactive Oxygen Species. Journal of Eukaryotic Microbiology 62(6): 711-721
De La Rosa, I.; Munjal, I.M.; Rodriguez-Barradas, M.; Yu, X.; Pirofski, L.-A.; Mendoza, D. 2016: Protease Inhibitors do not Affect Antibody Responses to Pneumococcal Vaccination. Clinical and Vaccine Immunology: Cvi 23(6): 524-529
Sargin Altunok, E.; Sayan, M.; Akhan, S.; Aygen, B.; Yildiz, O.; Tekin Koruk, S.; Mistik, R.; Demirturk, N.; Ural, O.; Kose, Şük.; Aynioglu, A.; Korkmaz, F.; Ersoz, G.ül.; Tuna, N.; Ayaz, C.; Karakecili, F.; Keten, D.; Inan, D.; Yazici, S.; Koculu, S.; Yildirmak, T. 2016: Protease Inhibitors Drug Resistance Mutations in Turkish Patients with Chronic Hepatitis C. International Journal of Infectious Diseases: Ijid: Official Publication of the International Society for Infectious Diseases 50: 1-5
Bagnis, C.I.; Stellbrink, H.-J.ür. 2015: Protease Inhibitors and Renal Function in Patients with HIV Infection: a Systematic Review. Infectious Diseases and Therapy 2015
Waldner, B.J.; Fuchs, J.E.; Schauperl, M.; Kramer, C.; Liedl, K.R. 2016: Protease Inhibitors in View of Peptide Substrate Databases. Journal of Chemical Information and Modeling 56(6): 1228-1235
Yau, M-Kwan.; Lim, J.; Liu, L.; Fairlie, D.P. 2016: Protease activated receptor 2 (PAR2) modulators: a patent review (2010-2015). Expert opinion on therapeutic patents 26(4): 471-483
Kim, H.N.; Kim, Y.R.; Ahn, S.M.; Lee, S.K.; Shin, H.K.; Choi, B.T. 2015: Protease activated receptor-1 antagonist ameliorates the clinical symptoms of experimental autoimmune encephalomyelitis via inhibiting breakdown of blood-brain barrier. Journal of Neurochemistry 135(3): 577-588
Kamato, D.; Thach, L.; Getachew, R.; Burch, M.; Hollenberg, M.D.; Zheng, W.; Little, P.J.; Osman, N. 2016: Protease activated receptor-1 mediated dual kinase receptor transactivation stimulates the expression of glycosaminoglycan synthesizing genes. Cellular Signalling 28(1): 110-119
Lin, C.; Rezaee, F.; Waasdorp, M.; Shi, K.; van der Poll, T.; Borensztajn, K.; Spek, C.A. 2015: Protease activated receptor-1 regulates macrophage-mediated cellular senescence: a risk for idiopathic pulmonary fibrosis. Oncotarget 6(34): 35304-35314
Barnes, J.A.; Singh, S.; Gomes, A.V. 2004: Protease activated receptors in cardiovascular function and disease. Molecular and Cellular Biochemistry 263(1): 227-239
Labudda, M.; Różańska, E.żb.; Szewińska, J.; Sobczak, M.ła.; Dzik, J.M. 2016: Protease activity and phytocystatin expression in Arabidopsis thaliana upon Heterodera schachtii infection. Plant Physiology and Biochemistry (Paris) 109: 416-429
Agrawal, K.; Kale, S.L.; Arora, N. 2015: Protease activity of Per a 10 potentiates Th2 polarization by increasing IL-23 and OX40L. European Journal of Immunology 45(12): 3375-3385
Wang, Y.; Xu, Q.; Lu, H.; Lin, L.; Wang, L.; Xu, H.; Cui, X.; Zhang, H.; Li, T.; Hua, Y. 2015: Protease activity of PprI facilitates DNA damage response: Mn2+-dependence and substrate sequence-specificity of the proteolytic reaction. PloS one 10(3): e0122071
Domingo, C.S.; Soria, M.; Rojas, A.M.; Fissore, E.N.; Gerschenson, L.ía.N. 2015: Protease and hemicellulase assisted extraction of dietary fiber from wastes of Cynara cardunculus. International Journal of Molecular Sciences 16(3): 6057-6075
Ozturkoglu-Budak, S.; Wiebenga, A.; Bron, P.A.; de Vries, R.P. 2016: Protease and lipase activities of fungal and bacterial strains derived from an artisanal raw ewe's milk cheese. International Journal of Food Microbiology 237: 17-27
Vergnolle, N. 2016: Protease inhibition as new therapeutic strategy for Gi diseases. Gut 65(7): 1215-1224
Ma, H.; Xiao-Peng, T.; Yang, S.-L.; Lu, Q.-M.; Lai, R. 2016: Protease inhibitor in scorpion (Mesobuthus eupeus) venom prolongs the biological activities of the crude venom. Chinese Journal of Natural Medicines 14(8): 607-614
Harper, K.N. 2016: Protease inhibitor monotherapy for long-term management of HIV infection. Aids 30(5): N5
Paton, N.I.; Stöhr, W.; Arenas-Pinto, A.; Fisher, M.; Williams, I.; Johnson, M.; Orkin, C.; Chen, F.; Lee, V.; Winston, A.; Gompels, M.; Fox, J.; Scott, K.; Dunn, D.T.; Fisher, M.; Clarke, A.; Hadley, W.; Stacey, D.; Johnson, M.; Byrne, P.; Williams, I.; De Esteban, N.; Pellegrino, P.; Haddow, L.; Arenas-Pinto, A.; Orkin, C.; Hand, J.; De Souza, C.; Murthen, L.; Crawford-Jones, A.; Chen, F.; Wilson, R.; Green, E.; Masterson, J.; Lee, V.; Patel, K.; Howe, R.; Winston, A.; Mullaney, S.; Gompels, M.; Jennings, L.; Beeching, N.; Tamaklo, R.; Fox, J.; Teague, A.; Jendrulek, I.; Tiraboschi, J.; Wilkins, E.; Clowes, Y.; Thompson, A.; Brook, G.; Trivedi, M.; Aderogba, K.; Jones, M.; DeBurgh-Thomas, A.; Jones, L.; Reeves, I.; Mguni, S.; Chadwick, D 2015: Protease inhibitor monotherapy for long-term management of HIV infection: a randomised, controlled, open-label, non-inferiority trial. LANCET. HIV 2(10): E417-E426
Torres-Cornejo, A.; BenMarzouk-Hidalgo, O.J.; Viciana, P.; Sánchez, B.; López-Ruz, M.A.; López-Cortés, L.F.; Gutiérrez-Valencia, A. 2016: Protease inhibitor monotherapy is effective in controlling human immunodeficiency virus 1 shedding in the male genital tract. Clinical Microbiology and Infection: the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases 22(1): 98.E7-98.E10
Ripamonti, D. 2016: Protease inhibitor monotherapy was non-inferior and cost-effective as maintenance therapy compared to triple therapy in viral load suppressed patients with HIV-1 infection. Evidence-Based Medicine 21(5): 184
Okumura, L.M. 2016: Protease inhibitors and azolic antifungals in HIV patients with histoplasmosis: a clinical pharmacokinetics perspective. Brazilian Journal of Infectious Diseases: An Official Publication of the Brazilian Society of Infectious Diseases 20(4): 405
Yee, T.T.; Amrolia, P.J.; Lee, C.A.; Mir, N.; Giangrande, P.L. 1997: Protease inhibitors and unusual bleeding in haemophiliacs. Haemophilia: the Official Journal of the World Federation of Hemophilia 3(3): 220-221
Han, S.; Li, Y.Y.; Chan, B.P. 2015: Protease inhibitors enhance extracellular collagen fibril deposition in human mesenchymal stem cells. Stem Cell Research and Therapy 6: 197
Bruyand, M.; Le Marec, F.; Lavole, A.; Leffondre, K.; Spano, J.P.; Le Moing, V.; Tattevin, P.; March, L.; Cadranel, J.; Bonnet, F.; Guiguet, M. 2015: Protease inhibitors exposure is not related to lung cancer risk in HIV smoker patients: a nested case-control study. Aids 29(9): 1105-1109
Li, Y.-S.; Liu, H.-W.; Zhu, R.; Xia, Q.-Y.; Zhao, P. 2016: Protease inhibitors in Bombyx mori silk might participate in protecting the pupating larva from microbial infection. Insect Science 23(6): 835-842
Duarte-Rojo, A.; Fischer, S.E.; Adeyi, O.; Zita, D.; Deneke, M.G.; Selzner, N.; Chen, L.; Malespin, M.; Cotler, S.J.; McGilvray, I.D.; Feld, J.J. 2016: Protease inhibitors partially overcome the interferon nonresponse phenotype in patients with chronic hepatitis C. Journal of Viral Hepatitis 23(5): 340-347
Zhou, Y.; Vedantham, P.; Lu, K.; Agudelo, J.; Carrion, R.; Nunneley, J.W.; Barnard, D.; Pöhlmann, S.; McKerrow, J.H.; Renslo, A.R.; Simmons, G. 2015: Protease inhibitors targeting coronavirus and filovirus entry. Antiviral Research 116: 76-84
Schaerer, V.; Haubitz, S.; Kovari, H.; Ledergerber, B.; Ambrosioni, J.; Cavassini, M.; Stoeckle, M.; Schmid, P.; Decosterd, L.; Aouri, M.; Böni, J.; Günthard, H.F.; Furrer, H.; Metzner, K.J.; Fehr, J.; Rauch, A.; Aubert, V.; Barth, J.; Battegay, M.; Bernasconi, E.; Böni, J.; Bucher, H.C.; Burton-Jeangros, C.; Calmy, A.; Cavassini, M.; Egger, M.; Elzi, L.; Fehr, J.; Fellay, J.; Furrer, H.; Fux, C.A.; Gorgievski, M.; Günthard, H.; Haerry, D.; Hasse, B.; Hirsch, H.H.; Hösli, I.; Kahlert, C.; Kaiser, L.; Keiser, O.; Klimkait, T.; Kouyos, R.; Kovari, H.; Ledergerber, B.; Martinetti, G.; de Tejada, B.M.; Metzner, K.; Müller, N.; Nadal, D.; Pantaleo, G.; Rauch, A.; Regenass, S.; Rickenbach, M.; Rudin, C.; Schöni-Affolter, F.; Schmid, P.; Sc 2015: Protease inhibitors to treat hepatitis C in the Swiss HIV Cohort Study: high efficacy but low treatment uptake. HIV Medicine 16(10): 599-607
Lupo, F.; Russo, R.; Iolascon, A.; Ieluzzi, D.; Siciliano, A.; Toniutto, P.; Matté, A.; Piovesan, S.; Raffetti, E.; Turrini, F.; Dissegna, D.; Donato, F.; Alberti, A.; Zuliani, V.; Fattovich, G.; De Franceschi, L. 2016: Protease inhibitors-based therapy induces acquired spherocytic-like anaemia and ineffective erythropoiesis in chronic hepatitis C virus patients. Liver International: Official Journal of the International Association for the Study of the Liver 36(1): 49-58
McKee, C.M.; Ding, Y.; Zhou, J.; Li, C.; Huang, L.; Xin, X.; He, J.; Allen, J.E.; El-Deiry, W.S.; Cao, Y.; Muschel, R.J.; Xu, D. 2015: Protease nexin 1 induces apoptosis of prostate tumor cells through inhibition of X-chromosome-linked inhibitor of apoptosis protein. Oncotarget 6(6): 3784-3796
Selbonne, S.; Francois, D.; Raoul, W.; Boulaftali, Y.; Sennlaub, F.; Jandrot-Perrus, M.; Bouton, M.-C.; Arocas, V.ér. 2015: Protease nexin-1 regulates retinal vascular development. Cellular and Molecular Life Sciences: Cmls 72(20): 3999-4011
Holinstat, M.; Bray, P.F. 2016: Protease receptor antagonism to target blood platelet therapies. Clinical Pharmacology and Therapeutics 99(1): 72-81
Vass, R.H.; Zeinert, R.D.; Chien, P. 2016: Protease regulation and capacity during Caulobacter growth. Current Opinion in Microbiology 34: 75-81
Salvesen, G.S.; Hempel, A.; Coll, N.S. 2016: Protease signaling in animal and plant-regulated cell death. Febs Journal 283(14): 2577-2598
Sandersjöö, L.; Jonsson, A.; Löfblom, J. 2017: Protease substrate profiling using bacterial display of self-blocking affinity proteins and flow-cytometric sorting. Biotechnology Journal 12(1)
Lima, L.A.; Cruz Filho, R.F.; dos Santos, Jário.G.; Silva, W.C. 2015: Protease with collagenolytic activity produced by Bacillus sp. DPUA 1728 from Amazonian soil. Brazilian journal of microbiology: 46(4): 1217-1223
Li, S.-Y.; Cheng, H.; Qiu, W.-X.; Liu, L.-H.; Chen, S.; Hu, Y.; Xie, B.-R.; Li, B.; Zhang, X.-Z. 2015: Protease-Activable Cell-Penetrating Peptide-Protoporphyrin Conjugate for Targeted Photodynamic Therapy in Vivo. Acs Applied Materials and Interfaces 7(51): 28319-28329
Jacob, J.A. 2016: Protease-Activated Fluorescent Probe Shows Promise as a Cancer Imaging Device. JAMA 315(12): 1217-1218
Abdel-Magid, A.F. 2016: Protease-Activated Receptor 1 (PAR-1) Antagonists as Potential Treatment for Acute Coronary Syndrome. Acs Medicinal Chemistry Letters 7(10): 881-883
Antoniak, S.; Cardenas, J.C.; Buczek, L.J.; Church, F.C.; Mackman, N.; Pawlinski, R. 2017: Protease-Activated Receptor 1 Contributes to Angiotensin II-Induced Cardiovascular Remodeling and Inflammation. Cardiology 136(4): 258-268
Antoniak, S.; Tatsumi, K.; Bode, M.; Vanja, S.; Williams, J.C.; Mackman, N. 2017: Protease-Activated Receptor 1 Enhances Poly I:C Induction of the Antiviral Response in Macrophages and Mice. Journal of Innate Immunity 9(2): 181-192
Al-Khafaji, K.; Mutyala, M.; Al-Khafaji, N.; Harper, Y.; Ismail, I.; Hakim, H.; Arora, R.R. 2017: Protease-Activated Receptor 1 Inhibitors: Novel Antiplatelet Drugs in Prevention of Atherothrombosis. American Journal of Therapeutics 24(6): E730-E736
Kouzoukas, D.E.; Ma, F.; Meyer-Siegler, K.L.; Westlund, K.N.; Hunt, D.E.; Vera, P.L. 2016: Protease-Activated Receptor 4 Induces Bladder Pain through High Mobility Group Box-1. Plos one 11(3): E0152055
Norman, J.E.; Cunningham, M.R.; Jones, M.L.; Walker, M.E.; Westbury, S.K.; Sessions, R.B.; Mundell, S.J.; Mumford, A.D. 2016: Protease-Activated Receptor 4 Variant p.Tyr157Cys Reduces Platelet Functional Responses and Alters Receptor Trafficking. Arteriosclerosis Thrombosis and Vascular Biology 36(5): 952-960
Tricoci, P. 2017: Protease-Activated Receptor-1 Antagonists Post-Percutaneous Coronary Intervention. Interventional Cardiology Clinics 6(1): 57-66
Shin, Y.-S.; Kim, H.W.; Kim, C.D.; Kim, H.-W.; Park, J.W.; Jung, S.; Lee, J.-H.; Ko, Y.-K.; Lee, Y.H. 2015: Protease-Activated Receptor-2 Is Associated with Terminal Differentiation of Epidermis and Eccrine Sweat Glands. Annals of Dermatology 27(4): 364-370
Suzuki, N.; Mihara, H.; Nishizono, H.; Tominaga, M.; Sugiyama, T. 2015: Protease-Activated Receptor-2 Up-Regulates Transient Receptor Potential Vanilloid 4 Function in Mouse Esophageal Keratinocyte. Digestive Diseases and Sciences 60(12): 3570-3578
Andersen, H.H. 2016: Protease-Activated Receptor-2: a Multifaceted Molecular Transducer in the Human Skin. Annals of Dermatology 28(6): 771-772
Rosero, R.A.; Villares, G.J.; Bar-Eli, M. 2016: Protease-Activated Receptors and other G-Protein-Coupled Receptors: the Melanoma Connection. Frontiers in Genetics 7: 112
Cromm, P.M.; Spiegel, J.; Küchler, P.; Dietrich, L.; Kriegesmann, J.; Wendt, M.; Goody, R.S.; Waldmann, H.; Grossmann, T.N. 2016: Protease-Resistant and Cell-Permeable Double-Stapled Peptides Targeting the Rab8a GTPase. Acs Chemical Biology 11(8): 2375-2382
Cheng, Y.; Huang, F.; Min, X.; Gao, P.; Zhang, T.; Li, X.; Liu, B.; Hong, Y.; Lou, X.; Xia, F. 2016: Protease-Responsive Prodrug with Aggregation-Induced Emission Probe for Controlled Drug Delivery and Drug Release Tracking in Living Cells. Analytical Chemistry 88(17): 8913-8919
Kaur, S.; Sharma, P. 2015: Protease-Sensitive Inhibitory Activity of Cell-free Supernatant of Lactobacillus crispatus 156 Synergizes with Ciprofloxacin, Moxifloxacin and Streptomycin Against Pseudomonas aeruginosa: An in Vitro Study. Probiotics and Antimicrobial Proteins 7(2): 172-180
Gao, C.; Vargo, K.B.; Hammer, D.A. 2016: Protease-Triggered, Integrin-Targeted Cellular Uptake of Recombinant Protein Micelles. Macromolecular Bioscience 16(9): 1398-1406
Johnson, J.J.; Miller, D.L.; Jiang, R.; Liu, Y.; Shi, Z.; Tarwater, L.; Williams, R.; Balsara, R.; Sauter, E.R.; Stack, M.S. 2016: Protease-activated Receptor-2 (PAR-2)-mediated Nf-κB Activation Suppresses Inflammation-associated Tumor Suppressor MicroRNAs in Oral Squamous Cell Carcinoma. Journal of Biological Chemistry 291(13): 6936-6945
Smith, T.H.; Coronel, L.J.; Li, J.G.; Dores, M.R.; Nieman, M.T.; Trejo, J. 2016: Protease-activated Receptor-4 Signaling and Trafficking Is Regulated by the Clathrin Adaptor Protein Complex-2 Independent of β-Arrestins. Journal of Biological Chemistry 291(35): 18453-18464
LeBeau, A.M.; Denmeade, S.R. 2015: Protease-activated pore-forming peptides for the treatment and imaging of prostate cancer. Molecular Cancer Therapeutics 14(3): 659-668
Hou, Y.; Zhou, J.; Gao, Z.; Sun, X.; Liu, C.; Shangguan, D.; Yang, W.; Gao, M. 2015: Protease-activated ratiometric fluorescent probe for pH mapping of malignant tumors. Acs Nano 9(3): 3199-3205
Lin, C.; von der Thüsen, J.; Daalhuisen, J.; ten Brink, M.; Crestani, B.; van der Poll, T.; Borensztajn, K.; Spek, C.A. 2015: Protease-activated receptor (PAR)-2 is required for PAR-1 signalling in pulmonary fibrosis. Journal of Cellular and Molecular Medicine 19(6): 1346-1356
He, R-Qing.; Tang, X-Feng.; Zhang, B-Li.; Li, X-Dong.; Hong, M-Na.; Chen, Q-Zhi.; Han, W-Qing.; Gao, P-Jin. 2016: Protease-activated receptor 1 and 2 contribute to angiotensin II-induced activation of adventitial fibroblasts from rat aorta. Biochemical and Biophysical Research Communications 473(2): 517-523
Lekic, T.; Klebe, D.; McBride, D.W.; Manaenko, A.; Rolland, W.B.; Flores, J.J.; Altay, O.; Tang, J.; Zhang, J.H. 2015: Protease-activated receptor 1 and 4 signal inhibition reduces preterm neonatal hemorrhagic brain injury. Stroke 46(6): 1710-1713
Tillu, D.V.; Hassler, S.N.; Burgos-Vega, C.C.; Quinn, T.L.; Sorge, R.E.; Dussor, G.; Boitano, S.; Vagner, J.; Price, T.J. 2015: Protease-activated receptor 2 activation is sufficient to induce the transition to a chronic pain state. Pain 156(5): 859-867
Xie, L.; Duan, Z.; Liu, C.; Zheng, Y.; Zhou, J. 2015: Protease-activated receptor 2 agonist increases cell proliferation and invasion of human pancreatic cancer cells. Experimental and Therapeutic Medicine 9(1): 239-244
Bao, Y.; Hou, W.; Yang, L.; Kong, X.; Du, M.; Zheng, H.; Gao, Y.; Hua, B. 2015: Protease-activated receptor 2 antagonist potentiates analgesic effects of systemic morphine in a rat model of bone cancer pain. Regional Anesthesia and Pain Medicine 40(2): 158-165
Sun, Z.; Cao, B.; Wu, J. 2015: Protease-activated receptor 2 enhances renal cell carcinoma cell invasion and migration via PI3K/AKT signaling pathway. Experimental and Molecular Pathology 98(3): 382-389
Al-Eryani, K.; Cheng, J.; Abé, T.; Maruyama, S.; Yamazaki, M.; Babkair, H.; Essa, A.; Saku, T. 2015: Protease-activated receptor 2 modulates proliferation and invasion of oral squamous cell carcinoma cells. Human Pathology 46(7): 991-999
Kolpakov, M.A.; Rafiq, K.; Guo, X.; Hooshdaran, B.; Wang, T.; Vlasenko, L.; Bashkirova, Y.V.; Zhang, X.; Chen, X.; Iftikhar, S.; Libonati, J.R.; Kunapuli, S.P.; Sabri, A. 2016: Protease-activated receptor 4 deficiency offers cardioprotection after acute ischemia reperfusion injury. Journal of Molecular and Cellular Cardiology 90: 21-29
Lindahl, T.L.; Macwan, A.S.; Ramström, S. 2016: Protease-activated receptor 4 is more important than protease-activated receptor 1 for the thrombin-induced procoagulant effect on platelets. Journal of Thrombosis and Haemostasis: Jth 14(8): 1639-1641
French, S.L.; Hamilton, J.R. 2016: Protease-activated receptor 4: from structure to function and back again. British Journal of Pharmacology 173(20): 2952-2965
Moschonas, I.C.; Goudevenos, J.A.; Tselepis, A.D. 2015: Protease-activated receptor-1 antagonists in long-term antiplatelet therapy. Current state of evidence and future perspectives. International Journal of Cardiology 185: 9-18
Tanaka, M.; Yoneyama, M.; Shiba, T.; Yamaguchi, T.; Ogita, K. 2016: Protease-activated receptor-1 negatively regulates proliferation of neural stem/progenitor cells derived from the hippocampal dentate gyrus of the adult mouse. Journal of Pharmacological Sciences 131(3): 162-171
Moss, C.R.; Gilbert, C.A.; Gabriel, S.A.; Gu, Q. 2015: Protease-activated receptor-2 inhibits BK channel activity in bronchopulmonary sensory neurons. Neuroscience Letters 589: 13-18
Bar-Shavit, R.; Maoz, M.; Kancharla, A.; Jaber, M.; Agranovich, D.; Grisaru-Granovsky, S.; Uziely, B. 2016: Protease-activated receptors (PARs) in cancer: Novel biased signaling and targets for therapy. Methods in Cell Biology 132: 341-358
Wojtukiewicz, M.Z.; Hempel, D.; Sierko, E.; Tucker, S.C.; Honn, K.V. 2015: Protease-activated receptors (PARs)--biology and role in cancer invasion and metastasis. Cancer Metastasis Reviews 34(4): 775-796
Hempel, D.; Sierko, E.; Wojtukiewicz, M.Z. 2016: Protease-activated receptors - biology and role in cancer. Postepy Higieny i Medycyny Doswiadczalnej 70: 775-786
Akiyama, T.; Lerner, E.A.; Carstens, E. 2015: Protease-activated receptors and itch. Handbook of Experimental Pharmacology 226: 219-235
Guenther, F.; Melzig, M.F. 2015: Protease-activated receptors and their biological role - focused on skin inflammation. Journal of Pharmacy and Pharmacology 67(12): 1623-1633
Nieman, M.T. 2016: Protease-activated receptors in hemostasis. Blood 128(2): 169-177
Palygin, O.; Ilatovskaya, D.V.; Staruschenko, A. 2016: Protease-activated receptors in kidney disease progression. American Journal of Physiology. Renal Physiology 311(6): F1140-F1144
Christensen, J.; Alfredson, H.åk.; Andersson, G. 2015: Protease-activated receptors in the Achilles tendon-a potential explanation for the excessive pain signalling in tendinopathy. Molecular Pain 11: 13
Sung, T.S.; Kim, H.U.; Kim, J.H.; Lu, H.; Sanders, K.M.; Koh, S.D. 2015: Protease-activated receptors modulate excitability of murine colonic smooth muscles by differential effects on interstitial cells. Journal of Physiology 593(5): 1169-1181
Grisaru-Granovsky, S.; Salah, Z.; Maoz, M.; Tevet, A.; Margalioth, E.; Samueloff, A.; Altarescu, G.; Bar-Shavit, R. 2015: Protease-activated-receptor 1 polymorphisms correlate with risk for unexplained recurrent pregnancy loss: a pilot study querying an association beyond coagulation. European Journal of Obstetrics Gynecology and Reproductive Biology 185: 13-18
Gutowski, S.M.; Shoemaker, J.T.; Templeman, K.L.; Wei, Y.; Latour, R.A.; Bellamkonda, R.V.; LaPlaca, M.C.; García, A.és.J. 2015: Protease-degradable PEG-maleimide coating with on-demand release of IL-1Ra to improve tissue response to neural electrodes. Biomaterials 44: 55-70
Foster, G.A.; Headen, D.M.; González-García, C.; Salmerón-Sánchez, M.; Shirwan, H.; García, A.és.J. 2017: Protease-degradable microgels for protein delivery for vascularization. Biomaterials 113: 170-175
Malolo, F.-A.ée.E.; Bissoue Nouga, A.; Kakam, A.; Franke, K.; Ngah, L.; Flausino, O.; Mpondo Mpondo, E.; Ntie-Kang, F.; Ndom, J.C.; Bolzani, V.d.S.; Wessjohann, L. 2015: Protease-inhibiting, molecular modeling and antimicrobial activities of extracts and constituents from Helichrysum foetidum and Helichrysum mechowianum (compositae). Chemistry Central Journal 9: 32
van Rijt, S.H.; Bölükbas, D.A.; Argyo, C.; Datz, S.; Lindner, M.; Eickelberg, O.; Königshoff, M.; Bein, T.; Meiners, S. 2015: Protease-mediated release of chemotherapeutics from mesoporous silica nanoparticles to ex vivo human and mouse lung tumors. Acs Nano 9(3): 2377-2389
Kitakaze, K.; Mizutani, Y.; Sugiyama, E.; Tasaki, C.; Tsuji, D.; Maita, N.; Hirokawa, T.; Asanuma, D.; Kamiya, M.; Sato, K.; Setou, M.; Urano, Y.; Togawa, T.; Otaka, A.; Sakuraba, H.; Itoh, K. 2016: Protease-resistant modified human β-hexosaminidase B ameliorates symptoms in GM2 gangliosidosis model. Journal of Clinical Investigation 126(5): 1691-1703
Rozema, D.B.; Blokhin, A.V.; Wakefield, D.H.; Benson, J.D.; Carlson, J.C.; Klein, J.J.; Almeida, L.J.; Nicholas, A.L.; Hamilton, H.L.; Chu, Q.; Hegge, J.O.; Wong, S.C.; Trubetskoy, V.S.; Hagen, C.M.; Kitas, E.; Wolff, J.A.; Lewis, D.L. 2015: Protease-triggered siRNA delivery vehicles. Journal of Controlled Release: Official Journal of the Controlled Release Society 209: 57-66
Natarajan, K.; Gottipati, K.R.; Berhane, K.; Samten, B.; Pendurthi, U.; Boggaram, V. 2016: Proteases and oxidant stress control organic dust induction of inflammatory gene expression in lung epithelial cells. Respiratory Research 17(1): 137
Musante, L.; Tataruch, D.; Gu, D.; Liu, X.; Forsblom, C.; Groop, P.-H.; Holthofer, H. 2015: Proteases and protease inhibitors of urinary extracellular vesicles in diabetic nephropathy. Journal of Diabetes Research 2015: 289734
Casas-Godoy, L.; Sandoval, G. 2016: Proteases and their Inhibitors: from Basic to High Throughput Screening. Combinatorial Chemistry and High Throughput Screening 19(8): 636-643
Pulz, L.H.; Strefezzi, R.F. 2017: Proteases as prognostic markers in human and canine cancers. Veterinary and Comparative Oncology 15(3): 669-683
Saftig, P.; Bovolenta, P. 2015: Proteases at work: cues for understanding neural development and degeneration. Frontiers in Molecular Neuroscience 8: 13
Ricard-Blum, S.; Vallet, S.D. 2016: Proteases decode the extracellular matrix cryptome. Biochimie 122: 300-313
Gonçalves, R.N.; Gozzini Barbosa, S.D.; da Silva-López, R.E. 2016: Proteases from Canavalia ensiformis: Active and Thermostable Enzymes with Potential of Application in Biotechnology. Biotechnology Research International 2016: 3427098
Romberger, D.J.; Heires, A.J.; Nordgren, T.M.; Souder, C.P.; West, W.; Liu, X.-d.; Poole, J.A.; Toews, M.L.; Wyatt, T.A. 2015: Proteases in agricultural dust induce lung inflammation through PAR-1 and PAR-2 activation. American Journal of Physiology. Lung Cellular and Molecular Physiology 309(4): L388-L399
Vandooren, J.; Opdenakker, G.; Loadman, P.M.; Edwards, D.R. 2016: Proteases in cancer drug delivery. Advanced Drug Delivery Reviews 97: 144-155
Lalmanach, G. 2016: Proteases in the limelight: Both ordinary digestive enzymes and smart signaling pathway regulators. Biochimie 122: 1-4
Inácio, F.ío.D.; Ferreira, R.O.; de Araujo, C.A.V.; Brugnari, T.; Castoldi, R.; Peralta, R.M.; de Souza, C.G.M. 2015: Proteases of Wood Rot Fungi with Emphasis on the Genus Pleurotus. Biomed Research International 2015: 290161
Kleyman, T.R.; Myerburg, M.M. 2014: Proteases, ENaCs and cystic fibrosis. Journal of Physiology 592(23): 5145
Hoelen, H.; Zaldumbide, A.; van Leeuwen, W.F.; Torfs, E.C.W.; Engelse, M.A.; Hassan, C.; Lebbink, R.J.; de Koning, E.J.; Resssing, M.E.; de Ru, A.H.; van Veelen, P.A.; Hoeben, R.C.; Roep, B.O.; Wiertz, E.J.H.J. 2015: Proteasomal Degradation of Proinsulin Requires Derlin-2, HRD1 and p97. Plos one 10(6): E0128206
Amanullah, A.; Upadhyay, A.; Chhangani, D.; Joshi, V.; Mishra, R.; Yamanaka, K.; Mishra, A. 2017: Proteasomal Dysfunction Induced by Diclofenac Engenders Apoptosis Through Mitochondrial Pathway. Journal of Cellular Biochemistry 118(5): 1014-1027
Ravi, D.; Beheshti, A.; Abermil, Néra.; Passero, F.; Sharma, J.; Coyle, M.; Kritharis, A.; Kandela, I.; Hlatky, L.; Sitkovsky, M.V.; Mazar, A.; Gartenhaus, R.B.; Evens, A.M. 2016: Proteasomal Inhibition by Ixazomib Induces CHK1 and MYC-Dependent Cell Death in T-cell and Hodgkin Lymphoma. Cancer Research 76(11): 3319-3331
Savchuk, O.I.; Orlovsky, M.O.; Iarmoliuk, I.S.; Goncharov, S.V.; Dosenko, V.E.; Skibo, G.G. 2015: Proteasomal activity in brain tissue following ischemic stroke in Wistar rats. Fiziolohichnyi Zhurnal 61(5): 11-20
Samanovic, M.I.; Tu, S.; Novák, O.ře.; Iyer, L.M.; McAllister, F.E.; Aravind, L.; Gygi, S.P.; Hubbard, S.R.; Strnad, M.; Darwin, K.H. 2015: Proteasomal control of cytokinin synthesis protects Mycobacterium tuberculosis against nitric oxide. Molecular Cell 57(6): 984-994
Inobe, T.; Nozaki, M. 2016: Proteasomal degradation of damaged polyubiquitin. Biochemical and Biophysical Research Communications 471(1): 34-40
Braunstein, I.; Zach, L.; Allan, S.; Kalies, K.-U.; Stanhill, A. 2015: Proteasomal degradation of preemptive quality control (pQC) substrates is mediated by an AIRAPL-p97 complex. Molecular Biology of the Cell 26(21): 3719-3727
McNaughton, M.; Pitman, M.; Pitson, S.M.; Pyne, N.J.; Pyne, S. 2016: Proteasomal degradation of sphingosine kinase 1 and inhibition of dihydroceramide desaturase by the sphingosine kinase inhibitors, SKi or ABC294640, induces growth arrest in androgen-independent LNCaP-Ai prostate cancer cells. Oncotarget 7(13): 16663-16675
Gierisch, M.E.; Pfistner, F.; Lopez-Garcia, L.A.; Harder, L.; Schäfer, B.W.; Niggli, F.K. 2016: Proteasomal Degradation of the EWS-FLI1 Fusion Protein Is Regulated by a Single Lysine Residue. Journal of Biological Chemistry 291(52): 26922-26933
Lee, K.C.; Bramley, R.L.; Cowell, I.G.; Jackson, G.H.; Austin, C.A. 2016: Proteasomal inhibition potentiates drugs targeting DNA topoisomerase Ii. Biochemical Pharmacology 103: 29-39
Nardi, F.; Hoffmann, T.M.; Stretton, C.; Cwiklinski, E.; Taylor, P.M.; Hundal, H.S. 2015: Proteasomal modulation of cellular SNAT2 (SLC38A2) abundance and function by unsaturated fatty acid availability. Journal of Biological Chemistry 290(13): 8173-8184
Kaiser, M.-L.; Römisch, K. 2015: Proteasome 19S RP binding to the Sec61 channel plays a key role in ERAD. Plos one 10(2): E0117260
Yadranji Aghdam, S.; Mahmoudpour, A. 2016: Proteasome Activators, PA28α and PA28β, Govern Development of Microvascular Injury in Diabetic Nephropathy and Retinopathy. International Journal of Nephrology 2016: 3846573
Sbardella, D.; Tundo, G.Raffaella.; Sciandra, F.; Bozzi, M.; Gioia, M.; Ciaccio, C.; Tarantino, U.; Brancaccio, A.; Coletta, M.; Marini, S. 2015: Proteasome Activity Is Affected by Fluctuations in Insulin-Degrading Enzyme Distribution. Plos one 10(7): E0132455
Shukla, N.; Somwar, R.; Smith, R.S.; Ambati, S.; Munoz, S.; Merchant, M.; D'Arcy, P.; Wang, X.; Kobos, R.; Antczak, C.; Bhinder, B.; Shum, D.; Radu, C.; Yang, G.; Taylor, B.S.; Ng, C.K.Y.; Weigelt, B.; Khodos, I.; de Stanchina, E.; Reis-Filho, J.S.; Ouerfelli, O.; Linder, S.; Djaballah, H.; Ladanyi, M. 2016: Proteasome Addiction Defined in Ewing Sarcoma Is Effectively Targeted by a Novel Class of 19S Proteasome Inhibitors. Cancer Research 76(15): 4525-4534
Maher, P. 2014: Proteasome Assay in Cell Lysates. Bio-Protocol 4(2)
Díaz-Ruiz, A.; Guzmán-Ruiz, R.ío.; Moreno, N.R.; García-Rios, A.; Delgado-Casado, N.; Membrives, A.; Túnez, I.; El Bekay, R.; Fernández-Real, J.é M.; Tovar, S.; Diéguez, C.; Tinahones, F.J.; Vázquez-Martínez, R.; López-Miranda, J.é; Malagón, M.ía.M. 2015: Proteasome Dysfunction Associated to Oxidative Stress and Proteotoxicity in Adipocytes Compromises Insulin Sensitivity in Human Obesity. Antioxidants and Redox Signaling 23(7): 597-612
Shirozu, R.; Yashiroda, H.; Murata, S. 2016: Proteasome Impairment Induces Recovery of Mitochondrial Membrane Potential and an Alternative Pathway of Mitochondrial Fusion. Molecular and Cellular Biology 36(2): 347-362
Vana, P.G.; LaPorte, H.M.; Wong, Y.M.; Kennedy, R.H.; Gamelli, R.L.; Majetschak, M. 2016: Proteasome Inhibition After Burn Injury. Journal of Burn Care and Research: Official Publication of the American Burn Association 37(4): 207-215
Yue, Q.; Zhen, H.; Huang, M.; Zheng, X.; Feng, L.; Jiang, B.; Yang, M.; Wu, W.; Liu, X.; Guo, D. 2016: Proteasome Inhibition Contributed to the Cytotoxicity of Arenobufagin after Its Binding with Na, K-ATPase in Human Cervical Carcinoma HeLa Cells. Plos one 11(7): E0159034
Pashevin, D.O.; Nagibin, V.S.; Tumanovska, L.V.; Moibenko, A.A.; Dosenko, V.E. 2015: Proteasome Inhibition Diminishes the Formation of Neutrophil Extracellular Traps and Prevents the Death of Cardiomyocytes in Coculture with Activated Neutrophils during Anoxia-Reoxygenation. Pathobiology: Journal of Immunopathology Molecular and Cellular Biology 82(6): 290-298
Choy, M.M.; Zhang, S.L.; Costa, V.V.; Tan, H.C.; Horrevorts, S.; Ooi, E.E. 2015: Proteasome Inhibition Suppresses Dengue Virus Egress in Antibody Dependent Infection. Plos Neglected Tropical Diseases 9(11): E0004058
Guo, N.; Peng, Z.; Zhang, J. 2016: Proteasome Inhibitor MG132 Enhances Sensitivity to Cisplatin on Ovarian Carcinoma Cells in Vitro and in Vivo. International Journal of Gynecological Cancer: Official Journal of the International Gynecological Cancer Society 26(5): 839-844
Huang, W.; Zhou, Q.; Yuan, X.; Ge, Z.-M.; Ran, F.-X.; Yang, H.-Y.; Qiang, G.-L.; Li, R.-T.; Cui, J.-R. 2016: Proteasome Inhibitor YSY01A Enhances Cisplatin Cytotoxicity in Cisplatin-Resistant Human Ovarian Cancer Cells. Journal of Cancer 7(9): 1133-1141
Kaplan, G.S.; Torcun, C.C.; Grune, T.; Ozer, N.K.; Karademir, B. 2017: Proteasome inhibitors in cancer therapy: Treatment regimen and peripheral neuropathy as a side effect. Free Radical Biology and Medicine 103: 1-13
de Bruin, G.; Xin, B-Tao.; Florea, B.I.; Overkleeft, H.S. 2016: Proteasome Subunit Selective Activity-Based Probes Report on Proteasome Core Particle Composition in a Native Polyacrylamide Gel Electrophoresis Fluorescence-Resonance Energy Transfer Assay. Journal of the American Chemical Society 138(31): 9874-9880
Gonos, E. 2014: Proteasome activation as a novel anti-aging strategy. Free Radical Biology and Medicine 75(Suppl 1): S7
Chondrogianni, N.; Voutetakis, K.; Kapetanou, M.; Delitsikou, V.; Papaevgeniou, N.; Sakellari, M.; Lefaki, M.; Filippopoulou, K.; Gonos, E.S. 2015: Proteasome activation: An innovative promising approach for delaying aging and retarding age-related diseases. Ageing Research Reviews 23(Part A): 37-55
Guo, J.; Hao, J.; Jiang, H.; Jin, J.; Wu, H.; Jin, Z.; Li, Z. 2017: Proteasome activator subunit 3 promotes pancreatic cancer growth via c-Myc-glycolysis signaling axis. Cancer Letters 386: 161-167
Ortega-Atienza, S.; Green, S.E.; Zhitkovich, A. 2015: Proteasome activity is important for replication recovery, CHK1 phosphorylation and prevention of G2 arrest after low-dose formaldehyde. Toxicology and Applied Pharmacology 286(2): 135-141
Zhu, Z.; Zhang, L.; Shi, G. 2015: Proteasome as a Molecular Target of Microcystin-LR. Toxins 7(6): 2221-2231
Yedidi, R.S.; Fatehi, A.K.; Enenkel, C. 2016: Proteasome dynamics between proliferation and quiescence stages of Saccharomyces cerevisiae. Critical Reviews in Biochemistry and Molecular Biology 51(6): 497-512
Lehrbach, N.J.; Ruvkun, G. 2016: Proteasome dysfunction triggers activation of SKN-1A/Nrf1 by the aspartic protease DDI-1. Elife 5
Caniard, A.; Ballweg, K.; Lukas, C.; Yildirim, A.Ö; Eickelberg, O.; Meiners, S. 2015: Proteasome function is not impaired in healthy aging of the lung. Aging 7(10): 776-792
Kammerl, I.E.; Meiners, S. 2016: Proteasome function shapes innate and adaptive immune responses. American Journal of Physiology. Lung Cellular and Molecular Physiology 311(2): L328-L336
Haynes, K.A.; Smith, T.K.; Preston, C.J.; Hegde, A.N. 2015: Proteasome inhibition augments new protein accumulation early in long-term synaptic plasticity and rescues adverse Aβ effects on protein synthesis. Acs Chemical Neuroscience 6(5): 695-700
Roelofs, J. 2015: Proteasome inhibition by bortezomib: a left hook and a right punch. Ebiomedicine 2(7): 619-620
Brouwer, A.J.; Herrero Álvarez, N.; Ciaffoni, A.; van de Langemheen, H.; Liskamp, R.M.J. 2016: Proteasome inhibition by new dual warhead containing peptido vinyl sulfonyl fluorides. Bioorganic and Medicinal Chemistry 24(16): 3429-3435
Dettmer, S.; Theile, D.; Schäfer, J.; Seckinger, A.; Burhenne, Jürgen.; Weiss, J. 2016: Proteasome inhibition correlates with intracellular bortezomib concentrations but not with antiproliferative effects after bolus treatment in myeloma cell lines. Naunyn-Schmiedeberg's Archives of Pharmacology 389(10): 1091-1101
Sun, Y.; Ponz-Sarvise, M.; Chang, S.-S.; Chang, W.-C.; Chen, C.-H.; Hsu, J.L.; Hung, M.-C. 2015: Proteasome inhibition enhances the killing effect of BikDD gene therapy. American Journal of Translational Research 7(2): 319-327
Rastogi, N.; Duggal, S.; Singh, S.K.; Porwal, K.; Srivastava, V.K.; Maurya, R.; Bhatt, M.L.B.; Mishra, D.P. 2015: Proteasome inhibition mediates p53 reactivation and anti-cancer activity of 6-gingerol in cervical cancer cells. Oncotarget 6(41): 43310-43325
Schlossarek, S.; Singh, S.R.; Geertz, B.; Schulz, H.; Reischmann, S.; Hübner, N.; Carrier, L. 2014: Proteasome inhibition slightly improves cardiac function in mice with hypertrophic cardiomyopathy. Frontiers in Physiology 5: 484
Zhou, W.; Zhu, W.; Ma, L.; Xiao, F.; Qian, W. 2015: Proteasome inhibitor MG-132 enhances histone deacetylase inhibitor SAHA-induced cell death of chronic myeloid leukemia cells by an ROS-mediated mechanism and downregulation of the Bcr-Abl fusion protein. Oncology letters 10(5): 2899-2904
Ji, M.-M.; Lee, J.M.; Mon, H.; Xu, J.; Tatsuke, T.; Kusakabe, T. 2016: Proteasome inhibitor MG132 impairs autophagic flux through compromising formation of autophagosomes in Bombyx cells. Biochemical and Biophysical Research Communications 479(4): 690-696
Zhu, W.; Zhan, D.; Wang, L.; Ma, D.; Cheng, M.; Wang, H.; Zhao, J.; Cai, Y.; Cheng, Z. 2016: Proteasome inhibitor MG132 potentiates TRAIL-induced apoptosis in gallbladder carcinoma GBC-SD cells via DR5-dependent pathway. Oncology Reports 36(2): 845-852
Zhang, Y.; Cheng, J.; Zhang, J.; Wu, X.; Chen, F.; Ren, X.; Wang, Y.; Li, Q.; Li, Y. 2016: Proteasome inhibitor PS-341 limits macrophage necroptosis by promoting cIAPs-mediated inhibition of RIP1 and RIP3 activation. Biochemical and Biophysical Research Communications 477(4): 761-767
Yui, J.C.; Van Keer, J.; Weiss, B.M.; Waxman, A.J.; Palmer, M.B.; D'Agati, V.D.; Kastritis, E.; Dimopoulos, M.A.; Vij, R.; Bansal, D.; Dingli, D.; Nasr, S.H.; Leung, N. 2016: Proteasome inhibitor associated thrombotic microangiopathy. American Journal of Hematology 91(9): E348-E352
Conley, B.A.; Donovan, E.; Muir, C.; Morris, J.; Colevas, A.D.; Gius, D.; Trehu, E.; Sausville, E.; Wright, J.; Vanwaes, C. 2016: Proteasome inhibitor bortezomib & re-irradiation (rRT) with scheduled treatment break in patients (pts) with head/neck squamous carcinoma (HNSCC). Journal of Clinical Oncology 23(16_Suppl): 5592-5592
Hsu, S.-M.; Yang, C.-H.; Shen, F.-H.; Chen, S.-H.; Lin, C.-J.; Shieh, C.-C. 2015: Proteasome inhibitor bortezomib suppresses nuclear factor-kappa B activation and ameliorates eye inflammation in experimental autoimmune uveitis. Mediators of Inflammation 2015: 847373
Lamothe, B.; Cervantes-Gomez, F.; Sivina, M.; Wierda, W.G.; Keating, M.J.; Gandhi, V. 2015: Proteasome inhibitor carfilzomib complements ibrutinib's action in chronic lymphocytic leukemia. Blood 125(2): 407-410
Lan, D.; Wang, W.; Zhuang, J.; Zhao, Z. 2015: Proteasome inhibitor-induced autophagy in PC12 cells overexpressing A53T mutant α-synuclein. Molecular Medicine Reports 11(3): 1655-1660
Asakura, T.; Yamaguchi, N.; Ohkawa, K.; Yoshida, K. 2015: Proteasome inhibitor-resistant cells cause EMT-induction via suppression of E-cadherin by miR-200 and ZEB1. International Journal of Oncology 46(5): 2251-2260
Nahi, H.; Våtsveen, T.K.; Lund, J.; Heeg, B.M.S.; Preiss, B.; Alici, E.; Møller, M.B.; Wader, K.F.; Møller, H.E.H.; Grøseth, L.A.; Østergaard, B.; Dai, H.Y.; Holmberg, E.; Gahrton, G.ös.; Waage, A.; Abildgaard, N. 2016: Proteasome inhibitors and IMiDs can overcome some high-risk cytogenetics in multiple myeloma but not gain 1q21. European Journal of Haematology 96(1): 46-54